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ABSTRACT 
The detection of gastrointestinal (GI) dysplasia is essential to improve the patient’s 
survival rate. The diagnosis of this condition can be performed using spectroscopy techniques, 
such as fluorescence and diffuse-reflectance, which have the potential to provide 
morphological and biochemical information regarding normal and dysplastic tissue. 
Research prototypes currently used for those clinical spectroscopy techniques have 
associated a few drawbacks: they are costly, bulky, too sophisticated and they use optical 
fibers, which are usually related with low-collection efficiency. Moreover, these catheter-
based instruments are invasive and very uncomfortable for the patient.  
In this context, the present work had the purpose to develop a miniaturized 
spectroscopy system, based on those two techniques, that features low-complexity and cost-
effectiveness. Furthermore, the integration of optical components in a single chip allows a 
high level of reliability. Such a system can be integrated in less-invasive devices (e.g., the 
endoscopic capsules), for an effective and comfortable detection of GI dysplastic lesions. 
The developed spectroscopy system core is based on thin-film optical filters and low-
cost silicon photodiodes, used for the selection and detection of a few light wavelengths 
significant for the diagnosis of dysplasia. Thin-film optical filters, centered at specific 
wavelengths, were designed, fabricated and characterized after the successful demonstration 
that the use of only 16 spectral bands (within the 350 to 750 nm spectral range) enabled an 
accurate extraction of tissue information. The feasibility of using the fabricated filters to 
establish a quantitative spectroscopy diagnosis was proved with measurements on tissue 
phantoms. Additionally, an even more compact device is proposed for qualitative diagnosis 
using only two different spectral bands, centered at 420 nm for fluorescence measurements 
and at 540 nm for diffuse-reflectance measurements. This approach enabled the construction 
of a diagnostic algorithm for the identification of dysplastic tissues, with a sensitivity and 
specificity of 77.8% and 97.6%, respectively.  
This thesis work was also directed towards the development of a fluorescence and 
diffuse-reflectance spectroscopy imaging system for excised tissue margins assessment, 
which results from mucosal resections in the GI tract. In the developed system, wide area 
imaging is achieved by mechanically scanning an optical probe along the tissue surface, with 
variable spatial resolution. This medical device can provide real-time feedback regarding the 
resected mucosal margins, which represents a huge impact in intra-operative diagnosis. The 
clinical utility of the spectroscopy imaging prototype was successfully demonstrated using 
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biological samples, i.e., different images containing reliable quantitative tissue information 
were obtained using analytical models. These images can be subsequently used to establish a 
diagnosis. 
This system may enable the reduction of the patient anxiety, avoiding the follow-up 
surgery, once a fast and real-time data analysis can be performed inside the operating room. 
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RESUMO 
A deteção de displasia gastrointestinal (GI) é essencial para melhorar a taxa de 
sobrevivência dos pacientes. O diagnóstico desta condição pode ser efetuado utilizando 
técnicas de espectroscopia, como a fluorescência e a reflectância difusa, que têm a capacidade 
de proporcionar informação morfológica e bioquímica acerca dos tecidos normais e dos 
tecidos com displasia. 
Os protótipos, ainda em investigação, actualmente utilizados em espetroscopia clínica 
e que implementam as técnicas mencionadas, têm associadas várias desvantagens, como por 
exemplo: têm elevado custo; são demasiado sofisticados e volumosos; e utilizam fibras óticas, 
que normalmente estão associadas a uma baixa eficiência na recolha de sinal. Para além disso, 
estes instrumentos baseiam-se em catéteres, o que os torna invasivos e, por isso, 
desconfortáveis para o paciente. 
Neste contexto, o presente trabalho teve como objetivo o desenvolvimento de um 
sistema baseado nas duas técnicas de espectroscopia acima referidas, que seja simples, de 
baixo custo e miniaturizado. A integração de componentes óticos num único chip possibilita a 
obtenção dispositivos óticos mais fiáveis e estáveis. Um sistema com estas características 
pode ser integrado em dispositivos de diagnóstico menos invasivos (por exemplo, nas 
cápsulas endoscópicas) para uma deteção eficaz e confortável das lesões displásticas do trato 
GI. 
O elemento principal deste sistema miniaturizado de espetroscopia consiste em filtros 
óticos baseados em filmes finos e fotodíodos de silício de baixo custo, ambos utilizados para a 
seleção e deteção de alguns comprimentos de onda importantes para o diagnóstico de 
displasia. Estes filtros óticos, centrados em comprimentos de onda específicos, foram 
desenhados, fabricados e caracterizados após ter sido demonstrado que a utilização de apenas 
16 bandas espetrais (na gama espetral compreendida entre os 350 e os 750 nm) permitia uma 
extração correta da informação dos tecidos. A viabilidade de utilizar os filtros fabricados para 
o estabelecimento de um diagnóstico espetroscópico quantitativo foi também demonstrada 
com êxito através de medições realizadas em fantomas. Adicionalmente, e tendo em vista o 
desenvolvimento de um dispositivo ainda mais compacto, foi proposto um diagnóstico 
qualitativo, ou empírico, utilizando apenas duas bandas espetrais, centradas em 420 nm no 
caso das medições de fluorescência e em 540 nm no caso das medições de reflectância difusa. 
Esta abordagem permitiu a construção de um algoritmo de diagnóstico para a identificação de 
displasia com uma sensibilidade e uma especificidade de 77,8% e de 97,6%, respetivamente.  
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Desenvolveu-se, igualmente, um sistema espetroscópico de imagem (envolvendo 
fluorescência e reflectância difusa) para a análise de margens de tecido excisado que resultam 
de ressecções da mucosa do tracto GI. 
Este sistema, através do varrimento mecânico de uma sonda de fibra ótica ao longo da 
superfície do tecido, com uma resolução espacial variável, possibilita a aquisição de imagens 
numa vasta área de tecido. Este dispositivo médico pode fornecer uma resposta em tempo real 
acerca das margens de tecido excisado, o que representa um enorme impacto no diagnóstico 
intra-operatório. A sua utilidade clínica foi demonstrada, com bons resultados, utilizando 
amostras biológicas, isto é, foi possível obter imagens contendo informação quantitativa 
fidedigna acerca dos tecidos, que pode ser subsequentemente utilizada para estabelecer um 
diagnóstico. 
Um sistema como este poderá reduzir a ansiedade dos pacientes e evitar a realização 
de novas cirurgias, uma vez que logo após a cirurgia, e ainda na sala de operações, pode 
efectuar-se uma análise aos tecidos. 
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Chapter 1 
1 Introduction 
 
 
Introduction 
 
In this Chapter it is presented the epidemiology of gastrointestinal cancers. Current 
detection methods and its limitations for the detection of gastrointestinal cancer in vivo and ex 
vivo are described. The impact of optical spectroscopy techniques for the detection of pre-
cancerous lesions, also in vivo and ex vivo, is then discussed. Finally, the motivation and 
specific objectives of this project are detailed. The Chapter is concluded with a description of 
the organization and contents of this thesis. 
1.1 Gastrointestinal cancer 
According to the World Health Organization (WHO) cancer can be defined as a group 
of diseases characterized by uncontrolled growth and spread of abnormal cells. When these 
abnormal cells grow beyond their usual boundaries and spread, cancer can result in death. It is 
estimated that, worldwide, one in eight deaths is due to cancer, but the global cancer burden is 
expected to grow. In 2030, 21.4 million new cancer cases are expected to be diagnosed, and 
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13.2 million cancer related deaths are predicted to occur [1-2].  
Cancer occurs mainly due to the exposure of people to carcinogenic agents (in what 
they eat, drink, inhale, and are exposed at work or in the environment) and biologic factors 
(virus and bacterial infections), and due to personal habits (alcohol consumption, tobacco 
smoking, unbalanced diet, physical inactivity), rather than inherited genetic factors. The 
disease is also associated with social and economic status: risk factors are high in people with 
least education, and cancer survival is poor in low social classes [2].  
Cancers arising in the gastrointestinal (GI) system, including cancers of the oral cavity, 
esophagus, stomach, colon and rectum, pancreas, and liver, occupy a prominent place in 
cancer statistics, accounting for significant morbidity and mortality worldwide. As a group, 
GI malignancies are considered the most common type of human solid cancer worldwide [3]. 
This section will take an overview of GI cancer, focusing on some of the most common GI 
cancers in the world: colorectal, stomach, and esophageal cancer [4].  
1.1.1 Epidemiology of GI cancer  
In 2010, for both sexes and all ages, it was estimated that there were approximately 
2.8 million new diagnosed cases of GI cancers and 1.8 million GI cancer deaths in the world 
(including in the same group colorectal, stomach and esophageal cancers). In Portugal, 
specifically, for the same year, colorectal cancer was expected to have the highest incidence, 
with 7,157 new cases diagnosed and 3,813 deaths. Esophageal and stomach cancers occupy, 
as well, a major place, contributing together for approximately 3 thousand deaths [4]. Figure 
1.1 represents the estimated numbers of cancer cases and deaths from these three types of GI 
cancers in the world, European Union, and Portugal, in 2010.  
 World European Union  Portugal  
Incidence 
(in thousands) 
   
 
Mortality 
(in thousands) 
   
Figure 1.1:  Distribution of the expected new cases (incidence) and deaths (mortality) for three types of GI 
cancers in the world, European Union, and Portugal, in 2010 [4]. 
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Asia. Its incidence continues to increase in Asian and Eastern European countries, which may 
reflect an elevated obesity and smoking prevalence associated with the adoption of western 
lifestyles. On the other hand, the incidence of colorectal cancers has been decreasing in long-
standing economically developed countries, such as the United States. This trend is related to 
an increased use of screening for the detection and removal of pre-cancerous lesions [1, 3, 5-
7]. Risk factors include: personal or family history of colorectal cancer and polyps; personal 
history of chronic inflammatory bowel disease; obesity and physical inactivity; diet high in 
red or processed meat; inadequate consumption of fruits and vegetables; alcohol consumption; 
and, smoking  [1, 5-6, 8].  
The incidence of stomach cancer varies widely around the world. Still, in general, the 
highest incidence rates are in Asia and South America, whereas the lowest rates can be found 
in North America and most parts of Africa. Over the last 50 years, in developed countries of 
Europe and North America, stomach cancer incidence rates have dropped by more than 80%. 
This decreasing trend was also verified in Japan (where the rate is still high) and China. An 
increased consumption of fresh fruits and vegetables, a decreased dependence on salted and 
preserved foods, a reduction in Helicobacter pylori (H. pylori) infection, and an increased 
screening have contributed to this reduction in the number of stomach cancer cases [1, 9-10]. 
Esophageal cancer incidence varies more around the world than the incidence of any 
other type of cancer. Still, the highest incidence rates are found in Asia and in East and South 
Africa [1, 3, 11]. Esophageal cancer can occur in two different ways: squamous-cell 
carcinoma (SCC), in the middle or upper third of the esophagus; and adenocarcinoma (ADC), 
in the lower third of the esophagus, or junction of the esophagus and stomach [1, 11]. The 
incidence of SCC has been increasing in some regions of Asia with a low socio-economic 
status and nutritional deficiencies, and declining in the United States and other developed 
countries due to a decrease in the consumption of alcohol and tobacco. In opposition, the 
incidence of ADC has been increasing in countries such as the United States and England. 
This trend might be due to an increase in obesity and physical inactivity, chronic 
gastroesophageal reflux disease (GERD), and Barrett’s esophagus (BE), which is a pre-
malignant condition that can lead to esophageal cancer  [1, 10-12].  
As demonstrated in Figure 1.1, the type of GI cancer with the highest incidence rate 
worldwide and in Portugal, specifically, is colorectal cancer. However, among GI cancers, 
esophageal cancer is the one with the highest mortality rate. In Portugal, approximately 96% 
of the patients diagnosed with esophageal cancer die from this disease [4]. In other developed 
countries the same trend is verified, which emphasizes the high aggressiveness and lethality 
of this tumor. Also, until the twenty-first century, ADC of the esophagus, in particular, has 
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increased with a rate of acceleration greater than that of any other cancer (e.g. in the United 
States it has increased approximately 300% to 500% in the second half of the twentieth 
century) [11, 13-14]. Therefore, and despite its small incidence numbers, esophageal ADC 
has become a significant health concern in Western countries due to its increasing incidence 
and due to the poor prognosis associated with this disease – it remains a deadly tumor [14]. 
For these reasons, this type of cancer will be the main subject of this thesis in the following 
Chapters. 
1.1.2 Detection of GI cancer in vivo 
The progress of normal epithelial GI tissues into a malignant tumor involves a series 
of sequential changes that can be generally divided in five phases: dysplasia; cancer in situ; 
localized invasive tumor; regional lymph node involvement; and distant metastases (Figure 
1.2) [2, 15].  
 
Figure 1.2: General phases of cancer development [2, 15-17]. 
Cancer survival rates are greatly affected by the phase or stage at which the cancer is 
diagnosed. The detection of dysplasia is essential for managing GI cancer since the chances of 
an effective treatment considerably increase if the disease is diagnosed at an early stage, 
significantly improving the survival rate [16-19]. WHO has estimated that nearly one-third of 
cancer burden could be decreased if lesions were diagnosed and treated at an early stage. Thus, 
worldwide, significant healthcare resources are spent each year in screening protocols for an 
early detection of cancer [16]. However, some types of cancer don’t display visible signs and 
symptoms early in the evolution of the disease (e.g. esophageal cancer) and, therefore, are not 
amenable to early diagnosis. On the other hand, GI cancer sites with early detection include 
colon and rectum, and stomach [2].  
When colorectal cancer is detected at an early stage the five-year survival rate 
increases up to 90%. Unfortunately, only 39% of these cancers are diagnosed at its earliest 
stages, mainly due to underuse of screening. In the case of stomach cancer, it was shown that 
in the United States survival rates improved from 26% to 63% if the diseased was detected at 
the dysplastic stage. However, similarly to colorectal cancer, less than 25% of stomach 
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cancers are diagnosed at an early stage. As previously mentioned, due to the absence of early 
symptoms, esophageal cancer is usually detected at a late stage, and, as a consequence, most 
people eventually die from this disease. In the United States the average five-year survival 
rate is around 18%, whereas in Europe, in average, 11% of patients survive at least five years 
after diagnosis [1]. 
Screening for colorectal cancer remains the most important means to reduce morbidity 
and mortality associated with this type of cancer, and can be performed using several different 
methods, such as: fecal occult blood testing; flexible sigmoidoscopy; colonoscopy; and, 
computed tomography colonography. Detailed information about colorectal cancer screening 
programmes and methods can be found in [1, 3, 6-8, 20-21]. In the majority of countries there 
are no routine screening tests for stomach cancer. Screening programs, based on upper 
endoscopy techniques or serum pepsinogen tests, are only available in countries where the 
incidence of this type of cancer is high (e.g. Japan and Korea) [1, 8, 10, 22]. Similarly, in the 
esophagus there are no standard screening tests established for the early detection of cancer. 
Endoscopic screening for SCC may be proposed only for individuals with high consumption 
of alcohol and tobacco, or with a past history of cancer. For ADC of the esophagus, and 
despite the increasing incidence and lethality of this cancer, the number of cases remains too 
small to consider screening [10-11].  
After the inspection of visible suspicious tissue sites, an invasive biopsy is usually 
required to establish a diagnosis. In a biopsy, a few cubic millimeters of tissue from a 
potentially abnormal site (previously identified by screening techniques or by a physician) are 
removed for further investigation. Biopsy specimens are then histopathologically evaluated 
for markers of early cancer: metabolic activity, epithelial thickness, stromal architecture, and 
nuclear morphology [16-17]. 
All this detection methodology may be problematic since the majority of early 
cancerous lesions don’t induce visible changes in the tissues, and thus are difficult to detect 
using the referred standard screening methods: dysplasia is not readily identifiable by direct 
visual inspection using routine white-light endoscopy techniques. As a consequence, 
physicians often take a large number of regularly spaced but random biopsies to increase the 
chances of detecting invisible lesions, which results in sampling errors and high costs 
associated with the procedure [23].  
Moreover, a high number of biopsies and false positive results may lead to 
unnecessary follow-up procedures and the patient to endure physical and mental discomforts 
[15, 17, 19, 24-26]. The histopathologic diagnosis and identification of degree of dysplasia is 
also difficult, as evidenced by low intra- and inter-observer agreement among GI pathologists 
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[27-29]. Thus, the development and validation of new tools for the detection of dysplasia in 
vivo represents an important priority [15-17]. 
1.1.3 Detection of GI cancer ex vivo 
Endoscopic mucosal resection (EMR) has become the treatment of choice for early 
cancerous lesions of the GI tract, specially the esophagus [30]. Fast and reliable intra-
operative diagnosis is critical for the success of these oncological surgeries. 
After any cancer tissue resection it has to be ensured that all malignant tissue was 
removed and for that a surgical pathologist has to examine the tissue margins [31]. Current 
procedures include visual inspection of the tissue, followed by the assessment of all 
suspicious sites by frozen sectioning and histological evaluation. This procedure is still not 
very efficient since, according to a study by the College of American Pathologists [32], a 
significant number of hospitals do not routinely provide intra-operative feedback to the 
surgeon within 20 minutes after the tissue is delivered for analyzing. This increases not only 
the costs but also the risk of morbidity associated with extra time spent by the patient in the 
operating room. Additionally, frozen section diagnoses are almost always performed on a few 
“representative” portions of tissue, which may result in discrepancies between the frozen 
section assessment and the definitive margin status. A definite diagnosis becomes only 
available once the entire tissue has been processed post-operatively.  
A 2005 study suggests that EMR achieves complete excision of dysplastic lesions in 
only 4% of all cases. This fact implies re-operation for positive surgical margins in a huge 
percentage of cases, adding significant costs and morbidity to the management of GI cancer 
[30]. Therefore, there is also a significant technological and clinical need for methods capable 
of a reliable evaluation of excised tissues in real-time.  
1.2 Optical spectroscopy for GI cancer detection 
Optical spectroscopy techniques may considerably improve the ability to detect 
dysplasia. In particular, diffuse-reflectance spectroscopy (DRS) and fluorescence 
spectroscopy (FS) have been proven to be highly sensitive for the identification of early 
cancer, by exhibiting different spectral features that can be correlated with normal and 
cancerous tissue [17, 19, 33]. Such techniques have the ability to reveal biochemical and 
morphological tissue information that can be used to characterize, in real-time, changes that 
take place during disease transformation [15, 19]. Diffuse-reflectance and fluorescence signal 
can be observed and analyzed through spectra (signal plots, usually measured at one specific 
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tissue point) or images (signal intensity images or maps that are able to cover a wide tissue 
area). Several studies have successfully applied reflectance and fluorescence point 
spectroscopy [18, 26, 34-36] and imaging spectroscopy [19, 25, 37-40] for detecting and 
classifying dysplasia in a variety of GI structures. Figure 1.3 shows some results obtained 
using point spectroscopy and imaging spectroscopy techniques [15, 36, 38, 40].  
 
 
 (a) 
 
 
 
(b) 
 
 
 
 
 
Figure 1.3:  Spectroscopy results obtained from esophageal tissue using: (a) point spectroscopy (Reprinted 
from [15, 36], Copyright (2000-2006), with permission from Elsevier); and (b) imaging 
spectroscopy (Reprinted from [38, 40], Copyright (2005-2006), with permission from Elsevier). In 
point spectroscopy, the higher intensity lines in the plots (in black) correspond to normal 
esophageal tissue, whereas the lower intensity lines (in grey) correspond to dysplastic and 
cancerous tissue sites. In the imaging mode, the left side images were acquired using white-light 
endoscopy, whereas the right side images were acquired using fluorescence and reflectance 
imaging spectroscopy. In the right side images, normal mucosa appears as a greenish tone, while 
dysplastic or cancerous lesions appear as well-contrasted purple or magenta. This way, it is 
possible to identify lesions that were previously “invisible” in the white-light images. 
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Point spectroscopy techniques have the advantage of providing numerical intensity 
values that enable a quantitative and objective analysis, whereas imaging spectroscopy 
techniques have the major benefit of allowing an analysis over a wide tissue area. In this last 
case, the diagnosis is qualitative and based on the visible differences of color. This thesis will 
focus in point spectroscopy techniques and in the construction of imaging maps using point 
spectroscopy data. 
In DRS, white-light delivered to the tissue is absorbed and multiple scattered by tissue 
constituents and part of it returns, carrying information about tissue optical properties 
(scattering, absorption) [15, 41]. Scattering is mainly originated by collagen fibers in 
connective tissue, whereas absorption is mainly due to hemoglobin [15]. A decrease in tissue 
scattering and an increase in absorption are generally associated with dysplasia [18-19, 42-44], 
as will be detailed in Chapter 3.  
Epithelial tissues produce fluorescence when excited by ultraviolet (UV) or short-
wavelength visible light. This fluorescence is emitted by several fluorophores that are related 
to the structural arrangement and metabolism of cells. A modification in fluorescence 
emission may be related to the emergence of pathological conditions [15, 33, 45-46]. 
Nicotinamide adenine dinucleotide phosphate (NAD(P)H) and collagen are considered 
fluorescent biomarkers of precancerous changes in epithelial tissues: an increase in NAD(P)H 
and a decrease in collagen occur with the progression of dysplasia [16, 42]. Also, the 
fluorescence intensity of dysplastic epithelial tissue is generally lower compared to healthy 
tissue [42, 47-48], as will be further explained in Chapter 3.   
By combining the complementary tissue information provided by diffuse-reflectance 
and fluorescence, it is achieve a more sensitive and specific diagnosis. These two techniques 
can be applied for the detection and classification of GI dysplasia using either: a 
discrimination criteria empirically determined from the acquired spectra (e.g. based on spectra 
intensity values in different spectral bands); or a model-based approach, which is detailed in 
Chapter 3, and enables the objective quantification of different tissue morphological and 
biochemical parameters. These parameters can be subsequently analyzed, using statistical 
methods, to develop diagnostic algorithms that will be correlated with specific pathological or 
normal tissue conditions.  
Ex vivo imaging strategies using DRS and FS have also been proposed as potential 
tools for surgical margin assessment of excised specimens [49-51]. Spectral imaging devices 
for the assessment of excised tissue have two major advantages over traditional practices of 
surgical margin assessment: real-time analysis in the operating room, with the benefit of 
reducing patient anxiety and avoid potential follow-up surgery; and, whole area assessment, 
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with the benefit of reducing the probability of missing an invisible lesion.  
Despite all the benefits associated with the use of diffuse-reflectance and fluorescence 
point spectroscopy techniques for the detection of early cancerous lesions, these are not yet 
available in commercial instruments. Currently, quantitative tissue diagnosis, using 
spectroscopy, is only performed with research prototypes. An optically-based endoscopic 
technique that may improve the early detection of GI cancer and is already commercially 
available to be used in clinical practice is narrow-band imaging (NBI) [52-55]. This method 
will be detailed next below. 
Detection of early GI cancer using narrow-band imaging  
NBI is an optical imaging technique, based on high-resolution endoscopy, which has 
the ability to enhance the superficial mucosal contrast without the use of staining agents. NBI 
is based on the optical phenomenon that the depth of light penetration into tissues is 
dependent on its wavelength. In the visible range, blue light penetrates most superficially (i.e., 
mucosal imaging) whereas red light penetrates deepest (i.e., submucosal imaging). In NBI, the 
band-pass ranges of the blue, green, and red components of excitation light are narrowed 
(blue 400-430 nm, green 530-550 nm, and red 600-620 nm) using optical filters, and the 
relative intensity of blue light is increased. These bands produce great contrast between 
microvascular structures and the surrounding mucosa, mainly as a result of the differential 
optical absorption of light by hemoglobin. Blue light is highly absorbed by hemoglobin 
enhancing the contrast of superficial mucosal and vascular patterns: structures with high 
hemoglobin concentration (i.e., blood vessels) absorb the light and thus appear darker, 
providing contrast to the brighter surrounding mucosa that reflects the light [40, 56-58]. Green 
light corresponds to another hemoglobin absorption band (less evident than the blue spectral 
band). While capillaries in the mucosa surface are emphasized by the blue light, deeper 
submucosal vessels are made visible by the green light [56]. The same way, with red light, 
deep layers of the mucosa, corresponding to large collecting vessels, can be observed [59].  
The use of NBI for the detection of dysplasia in the esophagus has shown that 
irregular mucosal and vascular patterns, as well as the presence of abnormal blood vessels, are 
associated with early cancerous lesions [58, 60-61]. NBI techniques also improve the 
detection of colorectal early cancers [52, 55, 62-63]. In Figure 1.4 it is shown the advantage 
of using NBI for the visualization of mucosal and vascular patterns, when compared with 
high-resolution white-light endoscopy [64]. 
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Figure 1.4:  Endoscopic photographs of areas with high-grade neoplasia in BE (no staining and 115 original 
magnification) viewed using (a) high-resolution endoscopy and (b) NBI. NBI is able to show an 
irregular, disrupted mucosal pattern and an irregular vascular pattern that can be used to 
differentiate dysplasia from non-dysplastic tissues. These patterns cannot be well seen using high-
resolution white-light endoscopy. Reprinted from [61], Copyright (2006), with permission from 
Elsevier. 
However, despite the good results obtained in several clinical studies, NBI is of 
limited value for primary detection of lesions, being more suitable for targeted detailed 
inspection of suspected areas. Moreover, this technique relies on improved anatomic 
resolution and contrast, being considered a surface imaging technique. It requires 
magnification for optimal use, which is also a limitation [40, 58, 64-65]. This way, the use 
and further development of detection methods based on functional contrast, with the ability to 
provide quantitative tissue information, which can also be used as red-flag techniques to 
identify dysplasia, is of research as well as clinical interest. The optical spectroscopy 
techniques fulfill these requirements. 
1.3 Motivation and objectives 
Early cancer detection is a major goal in medicine being the most important factor on 
which the patient’s survival rate depends. Thus, efforts to reduce mortality of GI cancer rely 
on the detection and complete removal of pre-cancerous or dysplastic lesions [17-19]. These 
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lesions are usually invisible, and, thus, difficult to identify in vivo using standard screening 
methods, whereas the ex vivo identification, after an excision surgery, is difficult to achieve in 
a timely manner.  
DRS and FS have the potential to provide morphological and biochemical information 
of normal and dysplastic tissue, which can be used to establish a diagnosis. The combination 
of both techniques should provide a powerful tool for guiding or, ultimately, replacing biopsy 
during in vivo screening for dysplasia, and for ex vivo, during surgery, for wide area detection 
of cancer margins. 
In DRS and FS studies performed in vivo, costly, bulky, and sophisticated prototypes 
for data collection are used. These are generally composed by a spectrograph, a high-
efficiency detector and optical fibers for light collection from tissues.  Such optical set-ups are 
not portable and compact, which might be cumbersome in the clinical environment. Moreover, 
regular optical fibers usually have low-collection efficiency, and the placement of the detector 
at its distal end significantly contributes to light losses. Therefore, the development of a low-
complex miniaturized spectroscopy system, without the need of optical fibers, spectrograph, 
or high-efficiency detectors could potentially increase the collection efficiency, while keeping 
the same throughput. Additionally, screening techniques using conventional endoscopes have 
the potential to be replaced by more comfortable and less invasive procedures using small 
devices, such as the endoscopic capsules (ECs). For that reason, one main goal of this 
research is the development of a small scale spectroscopy system that can be integrated not 
only within conventional endoscopes (making them more portable and cost-effective), but 
also in ECs for the detection of GI dysplastic lesions, adding essential diagnostic functions to 
current capsule imaging functions. This system is based on light-emitting diodes (LEDs) for 
illumination, and thin-film optical filters and low-cost silicon photodiodes for the selection 
and detection of several light wavelengths significant for the diagnosis of GI dysplasia. If 
successful, the output will be revolutionary in term of diagnostic functions, high-throughput, 
reduced cost and disposability. Also, the device is envisioned to have a huge clinical impact in 
early stage cancer management. Figure 1.5 depicts the main components of the miniaturized 
spectroscopy system. 
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            (b) 
Figure 1.5:  (a) Miniaturized system with LEDs as light sources, optical filters and photodiodes for wavelength 
selection and detection, respectively (not scaled). Data transmission is intended to be wireless. (b) 
Photograph of the detection system based on an array of silicon photodiodes. 
Spectroscopy diagnosis, using current available optical probes, can also be extended to 
imaging mode, enabling wide area surveillance of tissue. An imaging spectroscopy system 
can have a significant clinical utility for excised tissue margins assessment by providing 
structural and biochemical information which correlate to disease state of the tissue. Such a 
system will be able to reduce patient anxiety and avoid follow-up surgery because a rapid, 
real-time data analysis can be performed inside the operating room. Moreover, it can reduce 
the probability of missing a lesion because the whole ex vivo tissue area can be assessed. 
Therefore, this research will also focus on the development of a wide-area ex vivo diffuse-
reflectance and fluorescence spectroscopy imaging system for comprehensive assessment of 
surgical margins that result from mucosal resections in the GI tract. In Figure 1.6 the ex vivo 
spectroscopic imaging prototype is presented.  
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 (a) 
 (b) 
Figure 1.6:  (a) Schematic layout and (b) photograph of the ex vivo spectroscopic imaging system. 
Wide-area imaging of excised tissue is achieved by mechanically scanning an optical 
probe along the tissue surface, with variable spatial resolution. This medical device can 
provide real-time feedback regarding the resected mucosal margins, which represents a huge 
impact in intra-operative diagnosis.  
In summary, this thesis research is directed towards two main goals: (1) integration of 
spectroscopy functions in small and less invasive devices for in vivo detection of early cancer 
in the GI tract; (2) development of an ex vivo spectroscopy imaging system for tissue margin 
assessment in GI oncological surgeries. 
1.4 Organization of the thesis 
The present Chapter introduces the significance of optical spectroscopy techniques for 
the detection of early GI cancerous lesions, using both in vivo and ex vivo methods. The thesis 
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motivation and objectives are also presented. Chapter 2 generally describes the anatomy of 
the esophagus and the process involved in the development of esophageal cancer. Some 
limitations of current esophageal dysplasia detection methods conclude the chapter. Chapter 3 
presents the diffuse-reflectance and fluorescence spectroscopy techniques and the 
corresponding analytical models that are used to extract quantitative tissue information. 
Chapter 4 deals with the miniaturized spectroscopy system development. The design, 
fabrication, and characterization of its main components, namely the thin-film optical filters, 
are also described.  Chapter 5 presents the experimental results related to the use of thin-film 
optical filters for the establishment of a diagnosis, both in a quantitative and qualitative 
approach. Chapters 6 describes the experimental results obtained with the developed ex vivo 
spectroscopy system for the assessment of excised tissue samples, and discusses the main 
benefits of this system for oncological surgeries. Finally, conclusions are drawn in Chapter 7 
along with some recommendations for future work. 
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 Chapter 2 
2 Esophagus and Esophageal Cancer 
Esophagus and  
Esophageal Cancer 
 
In this Chapter it is presented an overview of the macroscopic and microscopic 
anatomy of the gastrointestinal organ studied in this thesis - the esophagus. The process of 
esophageal cancer development and the limitations of current dysplasia detection methods 
conclude this Chapter. 
2.1 Anatomy of the esophagus 
2.1.1 Macroscopic anatomy 
The normal esophagus is a flexible, hollow, muscular tube, with approximately 18 to 
22 cm long and an average diameter of 2 cm, that connects the pharynx, in the neck, to the 
stomach, in the abdomen (Figure 2.1). The esophagus wall is composed of striated muscle in 
its upper third, smooth muscle in its lower third, and a mixture of striated and smooth muscle 
in between [1-4]. The pressure in the esophageal lumen is negative compared with the 
atmosphere. Still, manometric recordings have identified two high-pressure zones that prevent 
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the backflow of food: the upper and lower esophageal sphincters. These functional zones are 
located at the upper and lower ends of the esophagus but they are considered physiologic in 
that there is not a clear anatomic landmark that delineates their limits [3-4].  
 
Figure 2.1:   Esophagus: some anatomic considerations. Reprinted by permission from Macmillan Publishers 
Ltd: GI MOTILITY ONLINE ([5]), Copyright (2006). 
The main function of the esophagus is to conduct food and fluids from the pharynx 
toward the stomach: food passes through the esophagus rapidly because of the peristaltic 
contractions of its musculature, aided by but not dependent on gravity; also, mucus produced 
by the esophageal mucosa provides lubrication, facilitating the passage of food. In addition, 
the esophagus prevents passive diffusion of substances from the food into the blood and 
reflux of gastric contents. These functions require motor activity coordinated with 
swallowing, namely a wave of peristaltic contraction, relaxation of the lower esophageal 
sphincter in anticipation of the peristaltic wave, and closure of the lower esophageal sphincter 
after the swallowing reflex. Maintenance of sphincter tone is necessary to prevent reflux of 
gastric contents [1, 3-4].  
2.1.2 Microscopic anatomy 
Epithelial tissue lines the interior of the GI tract. Epithelium consists of closely packed 
sheets comprising one or more layers of cells that are responsible by several important 
activities, such as: protection, sensory reception, and the secretion, absorption and transport of 
molecules [6].  
Epithelial cells are bound to adjacent cells by intercellular junctions that provide 
physical strength and mediate exchange of information and metabolites. All epithelia are 
supported by a basement membrane that links the epithelial cells to the underlying connective 
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tissue. Epithelial cells have some degree of polarity with one side facing the basement 
membrane and underlying supporting tissue (the basal surface) and the other facing outwards 
(the apical surface) [6-7].  
The lining epithelia can be morphologically classified according to: the number of cell 
layers, the shape of component cells, and the specialization of the apical surface. There are 
seven categories of epithelia: simple squamous; simple cuboidal; simple columnar; stratified 
squamous; stratified columnar; pseudostratified columnar; and transitional epithelium. The 
type of epithelium that lines the inner surface of the esophagus is stratified squamous 
epithelium (Figure 2.2) [7].  
 
 
Figure 2.2:  Stratified squamous epithelium: (a) drawing illustrating the shape and arrangement of cells (BM – 
basement membrane); (b) H&E 100 (hematoxylin and eosin stain, 100 original magnification). 
Reprinted from [7], Copyright (2006), with permission from Elsevier. 
Stratified epithelia are defined as epithelia consisting of two or more layers of cells. 
Stratified squamous epithelium consists of a variable number of cell layers that mature from a 
cuboidal basal layer adherent to the underlying basement membrane to a flattened surface 
layer. The cells resting on the basement membrane typically have a rounded appearance. As 
the cells move toward the surface, they become increasingly squamous in appearance [7].  
Structurally, the wall of the esophagus consists of four organizational layers of cells: 
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mucosa, submucosa, muscularis propria, and adventitia (Figure 2.3). This structure reflects 
the general organization of the GI tract, with the exception that the esophagus doesn’t have a 
true serosal outer layer, being covered, instead, by a thin layer of connective tissue [3-5]. The 
inexistence of a serosal covering allows esophageal infections and tumors to widespread more 
easily and makes them harder to treat surgically [3-4].  
 (a) 
 (b) 
Figure 2.3:  Structure organization of the esophageal wall: (a) drawing and (b) micrograph illustrating several 
organizational layers: LM – outer longitudinal layer of muscularis propria; CM – inner circular 
layer of muscularis propria; G – seromucous gland; MM – muscularis mucosae; SM – submucosa; 
E – epithelium; Ly – lymphoid aggregates. Reprinted from [7], Copyright (2006), with permission 
from Elsevier. 
The mucosa has a smooth, glistening, and reddish surface, being arranged in 
longitudinal folds that disappear upon distention. It consists of three sub-layers: a 
nonkeratinizing stratified squamous epithelial layer; lamina propria; and, muscularis mucosae. 
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The epithelial layer covers almost the entire inner surface of the esophagus, and has mature 
squamous cells overlying basal cells. The lamina propria is a thin layer of loose connective 
tissue (corresponding to the non-epithelial portion of the mucosa) above the muscularis 
mucosae; it is mainly composed by collagen produced by fibroblasts. The muscularis mucosae 
is a 2 to 3 cell thick layer of longitudinally oriented smooth-muscle bundles that provide 
support for the lamina propria and the epithelium [3-4, 6].  
The submucosa consists of a thick layer of supportive connective tissue containing a 
vascular network, lymphatics, nerve fibers, ganglia, adipose tissue, and submucosal 
glands [3 - 4, 6].  
The muscularis propria is responsible for motor function. As mentioned, the upper 5% 
to 33% of the esophagus is composed of striated (skeletal) muscle fibers, and the distal 33% is 
composed of smooth muscle. The layers of smooth muscle have different orientations: the 
inner layer has a circular orientation, whereas the outer layer has a longitudinal 
orientation [3 - 4, 6].  
The adventia is an external fibrous layer that covers the esophagus, being composed 
by connective tissue, small vessels, lymphatic channels, and nerve fibers [4, 6].  
2.2 Carcinogenesis 
A neoplasm, or tumor, can be defined as an abnormal mass of tissue with an 
uncontrolled and uncoordinated growth, compared with that of normal tissues. 
Carcinogenesis is a multistep process by which normal cells progressively transform into a 
malignant phenotype, which is characterized by excessive growth, invasiveness, and the 
ability to form distant metastases [3].  
All malignant tumors are commonly known as cancers. Cancers of epithelial origin 
are called carcinomas, which may be further classified into adenocarcinoma - ADC (when 
there is glandular growth pattern) and squamous-cell carcinoma - SCC (when recognizable 
squamous cells are produced) [3].  
The majority of esophageal ADCs develop in patients with BE, who have an increased 
risk of developing the disease when compared with the general population. It is estimated that 
10 to 40% of esophageal ADCs are linked with BE. This premalignant condition is 
recognized, nowadays, as the major risk factor for the development of ADC in the lower 
esophagus [8-13].  
Barrett’s Esophagus 
BE is a complication of long-standing GERD. The reflux of gastric contents into the 
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esophagus, due to a functional problem in the lower esophageal sphincter, the presence of a 
hiatal hernia, or a delayed gastric emptying, is the first cause of esophagitis [3, 14]. Reflux 
esophagitis is characterized by the development of esophageal mucosa injury, with 
subsequent inflammation, because of the acid-peptic action of gastric juices. BE appears as 
the most harmful complication of severe esophagitis, but bleeding and the development of 
stricture may also appear as a consequence. However, it is important to notice that some 
subjects with severe recurrent esophagitis never develop BE, whereas others with relatively 
few symptoms and little or no inflammation develop the disease [3, 14]. 
BE can be defined as a pathological condition in which the distal normal stratified 
squamous epithelium is replaced by metaplastic columnar epithelium, as a response to 
prolonged injury (due to an abnormal acidic milieu created by GERD). The replacement of 
one cell type by another is a process known as metaplasia. The pathogenesis of BE is not 
clear; still, it has been proposed that esophagitis is followed by ingrowth of pluripotent stem 
cells, that will then differentiate into a columnar epithelium, more resistant to acid-peptic 
injury [3, 14]. This layer of columnar epithelium is a single-cell layer, whereas in a clinically 
normal situation the esophageal epithelium is made up of several layers of squamous cells. 
For this reason, there is a reduction in thickness that makes the underlying blood vessels more 
visible, giving a reddish appearance to metaplasia [15]. 
Critical to the pathologic evaluation of patients with BE is the search for dysplasia, 
which is the precursor lesion of malignancy. BE develops through stages from non-dysplastic 
metaplasia, followed by increasing grades of dysplasia, and finally ADC [3, 13-14, 16]. The 
risk of developing ADC increases as the severity of the dysplasia increases. 
Dysplasia, which literally means disordered growth, is defined histologically as a 
neoplastic alteration of the epithelium that does not invade the lamina propria. It is recognized 
by the presence of cytologic and architectural abnormalities, such as: variation in size and 
shape of cells (pleomorphism); enlarged, crowded, and stratified hyperchromatic nuclei; 
neovascularization; and, loss of architectural orientation. It can be classified as high-grade or 
low-grade [3, 14, 16]. The risk of ADC in low-grade is not well defined, but it was already 
shown that it is smaller than in high-grade. The lesion is referred to as cancer in situ when 
these changes affect the full thickness of the epithelium [3, 14, 16].  
The typical progress from normal squamous epithelium to esophageal ADC is 
illustrated in Figure 2.4 [3]. 
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Figure 2.4:  Transition from normal squamous epithelium to esophageal ADC [3]. 
Epithelial dysplasia almost always precedes the appearance of cancer (still, it is 
important to notice that not all dysplastic lesions necessarily progress to cancer) [3]. The 
malignant potential of dysplastic cells makes the detection of dysplasia a crucial step in 
cancer prevention. Unfortunately, and as referred in Chapter 1, the detection of dysplasia is 
difficult in clinical practice. Figure 2.5 illustrates two images of BE with suspicious dysplastic 
areas. As the images show, it is hard to detect the dysplastic lesions in a BE mucosa with 
standard white-light endoscopy [17-18]. 
  
Figure 2.5:  White-light endoscopic view of BE, showing dysplastic lesions (arrow in the left-side image). 
Reprinted from [17-18] Copyright (2005-2006), with permission from Elsevier.  
The current validated method to detect dysplasia is based on endoscopy examination 
followed by biopsy and microscopic examination, i.e. histology, which is the gold standard 
for analysis of diseased tissue. Patients found to have BE should undergo upper endoscopy 
surveillance in the hope of detecting malignancy in an early and more curable stage [19-21]. 
This procedure has limitations since dysplasia is not endoscopically visible. Moreover, 
dysplastic lesions can be as small as one millimeter, and the probability of detecting such as 
small lesion in the entire suspected area is not favorable: the portion of tissue sampled may 
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not be representative of the diseased area. For these reasons, surveillance requires extensive 
and undirected biopsy, which is prone to sampling errors and associated with high costs. 
Since biopsy involves removing tissue it is considered an invasive procedure [15, 21]. 
A dependence on histology also has an inherent time delay between endoscopy and 
diagnosis, since biopsy samples need to be taken to a pathology laboratory to be analyzed. 
After the tissue is removed, the sample is fixed in formaldehyde, embedded in paraffin, sliced 
into sections, and stained with specific dyes. Then the pathologist analyzes the sections with a 
microscope, looking for patterns of disease (e.g. structural disorganization, increased nuclei 
size, among others). Overall, these procedure steps together may take hours. This limits the 
possibility to re-sample or over-sample abnormal or ambiguous areas because the need for 
further biopsies is not known until the pathologist analyzes the collected samples [15, 21]. 
Moreover, the histopathological diagnosis can be considered subjective and highly dependent 
on the pathologist that is performing the analysis [22-25]. 
Given what was said in the previous paragraph, it is clear that a real-time, more 
efficient and reliable method for diagnosis of esophageal dysplasia, with potential to guide 
biopsy, or eventually replace biopsy, is needed. In the next Chapter, two optical spectroscopy 
techniques will be described that have associated important advantages for the detection of 
early esophageal cancer: (1) ability to non-invasively probe tissue (without the need for 
biopsy; for further histopathological evaluation only diseased tissue is removed); (2) no need 
to process the tissue specimen for histopathological assessment (real-time diagnosis – data 
can be collected and analyzed in seconds); (3) potential to reveal information beyond what 
can be provided by standard endoscopy techniques (e.g. biochemical information which often 
precedes the morphological visible changes); (4) ability to provide quantitative information 
that can add objectivity to the diagnosis of dysplasia (pathological evaluation is qualitative in 
nature and thus sometimes subject to low inter-observer agreement). 
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In this Chapter it is described the two major optical spectroscopy techniques that have 
been used for the detection of gastrointestinal cancer: diffuse-reflectance and fluorescence. 
Some of the most relevant studies using these two techniques for the assessment of 
esophageal tissue, together with their main results, are summarized. The Chapter also deals 
with the description of some physical models used to analyze the obtained spectral data and to 
extract quantitative biochemical and morphological information. To conclude, the feasibility 
of using a few narrow spectral regions for the quantitative extraction of tissue information, 
used to establish the diagnosis of dysplasia, is discussed. 
3.1 Spectroscopy 
Optical spectroscopy techniques have the potential to detect endoscopically invisible 
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early cancerous lesions in epithelial tissues. They make the “invisible visible”. By gathering 
tissue morphological and biochemical information, spectroscopy techniques are able to 
establish a diagnosis in a fast, objective and non-invasive way (there is no need to remove, 
process, and histologically analyze the tissue) [1-2]. 
In spectroscopy, when tissue is illuminated, several photophysical phenomena can 
occur as a result of the light-tissue interactions: scattering, absorption, or fluorescence (Figure 
3.1). Scattering is the predominant interaction and occurs when light is redirected as a result 
of variations in the refractive indices of tissue constituents, relative to their surrounding 
medium [3]. The refractive index is defined as the ratio of the velocity of an electromagnetic 
wave in vacuum to that in a particular medium [4]. Absorption occurs when a molecule 
absorbs light without re-emission, whereas fluorescence occurs when a molecule absorbs light 
and re-emits it at a longer wavelength [1, 5-6].  
 
Figure 3.1:  Examples of different light-tissue interactions: scattering, absorption and fluorescence [5]. 
With the progression of dysplasia, changes in the architectural and biochemical 
properties of tissue perturb tissue absorption, scattering, and fluorescence, thus modifying the 
characteristics of the re-emitted light [7]. These tissue modifications, which are translated into 
specific spectroscopic signatures, include [5-6, 8-18]: 
(1) the degradation of the extracellular collagen matrix by various proteases, and the 
loss of basement membrane, which are translated by a decreased scattering and a reduced 
fluorescence signal from collagen. This degradation facilitates cell invasion and, eventually, a 
metastatic dissemination; 
(2) an increased metabolic activity because of rapid cell division, which results in an 
increased NAD(P)H fluorescence signal. NAD(P)H is a cellular metabolism related molecule. 
It is coupled to the production of cellular energy through the oxidation of glucose;  
(3) the thicknening of the epithelium, which is reflected by a collagen reduced 
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fluorescence signal and by a decrease in scattering. This occurs because with an increased 
thickness less incident light is able to reach the underlying collagen fibers; 
(4) the angiogenesis process, characterized by the growth of new blood vessels and 
hence by an increase in blood content, which is translated by an increased absorption by 
hemoglobin. Increased hemoglobin absorption causes a decrease in the fluorescence emission. 
Therefore, by monitoring the light emitted from the tissues (which is a function of 
light-tissue interactions aforementioned) it is possible to infer about the tissue disease state. 
Since it is considerably different from healthy tissue in structure and function, dysplasia or 
cancer, is expected to produce significant changes in the emitted light spectra (as shown in 
Chapter 1, Figure 1.3(a)). Still, it is important to note that these spectral changes also depend 
on the type of instrumentation used to collect the data [2, 19]. 
All the tissue biochemical and morphological information provided by optical 
measurements represents a valuable tool not only to establish an early diagnosis of a lesion 
(before macroscopically visible changes take place) but also to understand the biological 
processes involved in the progression from normal epithelium to dysplasia to cancer [6, 20]. 
Consequently, the knowledge about these processes can lead to the development of an 
improved therapeutic intervention [20]. 
In general, three types of optical spectroscopy technologies are used to assess 
epithelial tissue: DRS; FS; and Raman spectroscopy. The present thesis will focus on the 
detection of esophageal dysplasia using two of these modalities: DRS and FS. 
3.2 Diffuse-reflectance spectroscopy 
DRS measures light that is diffusely reflected from the tissue, i.e. light that is scattered 
many times before being detected. This scattering is elastic, which means that the scattered 
light as the same energy as the incident light – energy is conserved. During its travel through 
the tissue, light can also be absorbed. Thus, the resulting emission spectra will carry 
information not only about scattering but also about the absorption properties of the medium. 
This information can then be analyzed and correlated with tissue biochemical composition, 
morphology, and organization, to establish a diagnosis [10, 20-21]. 
In this modality, tissue is illuminated using a white-light source. The emitted light is 
usually collected and dispersed by a spectrograph, and then detected using a charge-coupled 
device (CCD). The detected diffuse-reflectance signal corresponds to light that has traveled 
through the tissue in a variety of paths and depths, and thus, the information extracted from 
the spectrum reflects the properties over a volume of tissue [3, 10, 14, 16].  
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Scattering  
Tissue scattering is originated by variations in the refractive index of tissue 
constituents, such as collagen fibers, elastin, cell nuclei and membranes, and mitochondrias 
[1].  Specifically, in epithelial tissues, scattering is mainly due to collagen fibers [9]. The 
amount of scattering is a function of three factors: (1) the density of particles; (2) the size of 
the particles compared to the incident wavelength; and (3) the ratio between the refractive 
index of the particles and the refractive index of the medium [1, 18, 22].  
Elastically scattered light can be detected at the tissue surface after being scattered just 
once (single scattering) or after being scattered many times within the tissue (multiple 
scattering). The last is the main form of elastic scattering. Re-emitted light that has been 
scattered many times is known as diffusely reflected and is measured from the tissue surface 
using DRS [1]. 
In general, a photon travels 0.05 to 0.2 mm in the tissue before it is scattered for the 
first time by a particle. Multiply scattered photons can penetrate several millimeters into the 
tissue, ending up traveling the majority of time in the connective tissue (lamina propria and 
submucosa, see Figure 2.3, Chapter 2) with collagen fibers. Thus, the diffuse-reflectance 
spectrum translates essentially the properties of the connective tissue [1, 9, 16, 20-21]. 
Absorption 
Tissue absorption depends on the amount of molecules within tissue that absorb light 
at specific wavelengths. The absorption phenomenon inherently causes a reduction in the 
amount of incident light that returns to the tissue surface. Tissue components (molecules and 
atoms) will convert the absorbed light into internal energy and heat [1]. 
In the epithelial tissue composition there are several absorbers, among which: nucleic 
acids (with maximum absorption around 260 nm), amino acids (with maximum absorption 
around 260-280 nm), and hemoglobin. For the esophagus, and epithelial tissues in general, 
hemoglobin is considered the only major absorber in the visible range [2, 9, 20, 22].  
Hemoglobin exists in the tissues in two different forms – oxygenated and 
deoxygenated, each of one has different absorption features, which are often use to obtain 
information about tissue oxygenation [20]. Oxyhemoglobin (HbO2) has maximum absorption 
peaks around 420, 540, and 580 nm, whereas deoxyhemoglobin (Hb) has its absorption 
maxima around 430 and 555 nm (Figure 3.2) [9, 23]. The extinction coefficient,   , measures 
how strong the molecules absorb light at a specific wavelength.  
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Figure 3.2:  Molar extinction coefficient spectra of HbO2 and Hb. The characteristic peaks of absorption for 
both forms of hemoglobin are clearly visible [23]. 
Absorption in tissue is highly dependent on the wavelength, tending to decrease with 
increasing wavelengths. As a result, the penetration depth of light into the tissue, which 
directly depends on tissue absorption, increases from the UV to the near-infrared spectral 
range. Visible light incident into the tissue usually penetrates at a depth of 0.5 to 2.5 mm. 
However, in the 650 to 1500 nm range, light can penetrate as deep as 10 mm before being 
collected. This happens because in this spectral range scattering predominates over absorption. 
In this region, known as diagnostic or therapeutic window, tissues are more transparent and, 
thus, it is possible to characterize them beyond surface and subsurface [1-2, 22].  
In summary, the measured DRS signal allows to obtain information regarding the 
tissue structure and its hemoglobin concentration and oxygenation. 
3.3 Fluorescence spectroscopy 
In FS tissue is illuminated with UV or short-wavelength visible light and the resulting 
emission is recorded. This emission depends on the fluorophores (biomolecules) present in the 
tissue, which have different fluorescence emission signals, and on the scattering and 
absorption properties of the tissue. GI tissue is composed of distinct fluorophores that occur in 
different concentrations and at different depths. Thus, the tissue layers (mucosa, submucosa 
and muscularis propria) have distinct fluorophore compositions and, as a consequence, 
distinct fluorescence emission spectra. Moreover, the fluorophores, which are related to the 
structure and metabolism of cells, are very sensitive to changes in the tissue 
microenvironment that may occur during disease development. This way, a modification in 
the fluorescence emission spectra (intensity and spectral shape) may be correlated to the 
emergence of pathological conditions [1-2, 5, 20, 24].  
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In the fluorescence process, the endogenous fluorophores, such as collagen, elastin, 
tryptophan, or NAD(P)H, absorb light and become excited. When they return to their ground 
state, the absorbed light is re-emitted at a lower energy in the form of fluorescence. The 
particular excitation and emission properties of some tissue fluorophores are presented in 
Table 3.1 [2, 20, 22, 24-25]. 
Table 3.1: Excitation and emission maxima of some tissue fluorophores. 
Fluorophores Excitation maxima (nm) Emission maxima (nm) 
Amino acids   
Tryptophan 280 350 
Tyrosine 275 300 
Structural Proteins   
Collagen 
325 400 
Elastin 
Enzymes and Co-enzymes   
NAD(P)H  290, 340 440, 450 
FAD (flavin adenine dinucleotide) 450 515 
Porphyrins 400-450 630, 690 
 
Scattering and absorption from tissue particles can significantly affect the measured 
fluorescence signal, introducing some distortions to the spectra, and ultimately masking the 
biochemical differences between normal and dysplastic tissues. This makes difficult the 
extraction of the tissues biochemical composition [2, 6, 16]. Still, and since fluorescence and 
reflectance spectra are affected similarly by absorption and scattering events, it is possible to 
remove the mentioned distortions from the fluorescence spectra, using the reflectance spectra, 
as will be detailed in section 3.5.2. The obtained spectra is known as “intrinsic fluorescence”. 
In summary, from the fluorescence signal it is possible to assess the biochemical and 
morphological composition of tissue, which helps to establish a diagnosis. 
3.4 Diffuse-reflectance and fluorescence studies in the esophagus 
A few studies have been published about the use of DRS for the detection of 
esophageal malignancy. Georgakoudi and co-workers have published two different studies 
using this technique for the detection of dysplasia in patients with known BE [9, 26-27]. In 
the 2001 study [9], diffuse-reflectance spectra was collected from 16 patients, and then 
analyzed to obtain information about the scattering and absorption properties of connective 
tissue. In specific, the data included 26 non-dysplastic BE sites, 7 low-grade dysplastic sites, 
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and 7 high-grade dysplastic tissue sites. Using DRS, it was possible to differentiate high-grade 
dysplasia (HGD) from non-dysplastic tissue and low-grade dysplasia (LGD) with a sensitivity 
and specificity of 86% and 100%, respectively. In 2003, a study enrolling 27 patients also 
applied DRS for the identification of malignancy [26]. The ability of this technique to 
establish a diagnosis was again successful demonstrated with sensitivities and specificities of 
90-95% and 85-90%, respectively. 
In 2006, Lovat et al. [27] conducted a study to assess the potential of DRS to detect 
HGD or cancer in patients with BE. Data was collected from 181 different tissue sites, in a 
total of 81 patients. DRS was able to differentiate low-risk tissue sites (including clinically 
normal and low-grade dysplastic tissue sites) from high-risk tissue sites (with histologically 
confirmed HGD or cancer) with a sensitivity and specificity of 92% and 60%, in that order. 
Moreover, it was demonstrated the ability of DRS to identify benign lesions in patients with 
BE: high-risk sites were distinguished from inflammation with a sensitivity and specificity of 
79%. 
Overall, these studies have shown the potential of DRS as a reliable technique to 
detect malignant lesions in patients with BE. 
Several studies have described the use of FS for the detection of esophageal dysplasia 
and cancer [9, 12-13, 28-32]. In these reports excitation wavelengths between 330 and 620 nm 
were used, and the collected emission spectra were analyzed using different methods, such as 
intensity ratios, area under the fluorescence curve, or principal component analysis. Overall, 
FS has shown great potential for the discrimination between clinically normal and malignant 
tissue. A brief description of some of these studies can be found next below. 
Panjehpour and co-workers [28] have excited the Barrett’s mucosa of 36 patients 
using 410 nm light. The collected fluorescence spectra were analyzed using differential 
normalized fluorescence (DNF) indices at 480 nm and 660 nm to differentiate HGD from 
LGD and healthy tissue. In this method, all fluorescence spectra are normalized to the total 
integrated light (area under the emission curve). An average normalized fluorescence 
spectrum, collected from 15 patients with normal esophagus, was used as a baseline. The 
DNF spectrum of each fluorescence spectrum is achieved by subtracting this baseline from 
the normalized collected spectrum. The DNF index at 480 or 660 nm corresponds to the 
magnitude of the DNF spectrum at these wavelengths. The main objective was to find 
significant differences between the indices of normal and cancerous tissue sites. This 
methodology was able to correctly identify 96% of non-dysplastic tissue sites, and 90% of 
high-grade dysplastic tissue sites. 
In one study by Georgakoudi et al. [9] the potential of intrinsic fluorescence 
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spectroscopy (IFS) to identify LGD and HGD in 16 patients with known BE was evaluated. A 
337 nm nitrogen laser was used as the light source. Other excitation wavelengths were tested, 
being obtained using different dye cuvettes mounted on a rotating wheel in front of the laser. 
In particular, emission fluorescence spectra that resulted from an excitation at 337, 397, and 
412 nm were modeled and analyzed. Significant differences were found between non-
dysplastic and dysplastic tissue sites: at 337 nm excitation the spectral line-shape shifted to 
the red spectral region as malignancy progressed; and at 397 nm excitation the fluorescence 
intensity increased in the red spectral region. Based on these findings a diagnostic algorithm 
was developed that was able to differentiate HGD from non-dysplastic tissue and LGD with a 
sensitivity and specificity of 100% and 97%, respectively. 
In 2001, Mayinger et al. [13] used violet-blue light (375-478 nm) to excite normal and 
malignant esophageal tissue. This study enrolled 13 patients and a total of 129 tissue sites 
from which fluorescence spectra were collected. The emitted fluorescence spectra were all 
normalized to the average intensity at a wavelength 657 to 700 nm. This spectral range was 
used since in this region the fluorescence spectra had the same shape, irrespective of the tissue 
disease state. Then, a mathematical algorithm was developed based on the ratio of the 
fluorescence intensity in the wavelength range between 500 and 549 nm. With this algorithm 
it was possible to diagnose esophageal ADC with a sensitivity and specificity of 97% and 
95%, respectively. 
IFS was also successfully used to extract quantitative information about two important 
tissue fluorophores: NAD(P)H and collagen [12]. In this report fluorescence spectra from 7 
patients with BE were collected, corresponding to a total of 10 non-dysplastic sites and 5 
high-grade dysplastic lesions. Physical models were then applied to the measured spectral 
data for the quantification of tissue properties. It was found that low collagen and high 
NAD(P)H fluorescence were associated with high-grade dysplastic lesions when compared 
with non-dysplastic tissues. With this information it was possible to describe in an objective 
way significant biochemical changes between normal and dysplastic tissues. 
3.5 Spectroscopy models 
As described in section 3.4, different methods and models can be applied to analyze 
spectra and to develop a diagnostic algorithm. These models can be qualitative or empirical 
(e.g. the ratio of two intensity values), or quantitative. Quantitative models have the huge 
advantage to quantitative determine different tissue properties.  
Thus, this section will describe the physical models that have been developed to be 
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applied to the measured diffuse-reflectance and fluorescence spectra to extract physical 
properties of the tissues. This is performed in order to develop any relevant and useful 
diagnostic algorithms that provide objective diagnostic differences between normal and 
malignant tissues, based on physiologically understood quantities of tissue constituents. 
3.5.1 Diffuse-reflectance spectroscopy 
A well-developed model [10], based on the diffusion approximation to the radiative 
transfer equation, enables the extraction of quantitative information about tissue constituents 
that contribute to reflectance. The radiative transfer equation describes light propagation in 
turbid media. The diffusion approximation assumes that light transport is dominated by 
scattering, and is not valid in highly absorbing or very dilute samples. Also, for very small 
source-detector separations (i.e. less than 0.2 mm) the diffusion approximation may not be 
valid since light may not experience sufficient scattering events before being collected [19]. 
This model, developed by Zonios et al. in 1999 [10], was based on a previous study by Farrell 
et al. [33]. This section will not discuss in detail the Farrell’s model, but the reader is referred 
to the literature for further information [33]. 
In the Zonios et al. model [10] three fundamental approximations were made to model 
DRS and determine the tissue biochemical and morphological parameters: (1) light is 
delivered to the tissue in an infinitesimally small point (point source); (2) hemoglobin is the 
only significant absorber in the visible range; (3) the scattering is modeled as if tissues were 
homogeneous systems of spherical particles with known refractive index. This last 
approximation allowed the characterization of tissue scattering in terms of the effective 
scatterer size and the effective scatterer density. The diffuse-reflectance measured by an 
instrument can then be expressed as: 
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  The radius of the circular collection spot,   
 , is an empirically determined value, 
derived by calibrating the spectroscopy instrument with a phantom (a physical tissue model, 
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with known scattering and absorption properties) [19]. Also, in equation 3.1: 
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where   
  and    are the reduced scattering and absorption coefficients of the tissue, 
respectively. 
To account for the refractive index mismatch between the tissue and the surrounding 
environment (usually air), the term    describes the internal reflection at the interface, and is 
expressed as the following equation: 
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where         and      correspond to the refractive indices of tissue and air, respectively. The 
critical angle for total internal reflection is defined as    [4]. 
In the DRS analysis, the experimentally measured reflectance spectra are fit to the 
described Zonios et al. model to determine the values of two key parameters that describe the 
light-tissue interactions:   
  and   . The reduced scattering and absorption coefficients 
represent the approximate number of scattering or absorption events that a photon undergoes 
while propagating a certain distance in the medium. The inverse of these coefficients values 
represents the average distance traveled by a photon before being scattered or absorbed. Both 
parameters are wavelength-dependent [18].  
The reduced scattering and absorption coefficients can be expressed as [3, 34]:  
  
       (
 
  
)
   
   (
 
  
)
  
 (3.7) 
                   
             (3.8) 
In equation 3.7,   is the wavelength and    is equal to 700 nm (   is the reference 
wavelength for the extraction of parameter As). The second term is used to accurately model 
reflectance at wavelengths below 400 nm, in which scattering from Rayleigh particles is 
significant [3, 34].  
For equation 3.8       is a correction factor to account for the vessel packaging effect. 
This effect accounts for alterations in the shape and intensity of hemoglobin absorption peaks, 
related to the fact that hemoglobin is restrained to finite-sized blood vessels that are more or 
less transparent to light depending on the incident wavelength. In equation 3.8,   
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   and corresponds to the volume fraction of blood sampled. In this expression 
    is the total concentration of hemoglobin, and 2.3  10
-3
 mol/L is the value assumed for the 
hemoglobin concentration of whole blood.       is defined by: 
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where     is the effective blood vessel radius and   
         is the absorption coefficient of 
whole blood: 
  
                                 (                     )        (3.10) 
where   is the hemoglobin oxygen saturation;       and     are the molar extinction 
coefficient spectra of the oxygenated and deoxygenated hemoglobin, respectively.  
As previously mentioned, the measured reflectance spectra are fit to the Zonios et al. 
model, usually over the 350 to 750 nm spectral range, using a nonlinear least-squares fitting 
algorithm. From the fitting, six DRS parameters, which translate six different tissue properties, 
are extracted for each spectrum: As, related to scatterer density and the overall magnitude of 
scattering; Bs, related to the average scatterer size; Cs, related to scattering by small particles; 
   , the total concentration of hemoglobin;    , the effective blood vessel radius; and α, the 
oxygen saturation of hemoglobin.   
3.5.2 Intrinsic fluorescence spectroscopy 
During propagation through the tissue, fluorescence photons are strongly influenced 
by the tissue’s turbidity (scattering and absorption), which can introduce significant 
distortions in the spectra lineshape and intensity. As a result, the measured fluorescence 
(known as bulk fluorescence) is not simply the intrinsic fluorescence from tissue fluorophores, 
i.e., it is not simply a linear sum of the intrinsic fluorescence of the endogenous fluorophores. 
This prevents the quantitative extraction of specific biochemical tissue constituents [3, 35]. 
The IFS algorithm is based on the photon migration model of Wu et al. [36] and 
extracts intrinsic fluorescence spectra combining the fluorescence and diffuse-reflectance 
spectra measured at the same tissue site. With this algorithm the intrinsic fluorescence can be 
determined by the ratio of bulk fluorescence to a function of reflectance. Since fluorescence 
and reflectance photons are affected similarly by scattering and absorption, the division of 
fluorescence by reflectance allows one to obtain the fluorescence not affected by scattering 
and absorption (i.e. the effects of turbidity are accounted and corrected).  
 The analytical model to determine IFS is expressed as [35, 37]: 
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(3.11) 
where, Sp and l represent geometric parameters of the spectroscopy instrument, and g is the 
anisotropy coefficient. The anisotropy coefficient represents the direction of scattering, and 
can vary from -1 (scattering is in the backwards direction) to 1 (all light is scattered in the 
forward direction). If g = 0, scattering is isotropic.  
In equation 3.11, fi and Fi correspond to the intrinsic and bulk fluorescence, 
respectively, and    and    are the excitation and emission wavelengths (e.g.       is the 
reflectance at the excitation wavelength).   corresponds to the experimentally measured 
diffuse-reflectance, whereas    represents the diffuse-reflectance that would be measured in 
the absence of absorption.    can be calculated using equation 3.1 and setting    to zero. 
Also, in equation 3.11, the scattering coefficient,   , can be calculated using parameters As, Bs 
and Cs, and coefficient  , with the following expression: 
  
          (3.12) 
Typical values of g for tissue are in the range of 0.7 to 0.95 [19, 35]. 
The combination of the two spectroscopy techniques - DRS and IFS - increases the 
amount of information that can be obtained from tisues, which in turn potentially improves 
the diagnostic accuracy of the developed algorithms for the differentiation of dysplastic and 
normal esophageal tissue. 
3.6 Spectroscopy models implementation: wavelength reduction study 
As mentioned in Chapter 1, one of the main goals of this thesis is to develop a 
miniaturized spectroscopy system. In conventional spectroscopy instruments, the 
discrimination of the different wavelengths is usually achieved in steps of 1 nm, using a 
spectrograph. However, it is difficult to integrate a spectrograph into a small-scale instrument 
and, this way, the discrimination of the different wavelengths has to be achieved using other 
approach: a narrow-band optical filtering system (the full miniaturized spectroscopy system 
and its components will be described in Chapter 4). As a consequence, this scale-down 
precludes the discrimination of the intensity at all wavelengths (i.e. with steps of 1 nm), which 
may be necessary for the quantification of tissue properties, using the described analytical 
models. To cover the full visible spectrum, it would be necessary to fabricate an extremely 
high number of filters, thus compromising the device small size.  
The use of a few optical filters, centered at discrete locations of the visible spectrum, 
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would be enough for an empirical diagnosis, based, for instance, in the ratio of the intensity at 
two different spectral regions (e.g. red and green). This type of analysis is useful and 
simplifies the diagnostic method. However, the possibility to determine physiological 
quantities from tissue, by analyzing the measured spectra with analytical models, is a huge 
benefit of using spectroscopy. For that reason, the miniaturized system should be able to 
accomplish the quantitative extraction of tissue information. This way, a study was conducted, 
prior to the optical filtering system design and fabrication, to show the feasibility of using a 
small number of spectral regions to establish diagnosis. If successful, these results will 
demonstrate that it is possible to replace the spectrograph, used in conventional systems, by 
several optical filters. 
3.6.1 Wavelength reduction analysis 
The possibility of replacing the spectrograph by a series of optical filters for the 
diagnosis of esophageal dysplasia was investigated using an existing spectroscopy data set, 
composed by fluorescence and diffuse-reflectance measurements. These data were taken from 
esophageal tissue using a system described elsewhere [9]. For this study, simulations on 
wavelength reduction were performed on the data set in order to assess the feasibility of 
reducing the 400 wavelengths used to perform a quantitative diagnosis (from 350 to 750 nm, 
in 1 nm steps) to only 16, while still achieving a good accuracy in the extraction of tissue 
optical properties (sixteen was considered the minimum number of wavelengths from which 
one could accurately extract tissue information, as will be detailed in section 3.6.2).  
For the wavelength reduction analysis, diffuse-reflectance and fluorescence algorithms 
(detailed in section 3.5) were implemented using MATLAB tools (from The MathWorks
TM
). 
Based on previously published results [9], several slightly different combinations of 16 
wavelengths were chosen and simulated. For all the simulations the following wavelengths 
were fixed: 350 and 750 nm (the first and last wavelength in the analysis); 420, 540 and 580 
nm (corresponding to HbO2 absorption peaks); and 700 nm (reference wavelength). The 
remaining wavelengths were selected within the full visible range. The spacing between 
selected points must take into account the filters fabrication constraints, namely their FWHM 
(Full-Width-Half-Maximum), i.e., the filters transmittance spectrum should not considerably 
overlap. Thus, the best 16 wavelengths group is composed by those 6 fixed points and by 10 
more wavelengths that are more or less equally spaced along the visible spectrum and 
correspond to filters which by design don’t overlap. 
The diffuse-reflectance and fluorescence data were then processed and data points 
from all wavelengths were eliminated, with exception for those corresponding to the selected 
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16 wavelengths. Thus, instead of having a continuous array of 400 wavelengths (from 350 to 
750 nm), and the corresponding reflectance and fluorescence intensity values, a discrete set of 
16 specific data points is obtained. The remaining spectrum intensities are achieved by linear 
interpolation within the range of the discrete data set. These newly generated spectra are then 
used to extract the tissue spectroscopy parameters. In the system to be developed, the 16 
optical filters, together with the detection system, will directly provide these 16 intensity 
values from which the spectra will be reconstructed. In this procedure unknown data points 
are being calculated, and therefore one must be aware that the results might not be exactly the 
same as when using the original spectrum. Still, the overall advantages of having a 
miniaturized system may offset the error.  
3.6.2 Wavelength reduction simulations 
The selection of wavelengths for the design of the optical filters (each filter will be 
centered at a different wavelength) was based on simulations of wavelength reduction on an 
existing spectroscopy data set. The data set consisted of 53 histologically confirmed non-
dysplastic tissue sites and 10 high-grade dysplastic esophageal tissue sites. The goal is to 
investigate if it is possible to accurately extract tissue properties using reflectance and 
fluorescence intensity values of only 16 wavelengths, and interpolating the remaining 
spectrum intensities to cover the whole visible range. 
For the simulations diffuse-reflectance and fluorescence parameters were extracted 
from high-grade dysplastic and normal squamous esophageal tissue. Several combinations of 
16 wavelengths were simulated. The combination that provided the best results comprises the 
following discrete points: 350, 370, 380, 400, 420, 450, 480, 510, 540, 560, 580, 600, 620, 
650, 700, and 750 nm. As previously mentioned, for the wavelength selection a compromise 
between the accuracy in parameters extraction and the constraints inherent to the filters 
fabrication process (e.g. materials, number of layers, FWHM, and maximum transmission) 
had to be achieved. This wavelength choice is very important for the intended diagnosis and 
highly depends on the clinical situation for which the system is going to be used for. Since the 
esophagus is expected as the first application of the microsystem, the used clinical data set is 
appropriate for the simulations. Representative diffuse-reflectance and intrinsic fluorescence 
spectra of HGD and non-dysplastic squamous tissue are shown in Figure 3.3 and in Figure 3.4. 
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(a) (b) 
Figure 3.3:  Representative diffuse-reflectance spectra for normal (upper line) and dysplastic tissue (bottom 
line), for (a) the full wavelength range (b) and only 16 wavelengths.  
  
(a) (b) 
Figure 3.4:  Representative intrinsic fluorescence spectra for normal (upper line) and dysplastic tissue (bottom 
line), for (a) the full wavelength range (b) and only 16 wavelengths. 
For the diffuse-reflectance data, the reduced scattering and absorption coefficients,   
  
and   , respectively, were determined for 16 different wavelengths, using the original 
spectrum and the reconstructed spectrum of high-grade dysplastic and non-dysplastic tissue 
sites (Figure 3.5). The algorithm described in section 3.5.1 was used for the calculation of 
these coefficients. In general, the extracted coefficients obtained using the reconstructed 
spectrum are in good agreement with the coefficients extracted from the original spectrum, 
with a strong and positive correlation: correlation coefficients of 0.951 and 0.933 for the 
reduced scattering coefficient of HGD and non-dysplastic tissue sites, respectively; and, 0.966 
and 0.987 for the absorption coefficient of HGD and non-dysplastic tissue sites, in that order. 
Thus, it is expected that the miniaturized system and the conventional systems will have 
comparable performance in the quantification of tissue optical information.  
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(a) (b) 
Figure 3.5:  Scatter plots with the (a) reduced scattering coefficient and (b) absorption coefficient, determined 
for several different wavelengths: 350, 370, 380, 400, 420, 450, 480, 510, 540, 560, 580, 600, 620, 
650, 700, and 750 nm. For each of these wavelengths, a different coefficient will be determined in 
each tissue site: a total of 10 high-grade dysplastic tissue sites and 53 non-dysplastic tissue sites 
were used, corresponding to 160 (10 times 16) and 848 (53 times 16) different values of reduced 
scattering and absorption coefficient. Y-axis represents the values of the coefficients extracted 
with the original spectrum; X-axis represents the values of the coefficients determined with the 
reconstructed spectrum, using only 16 points. The 45 degree black line represents a perfect 
agreement between the expected values, from the original spectrum, and the extracted values, from 
the reconstructed spectrum. 
An even more reduced number of wavelengths for spectra analysis could be useful to 
further reduce the size and complexity of the optical filtering system. However a trade-off 
between this number and an accurate extraction of optical parameters had to be achieved. 
Sixteen was considered the limit beyond which one could accurately determine those 
parameters.  
For demonstration, Figure 3.6 presents the same results of Figure 3.5 but extracted 
using only 10 wavelengths (350, 380, 400, 420, 480, 540, 580, 600, 700 and 750), instead of 
16. In this approach, the extracted coefficients using the reconstructed spectrum have weaker 
correlations with the coefficients determined from the original spectrum, when compared with 
the previous strategy. Specifically, for the reduced scattering coefficient of non-dysplastic 
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tissue sites, there is a weak and not very significant correlation between the expected and 
extracted values, with a correlation coefficient of 0.326. From the obtained results it is clear 
the performance improvement of using 16 over 10 wavelengths for quantitative spectroscopy.  
  
  
(a) (b) 
Figure 3.6:  Scatter plots with the (a) reduced scattering coefficient and (b) absorption coefficient, determined 
for several different wavelengths: 350, 370, 380, 400, 420, 450, 480, 510, 540, 560, 580, 600, 620, 
650, 700, and 750 nm. Y-axis represents the values of the coefficients extracted with the original 
spectrum; X-axis represents the values of the coefficients determined with the reconstructed 
spectrum, using only 10 points. 
The theoretical performance of the miniaturized system to extract tissue properties 
from the reflectance and fluorescence signal was then assessed. Scatter plots displaying the 
expected (using the full spectrum) and extracted (using only 16 wavelengths) parameter 
values, or tissue components values, are presented in Figure 3.7 for the six DRS parameters: 
three parameters extracted from the reduced scattering coefficient (As, Bs, and Cs), and three 
parameters extracted from the absorption coefficient (    , α, and    ).  
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Figure 3.7:  Scatter plots with the tissue parameter values for the six diffuse-reflectance parameters: As, Bs, Cs, 
   , α, and    , extracted using the full spectrum (expected values) and only 16 wavelengths 
(extracted values).  
In Figure 3.8 the correlations between the extracted and expected values of the relative 
contributions of two fluorophores (collagen and NAD(P)H) for the overall tissue fluorescence 
are also displayed in scatter plots. These tissue parameters are extracted from the intrinsic 
fluorescence spectra, which are obtained from the bulk fluorescence spectra in combination 
with the reflectance spectra, after a tissue excitation using 340 nm light. The intrinsic 
Spectroscopy systems for the detection of gastrointestinal dysplasia Chapter 3  
  47/137 
fluorescence spectra are then fit using a linear combination of the tissue fluorophore basis 
spectra. The tissue fluorophores basis spectra are extracted using multivariate curve resolution 
[34, 38]. For the particular excitation wavelength used (340 nm) the intrinsic fluorescence can 
be modeled as a linear combination of two spectral components: NAD(P)H and collagen. 
  
 
 
 
Figure 3.8: Scatter plots with the tissue parameter values for two fluorescence parameters: collagen and 
NAD(P)H, extracted using the full spectrum (expected values) and only 16 wavelengths (extracted 
values).  
Overall, the reported results demonstrate that reflectance and fluorescence tissue 
properties can be relatively well determined using a reduced number of wavelengths, and thus 
these parameters can be used with confidence for the development of predictive models, or 
diagnostic algorithms, to identify normal and malignant tissues. Still, for some tissue sites, 
optical parameters could not be accurately extracted, which might be due to loss of spectral 
information with interpolation. Among the tissue parameters, the oxygen saturation (α) and 
the vessel packaging (   ) correspond to the ones with the worst correlation coefficients. In 
particular, the correlation for the hemoglobin oxygen saturation values can be considered low 
or not very significant. This way, this tissue property should not be incorporated in the 
diagnostic algorithms to be developed with the miniaturized system because it cannot be 
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accurately estimated using a reduced number of wavelengths. For the remaining parameters 
there is a very strong and positive correlation between the expected and extracted values, with 
a mean correlation coefficient equal to 0.913. 
The use of a different interpolation method could minimize the errors in the 
quantitative extraction of tissue properties. Therefore, in the future, an alternative approach 
should be evaluated: a model discretization should be applied and the parameter results should 
be compared to the ones obtained using linear interpolation. 
This rough methodology was applied as an initial approach to select the 16 central 
wavelengths for fabricating the optical filters, and to demonstrate the feasibility of wavelength 
reduction for the assessment of tissue optical properties. In general, the 16 selected 
wavelengths provide good results, and, this way, it is now possible to move to the filters 
design and fabrication steps. 
3.6.3 Wavelength reduction measurements using tissue phantoms 
Before starting the filters design, it was decided to test the 16 selected wavelengths in 
a series of experiments using homogeneous physical tissue models (“phantoms”) with known 
scattering and absorption parameters. This was done to further evaluate the capability of a 
miniaturized spectroscopy system to accurately extract tissue optical properties using only 16 
wavelengths. These phantoms consist of mixtures of intralipid and hemoglobin at various 
concentrations (Sigma Aldrich Co.) and water. The intralipid and the water soluble 
hemoglobin are used for scattering and absorbing, respectively. Two groups of phantoms 
were measured by DRS: the first was composed by phantoms with different concentrations of 
hemoglobin and a fixed intralipid concentration; the second consisted of phantoms with 
variable intralipid concentrations and a fixed hemoglobin amount. A solid sample of barium 
sulfate (BaSO4) was used as a reflectance standard. A UV/visible/near-infrared 
spectrophotometer from Shimadzu (UV-3101PC) was used to measure the wavelength-
dependent reflectance spectra from the phantoms.  
Several measurements were performed on phantoms in a range of absorbing and 
scattering concentrations. The collected spectra were normalized by the reflectance spectra 
measured from the standard to correct for the wavelength dependent response of the system. 
Figure 3.9 shows the reflectance spectra taken from the same position on different phantoms 
using the full wavelength range (350-750 nm, with increments of 1 nm) and using only 16 
wavelengths. These 16 data points will be the signal that will be read by the photodiodes. 
Diffuse-reflectance parameters are subsequently extracted using the MATLAB implemented 
diffuse-reflectance model. 
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(a) (b) 
Figure 3.9:  Reflectance spectra measured from different tissue phantoms (phantom 3: blue line; phantom 4: 
black line; phantom 5: red line): (a) using the full wavelength range; (b) and only 16 wavelengths. 
The best fit spectra according to the implemented diffuse-reflectance model are also plotted 
(dashed lines). 
Table 3.2 summarizes the extracted values for parameters As and    , from the 
different phantoms. The value of As increases with intralipid concentration, as expected. The 
value of     is very similar to the expected value with less than 10% difference. Since all the 
phantoms were exposed to air during the measurements, the hemoglobin oxygen saturation is 
set equal to 1.0 for the analysis. 
Table 3.2:  Reflectance parameters extracted from tissue phantoms. 
   Full spectrum  16 wavelengths 
Phantom 
Intralipid mass 
concentration 
Hemoglobin 
concentration (mg/mL) 
     As       As  
1 0.5% 0.5 0.496 0.803 0.473 0.811 
2 0.5% 1.0 0.954 0.783 0.964 0.782 
3 1% 0.25 0.254 1.740 0.245 1.745 
4 1% 0.5 0.478 1.650 0.464 1.650 
5 1% 1 0.994 1.635 1.047 1.623 
 
The use of the full wavelength range to measure diffuse-reflectance or the use of only 
16 wavelengths seems to provide very comparable results in terms of optical properties in 
tissue physical models, as it was already expected by the previously shown wavelength 
reduction simulations.  
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Miniaturized Spectroscopy 
System: Components Design 
and Fabrication 
 
This Chapter describes the miniaturized spectroscopy system that can be integrated in 
less-invasive medical devices to improve the detection of esophageal dysplasia. This system is 
based on a narrow-band pass filter array and silicon photodiodes for the selection and 
detection of different spectral bands significant for diagnosis. The design, fabrication and 
characterization of the thin-film optical filters that compose the filtering array are exposed. 
The Chapter is concluded with a brief description of the photodiodes detection system. 
4.1 System overview 
Different studies have successfully applied DRS and FS for detecting and classifying 
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dysplasia or cancer in the esophagus [1-7]. The used research prototypes, usually composed 
by a spectrograph, a detector and optical fibers, are accurate in the identification of dysplasia, 
and, in some studies, in the quantification of tissue properties.  
However, these prototypes (not yet commercially available), designed to perform DRS 
and FS, suffer from several drawbacks. Regular optical fibers usually have low-collection 
efficiency, thus requiring high-quantum efficiency detectors (e.g. CCDs). Also, the detector is 
placed at the distal end of the collection fiber, where considerable light might be lost [8]. In 
addition, these research prototypes include costly, bulky and sophisticated illumination 
equipment (e.g. xenon arc lamps, UV lasers). Beyond the disadvantages already listed, 
catheter-based endoscopy systems using long optical probes are invasive and very 
uncomfortable for the patient.  
Therefore, the development of a low-complexity, miniature, and cost-effective 
spectroscopy system without the need of optical fibers, spectrograph or CCD cameras could 
potentially increase the collection efficiency, while simplifying the device. Moreover, such a 
system could be integrated in small and less-invasive devices, such as the EC, for the 
assessment of esophageal tissue. 
 Previous studies have aimed to develop a system with some of these features using 
LEDs as the illumination sources and photodiodes as the detector [8-9].  Yu et al. [9] 
developed an optical device able to quantitatively assess tissue optical properties using a 
silicon photodiode for detection. However, a xenon lamp, a monochromator and optical fibers 
were still used. Lo et al. [8] described a spectroscopy system that can integrate LEDs for 
illumination for wavelength selection, and silicon photodiodes for detection. Even though this 
study represents a big step towards decreasing the cost and size of conventional spectroscopy 
systems, only five LED wavelengths are used, which may not be enough to perform 
quantitative spectroscopy and accurately extract other tissue optical properties besides 
hemoglobin. The addition of extra LEDs, with an approximate size of 1 mm, can compromise 
a full integration and size reduction.  
In this thesis Chapter it is proposed the development of a potentially robust sub 
millimeter narrow-band pass filter array that offers prospects for a simplified miniature 
spectrographic detector that can be integrated, in the future, in a diagnostic device to improve 
the identification of dysplasia. The proposed miniaturized spectral instrument is based on 
thin-film optical filters and silicon photodiodes for wavelength selection and signal detection, 
respectively (Figure 4.1). The narrow-band pass optical filters are centered at 16 specific 
wavelengths, identified in the feasibility study described in Chapter 3, section 3.6. 
Up to the moment, it was not yet developed a miniaturized device that is able to 
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integrate both FS and DRS functions for early cancer diagnosis. The designed instrument has 
three major advantages over other spectroscopy systems: (1) it is miniaturized, and thus 
suitable for a future integration in a less invasive medical device; (2) it integrates components 
that are compatible with standard microelectronics fabrication techniques (complementary 
metal oxide semiconductor – CMOS); and, (3) it is able to combine two different 
spectroscopy techniques – diffuse-reflectance and fluorescence.  
 
(a) 
 
(b) 
Figure 4.1:  Spectroscopy systems. (a) Conventional system with excitation and collection fibers, white-light 
and UV illumination sources, spectrograph and CCD for detection. (b) Miniaturized system with 
LEDs as light sources, optical filters and photodetectors for wavelength selection and detection, 
respectively (not scaled). Data transmission is intended to be wireless. 
System components 
As previously mentioned, the designed system is composed of thin-film optical filters 
and silicon photodiodes that will, respectively, select and detect several light wavelengths. 
Overall, the miniaturized instrument is composed by a 16 narrow-band pass filter array (4 by 
4), placed on top of an array of 16 silicon photodiodes. All the 16 filters have a Fabry-Perot 
multilayer structure made with dielectric materials that are compatible with CMOS fabrication 
techniques (which is an asset towards the development of a fully miniaturized device, in a 
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single chip). Also, the use of all-dielectric layers allows a narrow and a high peak 
transmittance spectral band, as required for the application [10-12]. The reader is referred to 
section 4.2 for more details about the filters structure and materials.  
In addition, commercial small-size UV and white LEDs should be incorporated in the 
system as the illumination sources for FS and DRS measurements, respectively. UV LEDs are 
already available at the die level (Nitride Semiconductors Co., Ltd., The Fox Group Inc., 
among others) whereas white LEDs with high luminous efficiency have already been 
developed [13]. The use of these components obviates the need for sophisticated and 
expensive illumination and detection equipment, and optical fibers to deliver and collect light 
from tissues.  
Once a CMOS co-integration process is used, the array area can be scaled down to 
approximately 200200 μm2. The final encapsulation of the dies on a single chip also requires 
some space for wiring that will depend on the number of bonding pads (each bonding pad has 
a maximum size of 100100 μm2) and the encapsulation package. Still, it is expected that the 
final miniaturized device will not exceed a few millimeters (less than 10 mm
2
). The 
fabrication of the system in a compatible CMOS process will also allow the mass production 
of the microsystem at reduced costs.  
4.2 Thin-film optical filters 
The feasibility study described in Chapter 3, section 3.6, provided the group of the 16 
wavelengths that better fits the original continuous spectrum. These 16 wavelengths will be 
selectively detected using thin-film optical filters.  
To better understand the performance of thin-film optical filters, it is necessary to 
accept three statements [12]: 
(1) The amplitude of the reflected light at any interface between two media is given by 
             , where    is the ratio of the refractive indices (n). The reflectance is 
defined as the square of the amplitude. 
(2) There is a phase shift of 180º when the reflectance occurs in a medium that has 
lower refractive index when compared with its adjacent medium; there is a phase shift of 0º 
when the reflectance occurs in a medium that has higher refractive index when compared with 
its adjacent medium. 
(3) When the light is split into two components by reflection at the top and bottom 
interfaces of a thin-film, these components will recombine such that: the resultant amplitude 
is the difference between the amplitudes of the two components, when there is a phase shift of 
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180º - beams interfere destructively; or the resultant amplitude is the sum of the amplitudes of 
the two components, when there is a phase shift of 0º - beams interfere constructively. 
As an example, a high-reflective thin-film multilayer structure can be built using a 
stack of alternate high and low refractive index films, as shown in Figure 4.2. 
 
Figure 4.2:  Thin-film multilayer structure [12]. 
In this case, the various components produced by reflection at the different interfaces 
will reaper at the first interface all in phase, and, therefore, the beams will recombine 
constructively. This way, it is possible to increase the reflectance of a structure, by increasing 
only the number of layers. 
In these high-reflective structures, the reflectance is high only within a limited range 
of wavelengths; outside this range, the reflectance drops to low values. This way, the 
combination of several films or layers with specific thicknesses results in a reflectance 
spectrum with maxima and minima at specific wavelengths. Due to this behavior, thin-film 
multilayer structures, such as the one in Figure 4.2, can be used as filters. The filter 
characteristic in reflection is the complement of that in transmission, when the absorptance 
equals to zero. 
The design of a thin-film multilayer structure to be used as an optical filter is not a 
straightforward process merely based on calculations of the properties of the multilayer. It is a 
difficult and time consuming process that requires analytic calculations, computational 
simulations and a final structure optimization [12]. 
The first step of this whole process is to develop a possible structure for the filter, 
using analytical analysis and well-known building blocks. Besides the performance 
specifications of the filter, the materials to be used are also needed to start the design. The 
second step involves testing the performance of this initial structure on a computer. The 
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results will determine if adjustments to the design are needed or not. These adjustments can 
be done by a computer, or by additional calculations. A final refinement to the filter’s design 
involves an enormous number of parameters, which represent many possibilities of 
adjustment to match the designed performance with the desired performance. This is, perhaps, 
the most extensive and cumbersome step. 
4.2.1 Basic theory 
In this section it will be described some basic theory which is necessary to understand 
and make the calculations for the design of the multilayer thin-film filters. A summary of the 
main results will be provided. The reader is referred to the literature for a detailed description 
of the presented theory [12, 14-15]. 
Maxwell’s equations and electromagnetic waves 
Light is an electromagnetic wave, and therefore, the propagation of light in a thin-film 
multilayer structure is defined by the Maxwell equations. In an isotropic and uniform media 
these are [12, 15]: 
     
  
  
 (4.1) 
      
  
  
 (4.2) 
      (4.3) 
      (4.4) 
 
where   is the electric field strength,   is the magnetic field strength,   is the electric 
displacement, and   is the magnetic flux density or magnetic induction. Also,   represents the 
electric current density and   the electric charge density. 
The electric current density and the electric displacement relate with the electric field 
strength in the following way: 
     (4.5) 
     (4.6) 
 
where   is the electric conductivity and   is the electric permittivity of the medium. 
The magnetic flux density also relates with the magnetic field strength with the 
following expression: 
     (4.7) 
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where   is magnetic permeability of the medium. 
In free space, the electric permittivity and magnetic permeability are important 
constants with the following values: 
                   
         (4.8) 
             
       (4.9) 
 
 The permittivity of free space can be expressed as: 
   
 
      
 (4.10) 
 
where   is a constant identified as the velocity of light in a vacuum or in free space:   
                   . 
The following analysis is brief, and for further details the reader is referred to the 
literature in which this analysis was based [12, 15]. 
For this analysis, it will be considered a medium free of sources for the electric and 
magnetic fields, this is,     and    . The Maxwell’s equations for source free media 
show that the electric and magnetic fields are coupled: variations in the electric field act as a 
source for the magnetic field, which in turn acts as a source for the electric field, and so on. 
The electric and magnetic field can be seen as a unique entity (the electromagnetic field) and 
are mutually compatible: changes in one generate the other. 
In this case, equation 4.1 can be solved using equations 4.2, 4.3, 4.6, and 4.7, to obtain 
the following expression:  
      
  
   
  (4.11) 
 
Using the same procedure, it is possible to obtain the next equation for the magnetic 
induction: 
      
  
   
  (4.12) 
 
Equations 4.11 and 4.12 are wave equations that can be related to the velocity of light 
in a medium,  , with the following expression: 
  
 
√  
 (4.13) 
 
The ration between the velocity of light in a vacuum,  , and the velocity of light in a 
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specific medium,  , defines the refractive index of that medium,  : 
  
 
 
 √
  
    
 (4.14) 
In general, the magnetic properties of the medium have a negligible effect on the 
velocity of light propagation. For this reason one can consider      [15]. This way, the 
refractive index of a medium is basically determined by its permittivity,  , which depends on 
the frequency of the incident electromagnetic wave. 
Equations 4.11 and 4.12 have the following solutions for plane waves: 
    {   
           } (4.15) 
    {   
           } (4.16) 
 
where Re indicates the real part (the physical fields are always given by the real part of the 
complex fields that appear in the expressions),    and    represent the amplitudes of the 
oscillations, ω is the angular frequency,  is the phase of the wave,   is the position vector, 
and   is the wave vector, being defined as: 
| |    
   
 
 (4.17) 
where   is known as the wavenumber. 
The frequency,  , and the wavelength,  , of an electromagnetic wave are given by: 
  
 
  
 (4.18) 
  
  
 
 (4.19) 
 
An important feature of electromagnetic waves is that they are a form of energy 
transport. The electromagnetic energy density,  , can be defined as: 
  
 
 
          (4.20) 
 
The energy flux across unit area, in the wave propagation direction, is known as 
Poynting vector,  : 
      (4.21) 
The optical admittance of a medium is another important concept for the design of 
thin-film structures: it defines how easy or hard it is for light to pass through it. For free space 
it can be expressed as: 
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  √
  
  
               (4.22) 
 
The optical admittance of a material is numerically equal to its refractive index,  . The 
optical admittance, or the refractive index, connects the electric and magnetic fields,   and  , 
respectively, through the following expression: 
  
 
 
 (4.23) 
Thin-film structures 
A thin-film structure, with more than one interface or boundary, is schematically 
represented in Figure 4.3.  
For the analysis of light propagation in this thin-film structure, it is convenient to 
define the direction of incidence of the waves using a symbol + for waves that are in the 
direction of incidence (i.e. positive-going), and a symbol – for waves that are in the opposite 
direction (i.e. negative-going) [12, 16]. 
 
Figure 4.3:  Plane wave incident on a thin-film structure [12]. 
Considering now the interface between the film and the substrate (boundary b), there 
are no negative-going waves in the substrate, and the waves in the film can be summed into 
one resultant positive-going wave and one resultant negative-going wave. This way, it can be 
defined: 
      
     
  (4.24) 
        
       
  (4.25) 
 
where 
   
  
 
 
(
  
  
   ) (4.26) 
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   ) (4.27) 
   
       
  
 
 
          (4.28) 
   
        
  
 
 
          (4.29) 
 
The fields at the interface a, at the same instant and at the same point, can be 
determined by changing the phase factors of the waves, in order to allow a shift in the z 
coordinate, from 0 to – d. The phase factor of the positive-going wave will be multiplied by 
      , while the phase factor of the negative-going wave will be multiplied by        , 
where 
  
         
 
 (4.30) 
 
  represents the physical thickness of the film, and   represents the angle of incidence.   is 
known as the phase thickness and corresponds to the phase shift experienced by the wave as it 
traverses a distance   normal to the boundary [12, 16]. 
The optical path length      , which is defined as the distance traveled in an thin-
film by light, can also be expressed in the following way: 
            (4.31) 
The values of   and   at interface a, can now be defined as: 
   
  
 
 
(
  
  
   )  
  (4.32) 
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   (4.33) 
   
  
 
 
          
  (4.34) 
   
  
 
 
          
   (4.35) 
 
Using equations 4.32 to 4.35: 
      
     
    (
      
 
)    (
      
   
)           
    
  
 (4.36) 
      
     
      (
      
 
)    (
      
 
)
                 
(4.37) 
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These last two equations can be written in matrix notation: 
[
  
  
]  [
    
    
  
          
] [
  
  
] (4.38) 
 
This relation connects the components of   and   at the incident interface, with the 
components of   and   that are transmitted through the final interface. The 2 by 2 matrix is 
known as the characteristic matrix of the thin-film [12, 16]. 
The optical admittance of the thin-film structure is defined similarly to equation 4.23: 
  
  
  
 (4.39) 
 
The reflectance of an interface between an incident medium of admittance    and a 
medium of admittance   is given by: 
  (
    
    
) (
    
    
) (4.40) 
 
Equation 4.38 can be normalized by dividing through by   : 
[
 
 
 
  
  
  
  ]
 
 
 
 [
 
 
]  [
    
    
  
          
] [
 
  
] (4.41) 
 
where   and   are the normalized electric and magnetic fields at the front interface. These 
quantities are used to extract the properties of the thin-film. From Equations 4.39 and 4.41, it 
can be written: 
  
  
  
 
 
 
 
             
     (
  
  
)     
 (4.42) 
 
From equations 4.40 and 4.42, the reflectance can be calculated: 
[
 
 
]  
known as the characteristic matrix of the assembly [12, 16]. 
All the above analysis was done for a single film. A similar methodology can be 
applied to an assembly of thin-films. In Figure 4.4 a structure with two thin-films is 
represented. 
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Figure 4.4:  Structure with two thin-films and three interfaces (a, b, and c) [12]. 
The characteristic matrix of the thin-film N2 can be expressed by: 
[
     
     
  
            
] (4.43) 
 
Applying equation 4.38, the parameters at the interfaces b and a can be obtained: 
[
  
  
]  [
     
     
  
            
] [
  
  
] (4.44) 
[
  
  
]  [
     
     
  
            
] [
     
     
  
            
] [
  
  
] (4.45) 
 
The characteristic matrix of the assembly is given by: 
[
 
 
]  [
     
     
  
            
] [
     
     
  
            
] [
 
  
] (4.46) 
 
This result can be generalized and extended for a multilayer of Z layers. The 
characteristic matrix of the assembly is the basis for many thin-film calculations, and is 
defined by the product of the individual matrices, in the correct order: 
[
 
 
]  {∏[
     
     
  
            
]
 
   
} [
 
  
] (4.47) 
 
with 
   
           
 
 (4.48) 
 
The suffix m denotes the substrate. If the angle of incidence,   , is known, it is 
, N0
, N1
, N2
, N3
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possible to determine the values of    using the Snell’s law: 
                        (4.49) 
The reflectance,  , of the assembly can be determined using equation 4.40. Replacing 
the   and using equation 4.42, the reflectance expression can be re-written: 
  (
     
     
) (
     
     
) (4.50) 
The transmittance,  , into the substrate is given by: 
  
           
      
 (4.51) 
Combining equations 4.50 and 4.51, it is possible to obtain the final expression for the 
transmittance: 
  
         
              
 (4.52) 
 
The absorptance,    , is a phenomenon that occurs when the incident light in a thin-
film is converted to another form of energy, usually heat, inside that thin-film [12, 16]. It can 
be related to the transmittance and reflectance through the following expression: 
          (4.53) 
Therefore, the equation to calculate the absorptance using equations 4.50 and 4.52 can 
be written: 
    
            
              
 (4.54) 
Dielectric thin-films: quarter- and half-wave optical thicknesses 
The characteristic matrix of a dielectric thin-film, for a normal incidence, can be 
simplified if the optical thickness (which in a transparent medium is the same as the    ) is 
an integer number of quarter-wave or half-wave thicknesses. 
If     ,        and       , so that the layer is an integer number of half- 
wavelengths thick,       , the matrix becomes: 
[
   
   
] 
This is the unit matrix and has no effect on the reflectance or transmittance of an 
assembly, this is, the structure behaves as if there were no thin-film layers deposited on the 
substrate.  
If    
 
 
,        and       , so that the layer is an odd number of quarter-
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wavelengths thick,       , the matrix becomes: 
[ 
 
 
  
] 
In this case, if a multilayer structure has an admittance  , the addition of an odd 
number of quarter-waves of admittance    will alter the admittance of the whole assembly to 
     . This way, it is easy to calculate the properties of an assembly of quarter-wave 
thickness layers. For example, for a stack of three layers, the admittance is: 
  
   
    
 
   
     
 
(4.55) 
From the above analysis, it is possible to conclude that, at a normal incidence, if the 
film has an     of                   , with x being an odd integer number, the reflectance 
of the assembly will have its maximum or minimum peak, depending if the   of the thin-film 
is higher or lower than the   of the substrate, respectively. For a thin-film with and     of 
                  , with x being an integer number, the reflectance of the structure will not 
vary compared with the reflectance of the substrate without a deposited thin-film [12, 16]. 
4.2.2 Optical filters design  
As previously explained, it is simpler to calculate the properties of assemblies using 
quarter- or half-wave optical thicknesses. Thus, the design of the optical filters will be 
specified in terms of fractions or quarter-waves at a specific reference wavelength. In a 
multilayer with two different dielectric materials, quarter-wave thickness layers are generally 
represented by Hn and Ln, depending if the material has the highest (Hn) or lowest (Ln) 
refractive index. On the other hand, half-wave thickness layers are denoted by Hn Hn or Ln 
Ln [12]. 
Next below, it is shown an example of a multilayer structure with half-wave and 
quarter-wave thickness layers, with air as the incident medium, and glass as the substrate [16]: 
Incident medium  Hn Ln Hn Ln Ln Hn Ln Hn Substrate (4.56) 
 
The thin-film stack matrices (Hn Ln Hn Ln Ln Hn Ln Hn) can be written as: 
[ 
 
 
  
]  [
   
   
]  [ 
 
 
  
]  [
   
   
] 
  
Therefore, from equation 4.46, the characteristic matrix of the assembly can be 
expressed as: 
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]  [
   
   
]  [
 
  
] 
  
Given that the refractive index of the substrate (glass) is equal to 1.52: 
     
        
The refractive index of the incident medium (air) is equal to 1. The reflectance and 
transmittance of the structure can be then calculated using equations 4.50 and 4.51: 
         
         
Structure 
A narrow-band optical filter can be built using an assembly of thin-films that produce 
simultaneously pass and rejection bands. The filtering array for the miniaturized spectroscopy 
system will have a Fabry-Perot interferometer structure, with a total of 11 layers of dielectric 
materials. This type of structure allows for a narrow-band thin-film filter: for collimated light, 
the transmittance will be low for all wavelengths, except for a series of very narrow 
transmission bands.  
The Fabry-Perot interferometers consist of two flat parallel mirrors (reflecting surfaces) 
separated by a pre-defined distance,   , with a resonance cavity in the middle (Figure 4.5) [12, 
17].  
 
Figure 4.5:  Structure of a Fabry-Perot filter [12]. 
When an incident wave reaches the first surface of the resonance cavity in the Fabry-
Perot assembly (Figure 4.6) it is divided into two waves: one reflected (R1) and the other 
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transmitted into the cavity (first dashed arrow). This transmitted wave will, in turn, reach the 
second surface of the resonance cavity and again will be divided into two waves: one 
transmitted (T1) and the other reflected back at the Fabry-Perot in the direction of the first 
surface (second dashed arrow). This process continues and is repeated along the entire Fabry-
Perot assembly. The total transmitted light corresponds to the sum of the contributions of all 
the transmitted waves (indicated in Figure 4.6 by the letter T). 
 
Figure 4.6:  Schematic diagram of the propagation of light in a Fabry-Perot assembly. 
If the reflectance of mirrors is sufficiently high [12], the total intensity of the light 
transmitted by the Fabry-Perot filter can be determined using the following expression: 
   
  
        
 
(4.57) 
 
where    is the intensity of the incidente beam, and   is a Fabry-Perot interferometer function, 
known as coefficient of finesse: 
  
  
      
 (4.58) 
 
As   increases, and thus as the mirrors reflectivity increases, the widths of the 
transmitted peaks become much narrower [12]. 
When the peaks are very narrow, light is transmitted only if the resonance cavity 
thickness,   , the refractive index,  , and the wavelength,  , satisfy the following relation: 
  
        
 
    (4.59) 
where   is the peak order. 
This way, for a specific separation between the mirrors, the Fabry-Perot filter, will 
transmit only the wavelength that satisfies equation 4.59. However, it is important to note that 
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the Fabry-Perot transmission pattern will repeat when   increases by  . 
As a simplified approach to make the filters analytical calculations it will be 
considered an order of 1 and a normal incidence of light. This way, the separation between the 
mirrors can be calculated as follows:  
   
 
  
 (4.60) 
where   is the specific wavelength that will be transmitted by the structure. From this 
expression, and for the transmission of the same wavelength, the thickness of the quarter-
wave layers in the Fabry-Perot assembly can be calculated using the equation: 
   
 
  
 (4.61) 
The transmitted peak FWHM, which corresponds to the width of the band measured at 
half the peak transmission, can also be determined for large values of   using the following 
approximation: 
     
 
√ 
 
     
√ 
 (4.62) 
The obtained results in sections 3.6.2 and 3.6.3 showed the viability of using 16 
wavelengths to extract tissue biochemical and morphological information. The selection of 
these 16 wavelengths will be achieved, as already mentioned, using a 16 narrow-band pass 
optical filter array.  An array of 16 optical filters was designed instead of a tunable optical 
filter since in the latter approach it is hard to guarantee a high degree of flatness and 
parallelism of the mirrors. A conventional tunable filter usually comprises an air-gap cavity 
and one movable mirror using, for example, electrostatic actuation. Some include 
simultaneous displacement sensing, resulting in adjustable mirror spacing. This approach has 
four disadvantages: (1) fabrication requires complex micromachining, which is difficult to be 
merged with a standard microelectronics process; (2) large voltages are required for actuation; 
(3) it is necessary electronics to control the mirrors adjustment, which increases the silicon 
area; and (4) operation is difficult, mainly for achieving parallelism between the mirrors 
during the tuning of the filter. A widely used alternative to solve the problem of maintaining 
parallel mirrors is the one reported here: an array of non-tunable devices with differently sized 
fixed cavity thicknesses. Such a device is relatively simple to operate. As a drawback, it 
requires a larger area (proportional to the number of differently sized cavities) when 
compared to the tunable filter [18-19]. 
The filtering array is composed of three groups of optical filters to cover different 
regions of the spectrum: (1) near-UV/violet (350 to 450 nm); (2) central band of the visible 
spectrum (480 to 600 nm); (3) red (620 to 750 nm). In each group, the quarter-wave layers of 
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the assembly will all have the same thickness (but, of course, the thickness of the high-
refractive index layers is different from the low refractive index layers). This way, in each 
region, the assembly of thin-films can be easily tuned to transmit a different wavelength by 
adjusting only the thickness of the resonance cavity, e.g., the 6th layer (Figure 4.5). This 
enables the fabrication of several optical filters in each region of the spectrum while 
minimizing the global deposition time. 
Materials 
The designed filters are all-dielectric assemblies, with the mirrors composed of a stack 
of TiO2 (titanium dioxide) and SiO2 (silicon dioxide) thin-films (high and low refractive index 
materials, respectively, in the visible spectrum) that offer good performance characteristics: a 
narrow and high peak transmittance spectral band; high reflectivity; and low absorption losses 
because of its transparency. Moreover, TiO2 and SiO2 have been selected because they can be 
co-integrated on CMOS, thus being compatible with standard microelectronics fabrication 
techniques (which is an asset towards the development of a fully miniaturized device, in a 
single chip). Also, their deposition process is well characterized, and the refractive index of 
SiO2 for the spectral band between 350 nm and 750 nm is almost wavelength independent [12, 
17, 20-22].  
As an approximation for the analytical calculations of the layer thicknesses in each 
group of filters, equations 4.60 and 4.61 were used, together with the refractive indices 
provided by the Sopra database [23]. Since, in each group, the goal is to tune the filters for 
different wavelengths by changing only one layer (i.e. the resonance cavity), the thicknesses 
of the quarter-wave layers have to be calculated using as reference a central wavelength 
(          ) in that specific group or region. This is, 
(1) For the near-UV/violet region:            is equal to 400 nm; and              
and             . Therefore, and according to equation 4.61, the thickness of the      
layers is approximately equal to 68 nm, while the thickness of the      layers is 
approximately equal to 30 nm. The resonance cavity spacing is equal to 136 nm for the 
transmission of that specific wavelength (i.e. 400 nm).  
(2) For the central band of the visible spectrum:            is equal to 550 nm; and 
             and             . This way, and according to equation 4.61 the thickness 
of the      layers can be approximated to 95 nm, while the thickness of the      layers can 
be approximated to 45 nm. The resonance cavity spacing is equal to 190 nm for the 
transmission of that specific wavelength (i.e. 550 nm). 
 (3) For the red region:            is equal to 680 nm; and              and 
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            . Thus, and according to equation 4.61, the thickness of the      layers is 
approximately equal to 117 nm, while the thickness of the      layers is approximately equal 
to 60 nm. The resonance cavity spacing is equal to 234 nm for the transmission of that 
specific wavelength (i.e. 680 nm). 
After these initial calculations, computational simulations were performed for the 
structural optimization of the optical filters and for the determination of the other resonance 
cavity thicknesses, in order to select the remaining 13 wavelengths. All the determined 
thicknesses are indicated in Table 4.1. It was not possible to determine a thickness for the 
resonance cavity of the filter centered at 350 nm, as will be explained next in section 4.2.3. 
Table 4.1:  Layer thicknesses of the 16 Fabry-Perot optical filters. 
 Maximum wavelength transmission 
 350 370 380 400 420 450 480 510 540 560 580 600 620 650 700 750 
 Layer thicknesses (nm) 
TiO2 30 45 60 
SiO2 68 95 117 
TiO2 30 45 60 
SiO2 68 95 117 
TiO2 30 45 60 
SiO2 - 112 121 136 152 174 140 163 184 199 214 229 189 211 248 285 
TiO2 30 45 60 
SiO2 68 95 117 
TiO2 30 45 60 
SiO2 68 95 117 
TiO2 30 45 60 
 
4.2.3 Optical filters simulation results  
The thin-film optics software TFCalc
TM
 3.5 (Software Spectra, Inc., Portland, OR) 
was used for the structural optimization of the optical filters through computational 
simulations that included the materials optical properties. During this step the transmittance 
peak and bandwidth of the filters (FWHM) were analyzed. The FWHM translates the quality 
of the filter in terms of its ability to select a narrow band of the electromagnetic spectrum, and 
therefore, ideally, should be as low as possible. Additionally, the transmittance peak should be 
high, with at least twice the intensity of any background noise that might appear in the 
considered spectral range, so that it is possible to clearly discriminate the specific 
wavelengths, without noise overlap (if it is less, the background noise will significantly affect 
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the measurements) [12]. 
For all the simulations the following features were set in the software (Figure 4.7): 
(1) a glass substrate with optical properties similar to the glass that will be after used 
as a substrate in the fabrication process (i.e. Corning
®
 Eagle
2000TM
). The substrate thickness 
equals to 500 μm, and the refractive index equals to 1.5090 at 550 nm; 
(2) air as the incident medium; 
(3) normal incidence of light in the first surface; 
(4) an ideal detector. 
 
Figure 4.7:  Environment setting in the software TFCalc 3.5 for the transmittance simulations of the optical 
filters. 
Simulation results of the filters transmittance for this initial step are presented in 
Figure 4.8. 
For the near-UV/violet and red regions a short-pass filter at 500 nm and a high-pass 
filter at 550 nm, respectively, were assumed in order to eliminate the tails of the filters far 
outside these spectral regions. For the central visible region the simulations were performed 
assuming a wide-band pass filter (200 nm wide) on top of the optical filters. 
These three filters can be fabricated, as well, using an assembly of dielectric thin-films. 
This way, it is possible to deposit the three filters directly on top of each group of narrow-
band filters, in the same fabrication process. For example, a 200 nm wide-band pass filter for 
the 450-650 nm region can be easily obtained with a multilayer structure, composed by 11 
layers of SiO2 and TiO2, which can be represented by: Ln Hn Ln Hn Ln Hn Ln Hn Ln Hn Ln. All 
these layers have a thickness equal to 88 nm. The multilayer has an average transmittance 
higher than 90%. 
Still, the fabrication of these filters is beyond the scope of this thesis. Therefore, only 
the different narrow-band interference filters will be fabricated. It is important to notice that 
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knowing the theory and how to design the filters, and after studying and optimizing the 
fabrication process for the deposition of the narrow-band filters, the fabrication of the high-, 
low- and band-pass filters should not be a hard task. For the experimental measurements 
commercial filters will be used on top of the thin-film optical filters. 
 (a) 
 (b) 
 (c) 
Figure 4.8:  Simulated transmittance spectra for the designed thin-film optical filters, with layer thicknesses 
indicated in Table 4.1: (a) filters of the near-UV/violet region; (b) filters of the central region of 
the visible spectrum; (c) filters of the red spectral region. 
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The attenuation of the filter’s tails far outside their spectral region can also be 
achieved by designing photodiodes with higher quantum efficiency in particular regions of the 
spectrum. This will be discussed in section 4.3. 
It was not possible to present the transmittance of the 350 nm optical filter, using the 
materials and thicknesses indicated in Table 4.1, since the transmittance obtained for this filter 
in the simulations was smaller than 0.5%. This can be in part explained by the fact that the 
transmission of the glass used for the substrate (as most glasses) starts decreasing below 370 
nm. However, it may also be explained by the properties of the materials being used, namely 
their refractive indices. 
For the remaining 15 filters it can be seen that: each spectral band has a transmittance 
higher than 90%, except for three filters in the near-UV/violet spectral region, which may due 
to the same reasons previously indicated for the 350 nm filter; the FWHM is less than 10 nm 
(average around 6 nm); the transmittance background noise is less than 5%, except for the 
750 nm filter; and, the interference of each neighbor peak is less than 10% in each group.  
Table 4.1 represents, this way, an assembly of dielectric layers with a specific number 
of layers and a combination of thicknesses that allows one to obtain a good performance for 
the optical filters and in accordance with the requirements of the application (e.g. high 
transmittance, narrow-band pass), as illustrated in Figure 4.8. 
If, for example, the filters were designed with 7 layers instead of 11 layers (aiming at 
faster film deposition), the transmittance peak would not have a significant change, except for 
the near-UV/violet filters where the transmittance peaks are higher, but the FWHM, the 
background noise and the neighbor peak interference would be worse, with values around 20 
nm, 15% and 50%, respectively, as depicted in Figure 4.9.  
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 (a) 
 (b) 
 (c) 
Figure 4.9:  Simulated transmittance spectra for the same thin-film optical filters of Figure 4.8, but with only 7 
layers: (a) filters of the near-UV/violet region; (b) filters of the central region of the visible 
spectrum; (c) filters of the red spectral region. 
In an initial stage, only 6 of the 16 optical filters (corresponding to the central band of 
the visible spectra) were fabricated in order to adjust the manufacturing process before 
proceeding with the fabrication of the remaining filters. Thin-film optical filters fabrication 
needs to be well controlled and optimized, because the position of the peak is highly sensitive 
to thickness and refractive indices variation. For example, a thickness variation of only 1 nm 
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in each of the TiO2 layers, relative to what was initially designed, is enough to move the peak 
to a different central wavelength. This is demonstrated in Figure 4.10 where an increase of 
1 nm in the thickness of each of the TiO2 layers significantly affects the central peak position 
of the 540 nm filter in 3 nm (this effect might be noticed not only in the peak central 
wavelength, but also in its FWHM and transmission efficiency).  
 
Figure 4.10:  Simulated spectral transmittance for the 540 nm optical filter, with maximum intensity peaks at 
540 (regular TiO2 thicknesses) and 543 nm (when there is an increase of 1 nm in the thickness of 
each of the TiO2 layers). 
4.2.4 Optical filters fabrication 
 Before starting the deposition of the multilayers, some SiO2 and TiO2 thin-films were 
deposited at INESC-MN by ion beam deposition in a Nordiko 3000 tool equipped with both a 
deposition and assist guns, in a broad beam architecture [24] compatible with 150 mm 
diameter wafer deposition and ion milling. This equipment has a 1 nanometer resolution that 
enables a high level of control of the thicknesses to be deposited, which is very important as 
mentioned in the previous section.  
 In Figure 4.11 the geometry used for standard film deposition is illustrated, where the 
Xenon (Xe) ions created inside the deposition gun (by an external RF coil) are accelerated 
through a 3-grid assembly (15 cm diameter), into the target, at a pressure of 0.1 mTorr. The 
SiO2 films are prepared from a ceramic target, using a Xe beam. Beam distortion caused by 
charging at the target surface is avoided with a neutralizer (e-beam), which is of major 
importance for the SiO2 deposition control, since it assures a stable deposition rate along the 
several hours of deposition. Deficient neutralization causes different SiO2 film thickness 
across the multilayer, that is, the bottom layers (near the substrate) have different thickness 
than the top layers. 
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Figure 4.11:  Geometry of the fully automated deposition system (Nordiko 3000), with a 6-target configuration, 
allowing sequential deposition of the TiO2/SiO2 films. The sample rotates at 15 rpm during 
deposition, and film thickness uniformity is ± 2% over 150 mm diameter area. 
 The TiO2 films were prepared from a Ti metallic target, using ion beam assisted 
deposition, using a Xe deposition and an Ar-O2 (argon-oxygen) assist beam extracted from 
the assist gun through a 3-grid assembly (20 cm diameter), increasing the deposition pressure 
to 0.3 mTorr. In this work, the assist beam current was maintained in low values to minimize 
the material etching while depositing.  
The focused beam profile is controlled by the beam current (defined as I
+
, measured at 
the positive grid) and grid voltages (V
+
, V
-
), following the relation I
+
 ~ (V
+
 + V
−
)
3/2
 , where (V
+
 
+ V
−
) is the beam energy [25]. Phase diagram with the conditions to obtain focused or broad 
beams is plotted in Figure 4.12 for the assist gun, with the beam power calculated as I
+
  (V+ 
+ V
−
). The films described in this thesis were deposited using the same deposition conditions 
(22 mA, +1200 V, -300 V, 1.5 sccm Xe), only for the TiO2 reactive deposition, several lower 
energy conditions were tested (triangles in the figure). The assist beam energy must be 
adjusted so that the energy is high enough to promote the Ti film oxidation, but also must be 
in a range that prevents sputtering from dominating.  
Notice that if V
+
 ≤ V- the weakly accelerated ions are no longer a beam, reaching the 
sample by thermal drift (remote plasma oxidation). These, however, are still efficient in 
oxidizing the Ti films, and the final films have the correct composition, as will be shown 
below. Also shown in Figure 4.12 are the values used for conventional ion beam milling 
processes, usually done at high energies (> 26 W), at ~1 Å/s (solid curve). 
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Figure 4.12:  Assist gun phase space. Triangles indicate the low power beam conditions tested for assisted 
deposition of TiO2, at 12, 19 and 27 mA. These conditions correspond to a broad and week beam. 
The conditions used for ion beam milling (30 mA, +500 V, etch rate ~1 Å/s) are also shown for 
comparison. 
Simple SiO2 and TiO2 films were deposited on silicon (Si) substrates, for deposition 
rate, composition and refractive index calibration. The composition of TiO2 films deposited 
on Si was investigated by Rutherford backscattered spectroscopy (RBS) (at ITN, Sacavém). 
Figure 4.13 shows the experimental data obtained with a He
+
 beam, accelerated at 2 MeV, 
with a sample-beam angle of 0º and two detectors located at 140° and 180° scattering angles. 
Fittings of the data [26] indicates a Ti:O ratio of 32.6:67.4, corresponding to a TiO2 
compound. The density was also determined at 3.8 g/cc, which is in agreement with the 4.0 
g/cc reported in the literature and indicates a dense thin-film material.  
 
Figure 4.13:  Rutherford Backscattering data obtained at normal incidence, for a 40 nm thick TiO2 film 
deposited on a Si substrate. 
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The refractive indices of the dielectric materials used in the deposition process were 
measured by ellipsometry, on Si/SiO2 95 nm thick and Si/TiO2 45 nm thick test samples. The 
variation of the refractive index with the wavelength, in steps of 1 nm, was obtained by 
spectroscopic ellipsometry using a Nanofilm-ep3se instrument from Accurion (at INL, Braga). 
The experiments were performed at an angle of incidence of 50º. Optical modeling and data 
analysis was done with EP4model software package. The refractive index was determined by 
fitting the ellipsometric parameters with a Cauchy model. Figure 4.14 summarizes the 
dependence of the refractive index as a function of the wavelength for the SiO2 and the TiO2 
films (thickness 95 nm and 45 nm, respectively). The variation obtained is in accordance with 
values reported in the literature for SiO2 and TiO2 films [27].  
 (a) 
 (b) 
Figure 4.14:  Comparison between the refractive indices of the Sopra Database and the ones obtained 
experimentally, for (a) 95 nm thick SiO2 and (b) 45 nm thick TiO2. 
In addition, Figure 4.14 also compares the refractive indices of the Sopra database 
with the measured refractive indices. After the determination of the real refractive indices of 
the materials that will be used to fabricate the filters, it can be concluded that, in particular, 
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the measured refractive indices for the TiO2 are smaller than the ones used in the initial 
simulations. This is due to the ratio of the Ti:O compound that was obtained in the deposition 
process, slightly off-stoichiometry. As a consequence, the layer thicknesses to be used in the 
multilayers have to be adjusted for maintaining the desired optical properties and performance.  
Optical filters design adjustment 
After the first theoretical calculations using the refractive indices from the Sopra 
database, the experimental refractive SiO2 and TiO2 indices values (presented in Figure 4.14), 
were used in the analytical and computational code, to adjust the best possible the layer 
thicknesses. Since the refractive indices obtained for the TiO2 are smaller than the ones used 
from the Sopra database, the thickness of the TiO2 mirror layers had to be increased a few 
nanometers. This way, the new thicknesses for the filters of the central band of the visible 
spectrum are now equal to 95 nm for the SiO2 and 52 nm for the TiO2 layers. Thin-film 
assemblies with those layers thicknesses were then deposited using the same deposition 
system.  
The resonance cavity thicknesses were also adjusted due to the new SiO2 refractive 
indices, in order to obtain the peaks centered at the initial 6 wavelengths. This could be a 
minor adjustment since the refractive indices from the Sopra database and the measured SiO2 
refractive indices are very similar, as it can be seen in Figure 4.14. However, it was decided 
not to change the SiO2 mirror layers. Therefore, the changes in the cavity thicknesses were 
more significant to match the desired peaks.  
Table 4.2 summarizes the new layer thicknesses determined for the filters in the 
central region of the visible spectrum, while Figure 4.15 shows the corresponding simulated 
transmittance for each filter.  
 
Figure 4.15:  Simulated spectral transmittance for 6 optical filters in the central region of the visible spectrum. 
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Table 4.2:  Layer thicknesses of the 6 central Fabry-Perot optical filters. 
 Maximum wavelength transmission 
 480 510 540 560 580 600 
 Layer thicknesses (nm) 
TiO2 52 
SiO2 95 
TiO2 52 
SiO2 95 
TiO2 52 
SiO2 140 164 192 206 227 242 
TiO2 52 
SiO2 95 
TiO2 52 
SiO2 95 
TiO2 52 
  
From Figure 4.15, it can be concluded that, using the same optical filters structure, and 
after the adjustments, each spectral band has a transmittance higher that 90% with a FWHM 
less than 17 nm (average around 12 nm), a background noise of 15%, except for the 600 nm 
filter, and a neighbor interference less than 35%, again except for the 600 nm filter.  With 
these results it is possible to conclude that the performance of these filters in terms of a 
narrow transmission is not as good as in the first simulations. Still, it is an acceptable 
performance for the interference filters since the maximum transmittance to background noise 
is about 90/15. 
The overall performance of the optical filters could be improved by increasing the 
total number of dielectric layers, but the fabrication process complexity would also increase. 
Therefore, it must be achieved a compromise between the filters accuracy to transmit a 
narrow spectral band and the constraints inherent to the filters fabrication process (e.g. 
materials, number of layers, FWHM, and maximum transmission). 
For a better demonstration of the peak deviation that may occur with a variation of the 
refractive index, and to better justify the adjustment that was made, Figure 4.16 compares the 
simulations for a filter with a 164 nm resonance cavity thickness using the refractive indices 
provided by the Sopra database and the experimental refractive indices. The use of the same 
materials but with slightly different refractive indices causes a peak deviation of 
approximately 30 nm and different FWHM values.  
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Figure 4.16:  Simulated transmittance spectra for an optical filter with a resonance cavity thickness equal to 
164 nm, and with SiO2 and TiO2 layer thicknesses of 95 and 52 nm, respectively. The two curves 
are obtained using the refractive indices provided by the Sopra database (n from Sopra database) 
and the experimental refractive indices (experimental n). 
This can be better seen in Figure 4.17, where, for each spectral band, it is depicted the 
peak deviation of using the refractive index of the Sopra database materials and the 
experimental refractive index obtained by measuring the used materials, as a function of the 
SiO2 resonance cavity thicknesses. The thicknesses of the mirror layers are kept fixed and 
equal to 95 nm and 52 nm for the SiO2 and TiO2, respectively. 
 
Figure 4.17:  Transmitted peak variation (∆) as a function of the SiO2 resonance cavity thicknesses, when it is 
used the refractive indices provided by the Sopra database and the experimental refractive indices. 
For higher SiO2 thicknesses the peak deviation is higher. This can lead to the 
conclusion that the experimental SiO2 refractive index changes not only with the wavelength, 
but it also changes with thickness, which is proved by Figure 4.18. Thus one cannot use the 
same value for thin and thick films.  
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Figure 4.18: Experimental dependence of the SiO2 refractive index on the SiO2 film thickness. 
The thicknesses of the filters in the near-UV/violet and red regions will also be 
adjusted in order to compensate for the differences in the refractive indices. However, this 
will only be done after these first 6 filters are fabricated. The fabrication of the filters is a very 
complex, time-consuming and prone to errors process. Thus, it is wise to go step by step, so 
that one can obtain the best results. 
4.2.5 Optical and structural characterization of the filters 
The 6 optical filters corresponding to the central region of the visible spectrum were 
fabricated as described in section 4.2.4 but with new layer thicknesses. The optical filter 
properties, i. e. the filters transmittance, were measured using a spectrophotometer from 
Shimadzu (UV-3101PC), and are demonstrated in Figure 4.19.  
 
Figure 4.19:  Measured transmittance spectra for the 6 fabricated Fabry-Perot optical filters with the wide band-
pass filter included. 
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In order to eliminate the tails of the filters outside the 450-650 nm spectral region, a 
commercial wide-band pass filter (450-650 nm band, with 96% transmittance) was placed on 
top of each filter. The comparison between the experimental results and simulated results, in 
terms of maximum peak transmittance, is shown in Figure 4.20. 
 
Figure 4.20:  Comparison between the experimental and the simulated results for 6 optical Fabry-Perot filters: 
the wavelength of maximum transmittance is shown for each resonance cavity thickness. 
The results of Figure 4.19 show that a multilayer stack of TiO2 and SiO2 thin-films for 
the dielectric mirrors with a SiO2 resonance cavity is a good option in terms of optical 
characteristics. The presented results show that each filter is sensitive to a single spectral band, 
with FWHM less than 20 nm (average around 15 nm) and with transmittances higher than 
65%. As mentioned before, the performance of the optical filters could be improved by 
increasing the number of layers, but the fabrication process complexity would also increase.  
Finally, one can conclude from Figure 4.20 that there is a small peak deviation (of 
approximately 3 nm in average) between the simulated and the measured transmittances. That 
deviation is within the tolerance of the deposition system, which is about 10% for the 
fabricated layers range. These differences between the design and the outcome of the 
fabrication process may also be explained by the etching that might occur in some of the 
layers immediately below, when the multilayer is deposited. Indeed, the total thickness of the 
multilayers was measured using a profilometer, and the result was, in average, 2% less than 
what was initially designed. This event will obviously shift the central transmitted wavelength 
to the left. As mentioned before, the process needs to be optimized and the deposition rates 
need to be adjusted. 
Table 4.3 shows photographs of the 6 fabricated optical filters. The color differences 
can be clearly seen according to the spectral band that is transmitted.  
450
500
550
600
650
130 140 150 160 170 180 190 200 210 220 230 240 250
W
av
el
en
g
th
 (
n
m
)
Resonnace cavity thicknesses (nm)
Simulated
Experimental
esonance cavity thicknes es (nm)
Spectroscopy systems for the detection of gastrointestinal dysplasia Chapter 4 
  85/137 
Table 4.3:  Photographs of the 6 fabricated optical filters. 
 
   
Resonance 
cavity thickness 
(nm) 
140 164 192 
 
   
Resonance 
cavity thickness 
(nm) 
206 227 242 
 
The Scanning Electron Microscope (SEM) was then used to characterize the 
multilayer morphology, structure and quality of interfaces. SEM images of the structure are 
presented in Figure 4.21.  
 (a) 
 (b) 
Figure 4.21:  SEM photograph showing the cross-section of the 560 nm Fabry–Perot optical filter (the designed 
TiO2 and SiO2 layer thicknesses were equal to 52 and 95 nm, respectively, while the resonance 
cavity thickness was equal to 206 nm): (a) magnification 100,000 times; (b) magnification 200,000 
times. 
In these figures it is demonstrated a clear separation between the SiO2 and TiO2 layers, 
with very low interface mixing (brighter layers correspond to elements with high atomic 
number - TiO2). Thickness measurements show that the TiO2 and SiO2 film thicknesses are in 
good agreement with the nominal values. It is also shown very good film flatness along the 
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entire area. Small deviations in the deposited thicknesses in relation to what was designed, 
namely in the resonance cavity, are caused by instabilities on the beam neutralization during 
deposition. Both films have amorphous structure and very good adhesion signature on the 
glass substrate. Notice that the good film flatness shown in Figure 4.21 is extended along the 
entire sample area, resulting from the very good deposition uniformity of the ion beam N3000 
tool ((maximum-minimum)/2*(maximum+minimum)) = ± 2% over 150 mm wafer areas). 
This feature allows guarantee the parallelism of the mirrors concerning to the resonance 
cavity, which is a crucial feature for reproducible optical measurements in narrow-band pass 
optical filters. 
The multilayer surface roughness of the 560 nm filter was also evaluated, in a 400 by 
400 μm area, using a profilometer (Dektak 150 Surface Profiler, Veeco Instruments, Inc., 
Plainview, TX). The surface 3-D map of the optical filter is shown in Figure 4.22. 
  
Figure 4.22:  Surface 3D map of the Fabry–Perot optical filter. 
From Figure 4.22 it can be seen that in general the optical filter’s surface is smooth, as 
would be desirable in order to minimize potential interferences to the incident light beam. Its 
roughness profile is in average equal to 2.31 nm. Several tiny irregularities inherent to the 
filters manufacturing process are present in the surface; yet, these are not a major concern due 
to their small-size. The surface of this filter was also evaluated using an atomic force 
microscope. The results are displayed in Figure 4.23. In this case, the average surface 
roughness is equal to 0.41 nm, in an area of 5 μm by 5 μm. 
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 (a) 
 
(b) 
Figure 4.23:  AFM image of a thin-film optical filter: (a) 3-D image; (b) 2-D image. 
4.2.6 Optical filters for the near-UV/violet and red regions 
The filters corresponding to the central region of the visible spectrum were first 
fabricated and characterized, so that the fabrication process could be optimized before 
proceeding with the fabrication of the remaining structures. This way, after knowing the real 
refractive indices of the materials, the deposition process tolerances, and the problems that 
may occur during the materials deposition (e. g. etching in some of the layers), the structure of 
the filters centered at the lower and higher wavelengths was adjusted to try to offset these 
factors. 
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Design adjustment, fabrication and optical characterization 
Until this stage, the whole methodology presented in Figure 4.24 including up to step 
7 took about a year to be concluded. The next step (number 8) was related to the adjustment 
of the structure of the filters in the near-UV/violet region taking into account the previous 
experience. 
 
Figure 4.24:  Methodology used in the fabrication of the thin-film optical filters. 
For the filters of the near-UV/violet region the same approach was used for the 
structure adjustments: the thicknesses of the TiO2 mirror layers were increased several 
nanometers. In a first experiment, only the filter centered at 400 nm was fabricated. In order 
to keep the filter with its maximum transmittance at 400 nm, and taking into account the new 
refractive indices, the TiO2 mirror thicknesses increased from 30 to 36 nm, keeping the same 
SiO2 layers. The simulated spectral transmittance for this filter is shown in Figure 4.25. 
This specific filter was then fabricated and its optical transmittance is illustrated in 
Figure 4.26. 
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Figure 4.25:  Simulated spectral transmittance for the 400 nm thin-film optical filter, with TiO2 and SiO2 mirror 
thicknesses of 36 and 68 nm, respectively, and a resonance cavity with a thickness equal to 136 nm. 
 
Figure 4.26:  Experimentally measured spectral transmittance for the 400 nm thin-film optical filter, with TiO2 
and SiO2 mirror thicknesses of 36 and 68 nm, respectively, and a resonance cavity with a thickness 
equal to 136 nm. 
It can be concluded from Figure 4.26 that there is a small peak deviation 
(approximately 6 nm) between the simulated and measured transmittance of the optical filter. 
This deviation is within the tolerance of the fabrication process. However, the most noticeable 
feature of the fabricated filter is its small transmittance (less than 30%). The study of this 
event led to the conclusion that the ratio of the Ti:O compound that was being deposited was 
slightly off-stoichiometry, which led to the emergence of metallic contaminants in the TiO2 
films. Metallic materials have high absorption losses and, thus, are not suitable for high 
transmittances. 
This particular occurrence was solved and new depositions were performed in order to 
obtain transmittance peaks at: 350, 370, 380, 400, 420 and 450 nm. The same mirror layers 
were maintained: 68-nm thick for the SiO2 and 36-nm thick for the TiO2 mirror layers. The 
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resonance cavity thicknesses were changed in order to achieve the desired peaks. The 
different values of the cavities are indicated in the simulations plot, in Figure 4.27.  
 
Figure 4.27:  Simulated spectral transmittances for the different UV/violet thin-film optical filters using the 
experimentally measured refractive indices. 
It is important to note that with the obtained TiO2 refractive indices it is now possible 
to simulate the 350 nm filter since these values are lower when compared with the values of 
the material used in the initial simulations. This fact has linked a benefit – low absorption by 
the material (i.e. high transmittance), and also a drawback – loss of selectivity by the 
multilayer (i.e. high FWHM). For a better illustration, Figure 4.28 shows the optical 
transmittance simulated using a single layer of TiO2 over a glass substrate, with layer 
thicknesses of 30 nm (as used in the first simulation) and 36 nm (as used in the simulation of 
Figure 4.27). The layer with the low refractive index (i.e. the experimental measured 
refractive index) has a clear improvement in the transmittance over the violet/blue wavelength 
range.  
 
Figure 4.28:  Comparison between the transmittance obtained using TiO2 materials with different refractive 
indices: “TiO2_n_Sopra” - Sopra database refractive index, and TiO2 thickness equal to 30 nm (as 
in the first simulation, Figure 4.8(a)); “TiO2_n_experimental” - experimentally measured 
refractive index, and TiO2 thickness equal to 36 nm (as in the second simulation, Figure 4.27). 
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If they exist, the tails of the filters below 350 nm are not a major concern at this time 
because these correspond to wavelengths far outside the visible range, and, therefore, outside 
the range of tissues emission (i.e. there won’t be a signal emission from tissues in this range, 
and, thus, even with a high filters transmittance the detected signal will be null). 
The optical transmittance measured in the different filters is illustrated in Figure 4.29. 
 
Figure 4.29:  Experimentally measured spectral transmittances for the different UV/violet thin-film optical 
filters with the short-pass filter at 500 nm included in the measurements. 
The obtained results are not as good as expected, probably due to modifications in the 
refractive index of the materials. For the simulations, refractive indices measured from 95-nm 
thick SiO2 and 45-nm thick TiO2 samples were used. However, it is known that these indices 
also vary with the sample thickness. This way, new refractive indices should have been 
measured for thinner SiO2 and, mainly, TiO2 samples, over the filters transmittance 
wavelength range, in order to have a simulation as close as possible to the real case.  
All the obtained transmittance peaks are deviated to the left and it was not possible to 
discriminate the different peaks below 350 nm.  This is a major limitation in the approach 
used to design and fabricate all the presented filters. The use of a different structure, instead 
of a Fabry-Perot structure, an increase in the total number of layers in the assembly, and the 
use of different materials may potentially improve the chances of obtaining high transmittance 
filters at low wavelengths. A different approach to build filters in this spectral region will be 
discussed in the future directions of the last thesis Chapter. According to the results obtained, 
one of the fabricated filters will be used for the quantitative measurements in this particular 
spectral range. Even though it hasn’t been designed for this specific wavelength, the filter 
with the 182-nm thick resonance cavity will be used as the 400 nm filter. 
 Due to the poor results obtained, two more filters were fabricated, for the violet/blue 
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spectral region, at INESC-MN. In this new design, the TiO2 mirror layers were kept equal to 
45 nm, since the values of the refractive indices available for the computational simulations 
were measured using TiO2 samples with a thickness of 45 nm. With this approach one expects 
to minimize the offset between the design and the outcome of the fabrication process. The 
other mirror layers of the filters – the SiO2 layers – were designed to have a thickness of 
70 nm.  
 After the fabrication, the filters were characterized, and good results were obtained for 
one of the filters (with a cavity thickness of 138 nm) in terms of spectral transmittance. The 
transmittance performance of this optical filter is shown in Figure 4.30, ove. 
 
Figure 4.30:  Measured transmittance spectra of one violet/blue Fabry-Perot optical filter. The transmittance was 
measured using a UV-3101PC spectrophotometer. The filter has a maximum intensity peak at 
422 nm. 
The filters of the red region were then adjusted. A major concern in this adjustment is 
related to the fact that the SiO2 and TiO2 mirror layers of these filters are thicker (117 and 60 
nm, respectively) than the ones used to measure the refractive indices, as a function of 
wavelength, presented in Figure 4.14. This way, and as mentioned before, it is a hard task to 
adjust the layer thicknesses for unknown refractive indices. 
Since for the near-UV/violet group of filters the results were not satisfactory, for this 
last group of filters it was decided to adjust only the resonance cavity thicknesses and keep 
the thicknesses of the mirror layers equal to the initial design.  
To cover this spectral region only 4 filters are necessary. However, it was possible to 
deposit 6 more different filters at INESC-MN. Thus, it was decided to only fabricate filters 
centered at three different wavelengths (620, 650 and 700 nm) and to deposit two different 
resonance cavity thicknesses for each of them. This was done in order to account for potential 
deviations between the simulations and the outcome of the fabrication process, once there are 
some unknown variables in the process (e.g. refractive indices). The 750 nm filter was not 
fabricated since it is, among the four, the less important wavelength to extract tissue 
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properties and establish a diagnosis. 
From the computational simulations it was possible to conclude that a shift of 20 nm 
in the transmittance peak to the right or to the left could be obtained, using this particular 
structure, by increasing or decreasing the resonance cavity thickness by approximately 17 nm, 
respectively. Given this, 6 different filters were projected, centered at: 620, 640, 650, 670, 680 
and 700 nm. The simulated spectral transmittances for these 6 filters, together with the 
resonance cavity thicknesses, are shown in Figure 4.31. 
 
Figure 4.31:  Simulated spectral transmittances for the different thin-film optical filters in the red region using 
the experimentally measured refractive indices. 
The filters were finally fabricated and their optical transmittance was measured 
(Figure 4.32). 
 
Figure 4.32:  Experimentally measured spectral transmittances for the different thin-film optical filters in the red 
spectral region. The measurements were performed with a high-pass filter at 550 nm on top the 
thin-film optical filters. 
From the results presented in Figure 4.32 it is possible to conclude that the spectral 
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shape of the fabricated optical filters is in good agreement with the simulations. However, the 
feature that most stands out is that the filters are all deviated to the right approximately 32 nm. 
A good aspect is that this deviation is almost constant in all the filters. This means that there is 
probably a systematic problem in the deposition process, which may be easier to solve than if 
it was a random, non-uniform problem in some of the filters. 
Similarly to what was done in the near-UV/violet case, and even though the filters  
haven’t been designed for these specific wavelengths, the filter with the 218-nm thick 
resonance cavity will be used as the 650 nm filter, whereas the filter with the 263-nm thick 
resonance cavity will be used as the 700 nm filter. Unfortunately it was not possible to obtain 
a filter centered at 620 nm. 
For the two filters that are going to be used for the experiments, the results presented 
in Figure 4.32 show that each filter is sensitive to a single spectral band, with FWHM less 
than 20 nm, transmittance to background noise less than 10%, and with transmittances higher 
than 75%. Overall, one can consider the results satisfactory. 
4.3 Photodiodes and readout electronics 
In the designed miniaturized spectroscopy system, silicon photodiodes are used for 
signal detection, replacing, this way, the spectrograph and CCD camera that are used in the 
majority of spectroscopy prototypes for several clinical applications. The photodiodes convert 
light intensity that is transmitted through the optical filters into a photocurrent. The analog 
photocurrent signal is converted into a digital signal using a light-to-frequency converter 
integrated in the same die [20]. The digital output signal, with a suitable format for radio-
frequency transmission, will have a frequency proportional to the light intensity emitted by 
the tissues.  
As mentioned before in this Chapter, the integration of optical filters, photodiodes and 
readout electronics on a single-chip requires the system to fit in a microelectronics process, 
preferably CMOS. This technology features electronics in a small silicon area and offers low 
power consumption, an important requirement for the reported application. It is also critical 
for the economic viability of the detection system. For the miniaturized instrument pn-
junction photodiodes are used, fabricated in a standard 0.7 m CMOS process, without 
additional masks or steps, except for the signal detection in the near-UV/violet spectral region 
in which the designed photodiodes don’t have high quantum efficiency, as will be seen next 
below. For this spectral band, a photodiode with improved quantum efficiency at low visible 
wavelengths should be developed in a future step. This will be discussed in Chapter 7.  
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The CMOS process provides three photosensitive structures as vertical junction 
photodiodes: n-well/p-epilayer, n+/p-epilayer and p+/n-well. The principle of operation of 
these three types of photodiodes is very similar. When light shines onto the semiconducting 
material the photon energy is absorbed. For low photon energies the only effect is that the 
material heats up. For high photon energies the electrons in the valence band may get 
sufficient energy to reach the conduction band. This requires the photon energy to be larger 
than the bandgap of the material between the valence and conduction bands, which in the case 
of silicon is 1.14 eV. This process creates free electrons in the conduction band and holes in 
the valence band. These two types of carriers are seen as a photocurrent at the photodiode 
terminals [28]. 
The photon energy is wavelength dependent: for relatively larger wavelengths ( 950 
nm) the photon energy is not high enough to create and electron-hole pair in silicon; for lower 
wavelengths (< 400 nm) excess carriers are generated very close to the photodiode surface, 
due to a lower penetration depth. Because the surface recombination rate of electrons and 
holes is high, only a small part of the generated carriers contribute to photocurrent. Therefore, 
it is necessary to remove the created electrons from the conduction band. This is done using 
an inversely polarized pn-junction that originates a region deprived of mobile carriers, known 
as depletion region. The photodiodes should be designed to allow the largest number of 
photons to be absorbed near or in the depletion region. In an ideal situation, the photons 
should not be absorbed until they have penetrated as deep as the depletion region, and should 
be absorbed before they have penetrated beyond it [28]. 
At a particular wavelength, the photodiodes quantum efficiency (how well they collect 
the incident light) varies according to their junction depth. In the visible spectrum, the blue 
light is more efficiently collected by a shallower junction, close to the photodiode surface 
(p+/n-well and n+/p-epilayer) and the red light by a deeper junction (n-well/p-epilayer). Light 
with longer wavelengths may penetrate tenths of micrometers deep in the substrate. Despite 
its shallow junction, the n+/p-epilayer photodiode has high-quantum efficiency around 
500 nm due to the different doping concentration between the n and the p side. This extends 
the p side depletion area more deeply [29-30].  Therefore, this photodiode was selected for the 
detection of the signals filtered by the second group of optical filters (the filters in the central 
region of the visible spectrum). For the group of filters in the red spectral region, 
n-well/p-epilayer photodiodes are used. The light intensity that passes through the filters in 
the blue region will be detected, in a first approach, using p+/n-well photodiodes, since these 
cut more efficiently higher wavelengths. 
Each filter will be vertically aligned with one photodiode to build the optical channel 
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for the collection of fluorescence and diffuse-reflectance data in a 4 by 4 array configuration, 
in order to cover the full 350 to 750 nm range with good quantum efficiency (Figure 4.33). At 
this stage of the project, the three different photodiodes structures were fabricated. The layout 
of the detection system is shown in Figure 4.33, designed using the Tanner L-Edit Pro 
software. Each photodiode has an active area of 100 μm by 100 μm. 
 
Figure 4.33:  Layout of the photodiodes array: (a) n-well/p-epilayer photodiode; (b) n+/p-epilayer photodiode; 
and (c) p+/n-well photodiode.  
The photodiodes photocurrent is proportional to the incident light and can be 
calculated using the following expression: 
  
      
  
 (4.63) 
Where    is the electron charge,   is the quantum efficiency,   is the light wavelength, 
   is the incident optical power,   is the Plank constant, and   is the velocity of light in a 
vacuum. The quantum efficiency is defined as the average number of generated electron-hole 
pairs per incident photon. 
The penetration depth of light in silicon,   , strongly depends on its absorption 
coefficient,  , which in turn is wavelength dependent: 
      
 
     
 (4.64) 
The effect of using a CMOS photodiode to read the spectroscopic signal was 
demonstrated with new computational simulations for the 540 nm filter. These simulations 
took into account the optical effect of a n+/p-epilayer photodiode. The thickness of the 
photodiode junction depth is fixed by the microelectronics foundry, and equals to 350 nm. It 
was also included in the simulations the effect of the first oxide (SiO2), existent in the CMOS 
fabrication process, on top of the photodiode. A thickness of 625 nm was assumed for this 
a
b
a
c
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oxide (data from the CMOS foundry). Figure 4.34 illustrates the signal attenuation in the 
violet/blue region to less than 20%. As it was previously mentioned, the collection of out-of-
band light by the optical filter that can potentially confound the spectroscopy analysis can be 
attenuated not only by a wide-band pass filter, but also by the photodiode that will read the 
signal.  
 
(a) 
 
(b) 
Figure 4.34:  Simulated spectral transmittance of the 540 nm filter: (a) without the optical effect of the 
photodiode included; and (b) with the optical effect of the n+/p-epilayer photodiode included. 
The CMOS photodetectors were then fabricated in a 4 by 4 array. In Figure 4.35 a 
picture of the fabricated array is shown. 
 
Figure 4.35:  Picture of the fabricated photodiodes array that integrates three types of photodiodes: p+/n-well, 
n+/p-epilayer, and n-well/p-epilayer. 
The spectral response of each type of the fabricated photodiodes was individually 
measured, using a calibrated commercial photodiode as a reference (Hamamatsu S1336-5BQ). 
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The quantum efficiency of the three photodiodes was determined from their responsivity, 
which relates the photocurrent with the incident optical power, and is presented in Figure 4.36. 
In theory, the typical value of the quantum efficiency in a CMOS photodiode is about 40 to 
70% [28]. 
 
Figure 4.36:  Quantum efficiency of the three types of vertical junction photodiodes: (a) n-well/p-epilayer; (b) 
n+/p-epilayer; and (c) p+/n-well. 
According to the results presented in Figure 4.36, it is possible to conclude that, 
although having a similar quantum efficiency, the n-well/p-epilayer photodiode is a little more 
suitable for the red region of the spectrum, whereas the n+/p-epilayer photodiode has a 
slightly better efficiency in the 500 nm region. Also, the p+/n-well photodiode efficiency is 
increased at low wavelengths when compared with high wavelengths, as would be 
theoretically expected. Still, the efficiency of this photodiode is not considered good and the 
photodiode is not suitable for wavelengths below 420 nm. For this reason, other types of 
photodiodes will be studied in the future for this low wavelength range. 
The photocurrent produced by the photodiodes will be read and converted to a digital 
signal so that the data can be later analyzed. This conversion can be performed using one-bit 
first-order sigma-delta analog-to-digital converter for each photodiode, such as the one 
developed by Rocha et. al. [31]. More details and results about this circuit can be found in the 
literature [31]. It is just important to mention that the addition of the readout electronics will 
not significantly increase the size of the chip since the converter can be designed with only 19 
small-size MOSFETs [31]. 
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5 Experimental Results:  Optical Filters Ability for Diagnosis  
Experimental Results: Optical 
Filters Ability for Diagnosis  
 
This Chapter describes the utility of the spectroscopy system based on thin-film 
optical filters for the diagnosis of GI dysplasia. Two different approaches for the detection of 
malignancy are presented: (1) a model-based approach, where the full spectrum may be 
reconstructed from a few discrete data points from which tissue morphological and 
biochemical parameters can then be quantified (quantitative diagnosis); (2) the use of 
empirical discrimination criteria based on intensity values in different spectral bands 
(qualitative diagnosis). Both approaches are validated to be applied once the final prototype is 
assembled. 
5.1 Quantitative diagnosis 
As mentioned in Chapter 1 and Chapter 3, point spectroscopy techniques have the 
uniqueness of allowing a quantitative and objective diagnosis through the acquisition of 
fluorescence and diffuse-reflectance spectra. Using the full spectra over a wide spectral 
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region, e.g. from 350 to 750 nm, it is possible to extract several tissue parameters: total 
hemoglobin concentration and oxygen saturation; collagen and NAD(P)H, or other 
fluorophores, relative quantities; scatterers density and size [1-5]. 
 The use of the described miniaturized system, based on a few thin-film optical filters, 
makes impossible the acquisition of a full continuous spectrum. Instead, discrete points are 
obtained. Still, if the measured points are suitably approximated to the value in the original 
spectrum, at each particular wavelength, it is possible to reconstruct the original spectrum 
using interpolation methods (see Chapter 3, sections 3.6.1 to 3.6.3).  
5.1.1 Diffuse-reflectance spectroscopy 
In Chapter 4, the suitable optical characteristics of the thin-film filters, in terms of 
structure and transmittance, were demonstrated. The next step involves the performance of 
diffuse-reflectance measurements on tissue phantoms with different compositions using some 
of the thin-film optical filters to select specific spectral bands (see Table 5.1). The 
measurements were performed using a UV-3101PC spectrophotometer. The goal of the study 
is to determine how accurately each filter is able to detect the diffuse-reflectance signal.  
 
Table 5.1:  Tissue phantoms composition and thin-film optical filters used in diffuse-reflectance 
measurements. 
Phantom 
Intralipid mass 
concentration 
Hemoglobin 
concentration (mg/mL) 
Thin-film optical filters used  
(central wavelength, nm) 
1 0.5% 0.5 
404, 481, 510, 543, 558,  
575, 598, 651, 703 
2 1% 0.5 
3 1% 1.0 
4 0.5% 0.25 
5 2% 0.25 
 
 For this study, diffuse-reflectance spectra measured from the tissue phantoms without 
using optical filters were first acquired (Figure 5.1). In all measurements, the characteristic 
absorption bands of hemoglobin at 420 nm, 540 nm and 580 nm are clearly noticeable.  
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(a) (b) 
  
(c) (d) 
 
(e) 
Figure 5.1:  Diffuse-reflectance spectra measured with a UV-3101PC spectrophotometer: (a) phantom 1; (b) 
phantom 2; (c) phantom 3; (d) phantom 4; (e) phantom 5.  
 After, consecutive DRS measurements using the 9 fabricated filters placed in front of 
the detection system were performed on all tissue phantoms (Figure 5.2).  
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(a) (b) 
  
(c) (d) 
 
(e) 
Figure 5.2:  Diffuse-reflectance spectra measured with the 9 fabricated narrow-band pass optical filters: (a) 
phantom 1; (b) phantom 2; (c) phantom 3; (d) phantom 4; (e) phantom 5.  
 The resulting Gaussian distributed spectra, shown in Figure 5.2, were then integrated. 
The obtained 9 intensity values, for each phantom, correspond to the signal that will be read 
in the future by the optical microsensors. 
 In a further processing, the filters measured transmittance spectra (see Chapter 4, 
Figures 4.19, 4.29, and 4.32) were also integrated, and the intensities read by the optical 
microsensors were divided by these 9 values. This way, one can obtain the final 9 data points, 
for each phantom, that will compose the wavelength-reduced spectrum. In Figure 5.3 these 
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discrete data points are shown together with the original continuous diffuse-reflectance 
spectra.  
  
(a) (b) 
  
(c) (d) 
 
(e) 
Figure 5.3:  Original diffuse-reflectance spectra together with the 9 integrated intensity values that will be 
obtained using the miniaturized spectroscopy system (a trendline was also added to the discrete 
data points): (a) phantom 1; (b) phantom 2; (c) phantom 3; (d) phantom 4; (e) phantom 5.  
 From Figure 5.3 it is possible to conclude that the intensity values obtained with the 
fabricated thin-film optical filters are similar to the originally obtained diffuse-reflectance 
intensities measured over the full wavelength range. For a better visualization of the results, 
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Figure 5.4 shows the comparison between the original results and the results obtained using 
the thin-film optical filters. 
 
Figure 5.4:  Comparison, or difference, between the original results (obtained with the UV-3101PC 
spectrophotometer) and the results obtained using the 9 thin-film optical filters, for the different 
tissue phantoms. 
 The two filters in the red spectral region (centered at 651 and 703 nm) are the filters 
with the poorest results. On the other hand, the filters centered at 558 nm and 598 nm are the 
ones that provide the best agreement with the original diffuse-reflectance spectra values. 
 The divergences that exist between the two measurement approaches are mainly 
explained by the filters FWHM. Future optimizations to the fabrication process should enable 
the fabrication of more accurate filters, correctly centered at specific wavelengths, and with a 
smaller FWHM. Still, currently the mean relative error between the two measurements is less 
than 5%, while the maximum relative error is around 20%, which means that, overall, it is 
reasonable to consider that the results validate the possibility of replacing the spectrograph by 
an array of thin-film narrow-band pass filters for diffuse-reflectance measurements. 
5.1.2 Fluorescence spectroscopy 
 Fluorescence measurements were also performed on two tissue phantoms composed 
by a different mixture of water based intralipid, hemoglobin, and furan (fluorophore). This 
fluorescent dye was selected because it has an excitation and emission spectra similar to that 
of collagen, which, as mentioned in Chapter 3, is an endogenous tissue fluorophore important 
for diagnosis. The goal of this study was to extract intrinsic fluorescence from bulk 
fluorescence measurements and, also, to assess the capability of the thin-film optical filters to 
accurately detect the fluorescence signal. 
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 During this study it was not possible to perform the experiments using the fabricated 
filters due not only to technical problems with the equipment, but also because the majority of 
filters in the blue region didn’t provide suitable transmittance results to be used, as it was 
explained in Chapter 4.  
 However, fluorescence measurements were performed and the algorithm to extract the 
intrinsic fluorescence (described in Chapter 3) was implemented using MATLAB tools and 
successfully applied to the measurements, as will be next described next below. A 
theoretically feasibility study was also executed using the measured transmittance curve of 
one of the fabricated filters in the blue region (centered at 404 nm) for assessing the 
performance of this filter when used for fluorescence spectroscopy. For the present analysis, 
fluorescence measurements were performed on the two phantoms with intralipid, hemoglobin 
and furan (Sigma Aldrich Co.) - bulk fluorescence, and on a solution of pure furan - 
equivalent to the intrinsic fluorescence, using a conventional fluorometer (SPEX
®
 
FluoroLog
®
). The results are shown in Figure 5.5. As it was predicted, the emitted 
fluorescence intensity decreases as the hemoglobin concentration increases, due to an increase 
in absorption.  
 (a) 
 (b) 
Figure 5.5:  Bulk fluorescence and intrinsic fluorescence (pure furan) measured from two tissue phantoms: (a) 
phantom with intralipid mass concentration equal to 2%, hemoglobin concentration of 0.25 mg/mL, 
and furan concentration of 0.25 μg/mL; (b) phantom with intralipid mass concentration equal to 
2%, hemoglobin concentration of 0.5 mg/mL, and furan concentration of 0.25 μg/mL. 
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 For the feasibility study, the fluorescence measured from the two phantoms was first 
multiplied by the filter’s transmittance curve (see Chapter 4, Figure 4.29). The resulting two 
Gaussian distributed spectra were then integrated over the fluorescence emission range. This 
way, the obtained intensity values are equivalent to the signal that will be read by photodiode 
below the blue filter. After, the filter’s transmittance spectrum was also integrated, and the 
two intensities theoretically read by the photodiode were divided by this value to obtain the 
final data points. These points are represented in Figure 5.6. 
 
 (a) 
 (b) 
Figure 5.6:  Bulk fluorescence and intrinsic fluorescence (pure furan) measured from two tissue phantoms, 
together with the two intensity values that would be obtained using the blue optical filter: (a) 
phantom with intralipid mass concentration equal to 2%, hemoglobin concentration of 0.25 mg/mL, 
and furan concentration of 0.25 μg/mL; (b) phantom with intralipid mass concentration equal to 
2%, hemoglobin concentration of 0.5 mg/mL, and furan concentration of 0.25 μg/mL. 
 From Figure 5.6 it can be concluded that the intensity values obtained with the optical 
effect of the filter are similar to the originally obtained bulk fluorescence intensities measured 
over the full wavelength range. This also validates the possibility of replacing the 
spectrograph by thin-film optical filters. 
 The intrinsic fluorescence algorithm was finally applied to the original bulk 
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fluorescence spectra in order to obtain a spectrum similar to the pure furan spectrum, i.e., not 
subjected to scattering and absorption effects. The obtained results are shown in Figure 5.7. 
 (a) 
 (b) 
Figure 5.7:  Bulk fluorescence spectra and the corresponding intrinsic fluorescence spectra measured from two 
tissue phantoms: (a) phantom with intralipid mass concentration equal to 2%, hemoglobin 
concentration of 0.25 mg/mL, and furan concentration of 0.25 μg/mL; (b) phantom with intralipid 
mass concentration equal to 2%, hemoglobin concentration of 0.5 mg/mL, and furan concentration 
of 0.25 μg/mL. The blue spectra in both figures are the fluorescence measured from pure furan in 
water.  
From Figure 5.7 it is possible to conclude that the extracted intrinsic fluorescence 
spectra, which are independent to the absorbers and scatterers, and the raw spectrum of pure 
furan are well overlapped. This successfully proves the ability of the algorithm to extract only 
the tissue fluorophores fluorescence. 
5.2 Qualitative diagnosis 
A less-complex spectroscopy system can be built using only two optical microsensors. 
One microsensor will be used for fluorescence measurements, while the other will be used to 
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collect the reflectance signal. Alternatively, the same array of 16 optical microsensors can be 
used, but the data analysis can be performed for only two microsensors. This potentially 
speeds up the analysis. Also, for this less complex approach, data from wavelengths above 
650 nm is going to be excluded since it doesn’t add significant information for a qualitative 
diagnosis. 
To design the optical microsensors, i.e., to define the two specific transmittance 
spectral bands of the optical filters, diffuse reflectance and fluorescence data from normal and 
dysplastic gastrointestinal tissue was used (examples are shown in Figure 5.8). This data set 
comprised 9 dysplastic tissue sites and 42 normal tissue sites. 
 
 
Figure 5.8:  Diffuse reflectance (dashed lines) and fluorescence (solid lines) spectra examples. Higher intensity 
spectra correspond to normal tissue, whereas dysplastic tissue sites exhibit low intensity spectra. 
For this illustration, reflectance and fluorescence intensity spectra were normalized to their 
maximum intensity values for a better comparison of their spectral shape (peaks and valleys). 
 From Figure 5.8, and using only two spectral bands, the optical filters should be able 
to select one fluorescence band in the violet/blue region of the spectrum (centered at 420 nm) 
and one reflectance band in the green region of the spectrum (centered at 540 nm). These 
central wavelengths were selected in order to detect approximately the maximum fluorescence 
emission of tissues, and to detect one of the hemoglobin absorption peaks in the reflectance 
signal. A previous study [6] has shown that it is very important to take into account a green 
reflectance band, to help in the differentiation of inflammation from tumors, and thus reduce 
the number of false-positives. For this reason, the 540 nm spectral band was selected for the 
reflectance measurements, instead of the 420 nm spectral band. 
 For the green region, the filter composed by 52 nm thick TiO2 and 95 nm thick SiO2 
mirror layers, and with a 192 nm thick resonance cavity was used. For the violet/blue region, 
the filter composed by 45 nm thick TiO2 and 70 nm thick SiO2 mirror layers, and with a 138 
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nm thick resonance cavity was used. 
 The tails of the green and violet/blue filters at wavelengths farther from their 
transmittance peak may raise some concerns. For the violet/blue optical filter the 
transmittance increases from 550 to 650 nm (see Chapter 4, Figure 4.30). Given that this 
optical filter is going to be used solely for fluorescence measurements, this collection of out 
of band light is not a problem once fluorescence emission in this band tends to zero (see 
Figure 5.8). In turn, the green optical filter tail at low wavelengths will be collecting 
significant out of band light that will confound the reflectance analysis (see Chapter 4, Figure 
4.34(a)). Still, this problem can be exceeded when the effect of the silicon photodiode is 
integrated in the measurements, as described in Chapter 4, section 4.3 (see Figure 4.34(b)).  
 The feasibility of using the developed optical microsensors for distinguishing 
dysplasia from normal tissue was theoretically assessed with a spectral analysis. For this 
study, the optical filters transmittance curves were used together with spectroscopy diffuse-
reflectance and fluorescence data. Histopathology diagnoses are used as the standard against 
which the spectroscopic-qualitative diagnoses are compared.  
 In this analysis, all diffuse-reflectance and fluorescence spectra (not normalized) were 
first multiplied by the green and violet/blue filters measured transmittance curves, 
respectively (see Chapter 4, Figure 4.30 and Figure 4.34(b)). The resulting Gaussian 
distributed spectra were then integrated over the full transmittance range (from 350 to 
650 nm).  The obtained integrated intensity values correspond to the signal that will be read 
by the photodiodes.  
 Subsequently, a statistical analysis was performed on the processed spectral data using 
the Student’s t-test, the Mann-Whitney test, and the logistic regression model. This analysis is 
performed in order to extract any relevant diagnostic algorithm that provides diagnostic 
differences between normal and dysplastic tissues. A statistical software (SPSS) was used for 
this study.  
 The Student’s t-test and the Mann-Whitney test, respectively, were used to compare 
normally and not normally distributed continuous variables (diffuse-reflectance intensity in 
the green spectral band, and fluorescence intensity in the violet/blue spectral band) for two 
distinct groups of tissue sites: dysplastic and normal. A p-value less than 0.05 was considered 
to be statistically significant. For both variables the null hypothesis was rejected. This means 
that the measured intensity values of diffuse-reflectance at 540 nm, and of fluorescence at 420 
nm, are significantly different between the two groups. In nearly all cases, compared with 
dysplasia, normal tissue sites exhibit significantly higher intensity values, both for diffuse-
reflectance and fluorescence, as it was expected. As explained in Chapter 3, a decrease in the 
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fraction of collagen fibers with progression of dysplasia is translated by low fluorescence 
intensities, and by a reduced reflectance signal as a result of low scattering. Also, a high 
hemoglobin concentration, which is characteristic of dysplastic tissues, may attenuate the 
diffuse-reflectance and endogenous fluorescence signal due to absorption. 
 The spectral algorithm for classifying tissue as normal or dysplastic was developed by 
using binary logistic regression. A model with a good predictive capability includes both the 
diffuse-reflectance and fluorescence data. The accuracy of the final logistic regression
 
model 
is evaluated by the area under the ROC (Receiver Operating Characteristic) curve (AUC), and 
the sensitivity and specificity. The box plots of the reflectance and fluorescence variables, as 
well as the ROC curve for the differentiation of dysplasia from normal tissue are presented in 
Figure 5.9. 
 
(a) 
  
(b) (c) 
Figure 5.9:  Discrimination of normal from dysplastic tissue sites: (a) ROC curve for the logistic regression 
algorithm: ROC curve (blue solid line); 45 degree green line (AUC = 0.5). The AUC measures the 
accuracy of the model to correctly classify normal and diseased tissue. A perfect discrimination is 
achieved with an AUC value of 1; an AUC value of 0.5 indicates an inability to differentiate the 
two tissue types. Box plots of the two variables included in the model: (b) fluorescence data from 
the violet/blue spectral region for the two tissue types; (c) reflectance data from the green spectral 
region for the two tissue types. Outliers are symbolized by circles. 
 From the results of Figure 5.9 one can say that the violet/blue fluorescence and green 
diffuse-reflectance intensities are good predictors for the discrimination of tissue disease 
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status.  The model has an overall accuracy of 94.1%. Dysplasia and normal tissue can be 
distinguished with an AUC, sensitivity, and specificity of 0.995, 77.8%, and 97.6%, 
respectively. Sensitivity is defined as the fraction of dysplastic tissue sites correctly identified 
by the model, whereas specificity is defined as the fraction of correctly identified normal 
tissue sites. The not very high value of sensitivity might be explained by the small number of 
dysplastic tissue sites used, which is a limitation in this study. The positive predictive value 
(PPV), which is the probability that a positive result is accurate equals to 87.5%.  The 
negative predictive value (NPV), which is the probability that a negative result is accurate, is 
equal to 95.3%. A high NPV (low number of false negatives) is very important for an 
effective clinical practice, especially when the system is going to be used to guide biopsies, 
since the physician has to be confident that none of the dysplastic lesions are identified as 
normal, and consequently not subjected to biopsy. A low NPV might be indicative that 
cancerous tissue is left in the patient without being identified. 
 Mayinger et al. [7] described a measurement system that uses differences in the 
fluorescence spectral intensities to identify cancerous tissue in the upper GI tract. Tissues 
were excited with violet-blue light and fluorescence spectra were collected using an optical 
fiber and analyzed with a spectrograph. The developed algorithm was based on the intensity 
ratio in the green and red spectral bands and provided a sensitivity of 97% and a specificity of 
95% for the diagnosis of esophageal cancer. However, in his study it was not included data 
for benign lesions (e.g. inflammations) that might influence fluorescence spectroscopy. Uedo 
et al. [6] found that a superficial neoplasm and an inflamed tissue with edema could be 
misunderstood using only fluorescence measurements. For this reason, green reflectance 
information was added to his algorithm, and proved to be helpful for the differentiation of 
inflammation from tumors. Bourg-Heckly and co-workers [8] also used a fluorescence 
spectroscopy system for the detection of dysplasia in the upper GI tract. The instrument was 
composed by a UV xenon lamp, band-pass filters, optical fibers for light delivery and 
collection, and a spectrometer with a CCD camera for detection. Overall, this optical set-up is 
not portable and compact to be used in the clinical environment. In this study of Bourg-
Heckly, a model based only on the fluorescence intensity ratio at two different wavelengths 
(390 and 550 nm) was able to discriminate neoplastic tissue from normal mucosa with a 
sensitivity of 86% and specificity of 95%.  
 In summary, this study approach has two major benefits when compared to others: (1) 
there is a combination of diffuse-reflectance and fluorescence information, which 
combination was shown to be helpful for the discrimination of benign and malignant lesions; 
(2) it is demonstrated that it is possible to identify dysplastic and healthy tissue sites, with a 
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suitable sensitivity and specificity, using a much smaller instrument, compared with the 
instruments used in similar studies. 
 Despite that the obtained results with only two optical filters are very promising, 
further study should be done. As an important next step, the performance of the presented 
diagnostic algorithm should be tested in a large clinical study. Moreover, the overall 
predictive capability of the model could be improved by adding other fluorescence and 
reflectance spectral bands as predictors, having this, however, attached the disadvantage of 
increasing the overall complexity of the system and/or of the data analysis. 
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Experimental Results:  
Ex Vivo Spectroscopy System  
 
This Chapter describes an ex vivo quantitative spectroscopy scanning platform which 
enables integration of different optical modalities for the assessment of ex vivo tissue 
properties. The system is intended to be used in operating rooms, with the ultimate goal of 
imaging excised tissue margins. The clinical utility of the system is demonstrated using ex 
vivo tissue samples. This work was developed at the GR Harrison Spectroscopy Laboratory, at 
the Massachusetts Institute of Technology (MIT). 
6.1 Clinical need 
In the majority of Western countries, surgery is the standard treatment for cancers in 
the GI tract [1]. The introduction of EMR techniques with the ability to remove 2 to 3 cm 
pieces of mucosa and submucosa represents one of the most important advances in the 
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treatment of GI cancers over the last ten years [2]. In particular, EMR is the treatment of 
choice for high-grade dysplasia arising from BE and esophageal ADC [2-3].   
EMR has two major benefits: (1) it has a curative ability since it completely removes 
the diseased mucosa by resecting through the middle or deeper part of the submucosa; (2) it 
can provide larger and deeper biopsy specimens that allow a more precise determination of 
the depth of tumor penetration [2, 4]. The depth of tumor penetration is critical to determine 
the potential for nodal spread [2].  
The success of EMR greatly depends on a precise examination of the resected tissue: 
the location, size, gross appearance, histology, degree of cancer differentiation, depth of 
cancer invasion, involvement of lymphatics or blood vessels in the submucosa, and cancer 
involvement of lateral and vertical margins (distance of cancer from the resection margins) 
must be reported in detail for each specimen [1, 5]. Specifically, lateral and vertical margins 
of a specimen must be carefully pathologically assessed since EMR of a discrete lesion risks 
leaving a positive resection margin (i.e. there are cancer cells at the outer edge of the excised 
specimen) [2]. 
 As mentioned in Chapter 1, this pathological examination is time-consuming, which 
limits the ability of the surgeon to know within the surgery time if he had removed all the 
cancerous tissue from the patient (i.e. if there are no positive margins), or if he needs to re-
excise more tissue. However, currently, there are no alternative reliable tools to assess tissue 
intra-operatively [6]. A significant number of oncology surgeries are, this way, concluded 
before the pathology laboratory results are known [7]. As a major consequence, re-operation 
due to the existence of positive surgical margins is common, which means that cancer has not 
been completely removed with the first surgery [6].  
 Indeed, a study by Mino-Kenudson et al. suggests that EMR only achieves complete 
excision of Barrett’s related cancerous lesions in 4% of all cases [8]. This not only increases 
healthcare costs but, most important, it increases the risk of morbidity associated with extra 
time spent by the patient in the operating room. Therefore, there is a significant technological 
and clinical need for methods and systems capable of a fast and reliable evaluation of excised 
tissues. 
 Ex vivo wide-field imaging strategies, based on an optical diagnosis, have already 
been proposed as potential tools for surgical margin assessment [6, 9-10]. Mahadevan-Jansen 
and coworkers have successfully applied contact probe autofluorescence and DRS, and a 
spectral imaging to classify positive and negative margins of excised breast specimens with 
high sensitivity and specificity [9]. However, a quantitative analysis using images was not 
performed. Pogue and co-workers used confocal reflectance microscopy and spectrograph to 
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raster-scan ex vivo tumors margins and obtained mainly quantitative scattering parameters 
associated with tissue morphology [10].  Similar to previous wide area spectroscopic imaging, 
the non-probe method requires some correction to deal with lines shape spectra if the 
technique is used to acquire quantitative absorption parameters [9]. A quantitative optical 
imaging device to assess breast tumor margins was developed by Ramanujam et al.
 
[6] using 
diffuse-reflectance spectroscopy for the extraction of scattering and absorption information. In 
this work the margin surface is obtained by manually translating an imaging probe that 
contacts the specimen in a container through pre-drilled holes with 5 mm center to center 
spacing, which may limit the image resolution. 
 In this Chapter, it is presented a new and complementary strategy to enable real-time 
comprehensive assessment of surgical margins in excised GI tissues. This system can have a 
great impact in esophageal EMR, but it is not limited to this organ. An ex vivo spatial high-
resolution quantitative spectroscopy (QS) scanning platform for wide area surveillance of 
tissue has been developed. This QS scanning platform enables integration of different optical 
modalities which provide quantitative tissue information that correlates to disease state of the 
surrounding tissue. However, currently the platform only integrates DRS and IFS for the 
extraction of several spectroscopic parameters, but it is adaptable to assemble many other 
optical modalities. DRS and IFS have been first implemented on the scanning platform since, 
and as referred in Chapter 3, they have shown great ability for the detection of dysplasia and 
cancer in the esophagus.  
 The design and feasibility studies of the multi-modal scanning platform for an intra-
operative medical device, that is able to perform a rapid, real-time, detailed, and reliable 
quantitative spectroscopic analysis of tissue surfaces, are described in the sections below. The 
major benefit of this “adaptable scanning platform” concept is that it is not limited to only one 
optical modality, enabling the selection of the appropriate technique for each margin 
assessment, or to use a combination of different techniques. 
6.2 System overview 
Given that ex vivo tissue analysis does not have typical restrictions of in vivo imaging 
such as imaging geometry, surface contour, or patient motion, spectroscopic mapping of an 
arbitrarily wide area is achieved by mechanically scanning an optical probe (the FastEEM 
probe) in an inverted geometry. Spectroscopic data are then taken one grid at a time, as the 
probe moves, with variable grid-to-grid (GTG) distance and field of view (FOV).  
 In the developed instrument, the ex vivo tissue surface under examination can have a 
variable size from 2 square mm to 4 square cm. Still, if necessary, the area for tissue analysis 
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can be easily increased by including a larger sample holder to the scanning platform. The 
samples are placed for analysis in a flat platform, which enables an equal pressure across time 
and an equal distance between probe and tissue throughout the analysis. 
 The FastEEM contact probe
 
[11] consists of a single light delivery fiber surrounded by 
six collection fibers that collect light from tissue and deliver it back to the spectrograph (all 
seven fibers with 200 µm core and NA = 0.22). All fibers are fused together at the tip and 
polished at 17 degree angle to provide the overlapping of detector and collector optical cones. 
For spectroscopic scanning, only one of the collection fibers will be used to collect tissue 
reflectance and fluorescence from a spot size of approximately 500 µm. Wide area coverage 
is achieved by scanning the spot of illumination light over the tissue, using XY mechanical 
scanning. The spectroscopic scanning can be performed with variable resolution, which can 
be as high as a quarter of the spot size since both GTG distance and FOV are controllable. 
 Figure 6.1 depicts the schematic diagram (a) and the photographs (b) of the developed 
instrument.  
 (a) 
 (b) 
Figure 6.1:   (a) Schematic layout and (b) photographs of the ex vivo quantitative spectroscopy scanning 
platform; a regular white-light camera is used to take pictures of the samples under analysis. 
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 To perform DRS measurements, white-light from a 75W CW xenon arc lamp (Oriel 
Instruments, USA) is coupled via the delivery fiber, to illuminate a “diagnostic spot” of ~0.5 
mm in diameter on the tissue sample. DRS signal from the sample is collected, with adjacent 
collection fibers, and coupled to a spectrometer (USB 2000+, Ocean Optics, USA). A 
personal computer equipped with Labview 8.5.0 software and DAQ data acquisition board NI 
PCI-6221 (National Instruments, USA) are used to control and coordinate the various 
components, including the GTG distance and FOV of the 2-D mechanical scanning (M-
605.1DD and M-126.DG1, Physik Instrument, Germany). Spectroscopic data from the 
spectrometer and 2D stage positions are acquired and then analyzed using model-based 
diagnostic algorithms [12-13]. This way, the instrument will be able to correlate spectroscopic 
parameters with disease status in real-time. 
 Same resources, data handling and data acquisition are utilized  for IFS measurements, 
except the light source is a pulsed diode pumped solid state laser that delivers 355 nm light 
pulses of duration ~0.6 ns and energy ~0.26 μJ at ~38 kHz (SNV-40F-000, Teem Photonics, 
France). Note that different measurements are accomplished through switching the excitation 
sources with an installed flipping mirror. Without any significant changes to the scanning 
engine, the integration of other optical modalities, such as infrared or Raman spectroscopy, 
would only require add-on and data acquisition to the platform. This all-in-one device could 
be a powerful tool in intra-operative clinical tissue diagnostics. 
6.3 System calibration 
 The instrument calibration was performed using liquid phantoms with known 
scattering, absorption and fluorescence properties. These phantoms were constructed by a 
mixture of water based intralipid - scatterer - (Fresenius Kabi AG), hemoglobin – absorber - 
(Sigma Aldrich Co.) and furan – fluorophore - (Lambda Physik) at various concentrations. All 
the measurements were performed using a wavelength range from 350 to 750 nm for DRS and 
380 to 750 nm for IFS. 
 The accuracy and capability of the system for reflectance measurements was carried 
on using several combinations of various concentrations of intralipid, furan (0.5 µg/mL) and 
hemoglobin (0.6, 1, and 1.5 mg/mL). Reflectance spectra were acquired from one spot in each 
sample. All the spectra were normalized by a reflectance standard (Labsphere SRS-20) in 
order to remove spectral distortions and spatial inhomogeneities related with the instrument’s 
spectral and spatial responses. 
 Figure 6.2 shows the calibrated DRS spectra, from the same position on the sample, 
for different phantoms. DRS was used for the extraction of diagnostic information: by fitting 
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the reflectance spectrum to the diffuse scattering model described by Zonios et al. [12], and 
presented in Chapter 3, three DRS parameters were extracted for each pixel: As, the reduced 
scattering coefficient at the reference wavelength; Bs, related to the average scatter size; and 
cHb, the total concentration of hemoglobin. However, it is important to notice that in the 
presented results all the samples were exposed to air and, thus, their estimated oxygen 
saturation is close to 1.0. 
 
Figure 6.2:  Calibrated reflectance spectra (solid lines) measured on different tissue phantoms. The best fit 
spectra are also plotted (dashed lines). The characteristic absorption bands of hemoglobin at 420, 
540, and 580 nm are clearly visible. 
 Figure 6.2 shows that optimal fits were obtained between the measured and computed 
spectra from the samples. From the excellence agreement, the computed spectra give the 
correct values of reflectance spectroscopy parameters, which ensure that the instrument can 
accurately measure the scatter and absorber parameters. The values for parameters As, Bs, and 
cHb are compiled in Table 6.1. 
 
Table 6.1:  Reflectance parameters (As, in mm
-1
, Bs, and cHb in mg/mL) measured from tissue phantoms with 
different hemoglobin concentrations. 
Parameters cHb = 0.6 cHb = 1.0 cHb = 1.5 
As 1.072 1.072 1.069 
Bs 0.318 0.301 0.254 
cHb 0.623 1.004 1.473 
   
 The accuracy of fluorescence measurements was then assessed using the same set of 
phantoms. The fluorescence at each spot is analyzed using IFS: reflectance measurements are 
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used to correct the bulk fluorescence spectra (affected by scattering and absorption) using the 
model described by Müller et al. [14] (described in Chapter 3) to extract the IFS spectra. 
Figure 6.3 shows the fluorescence spectrum of pure furan in water (blue line), and the several 
bulk and IFS spectra measured using phantoms with different hemoglobin concentrations. As 
expected, the data confirms that bulk fluorescence spectra vary considerably with hemoglobin 
concentration in opposition to the IFS spectra. The excellent agreement between the IFS 
spectra and the spectrum of pure furan in water indicates that IFS method can be used to 
remove the distortions caused by tissue scattering and absorption. These data provide 
evidence for an accurate calibration of the QS scanning platform. 
 
Figure 6.3:  Bulk fluorescence spectra (dashed lines) measured on different tissue phantoms. The 
corresponding intrinsic fluorescence spectra (IFS) are also plotted (solid lines). The blue spectrum 
is the fluorescence measured from pure furan in water. Note that the calculated IFS spectra, which 
are independent to the absorbers and scatterers and the raw spectrum of pure furan are well 
overlapped. 
6.4 Tissue imaging 
 In order to assess the performance of the developed system, in an initial approach, a 
series of experiments was performed using breast tissue with two previously identified 
distinct areas: normal and malignant. Figure 6.4 shows a white-light picture of the analyzed 
tissue specimen. This picture was taken using the white-light camera installed below the 
sample holder (Figure 6.1). 
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Figure 6.4:  White-light picture of the analyzed breast tissue sample with a normal and a malignant area. The 
dashed square represents the region of interest that will be scanned using the described instrument. 
 Some parameter maps, extracted from the diffuse-reflectance signal of breast tissue, 
using the algorithm described in Chapter 3, section 3.5.1, are shown in Figure 6.5 (a) and 
Figure 6.5 (b). These maps were obtained using a step size of 125 μm, and an integration time 
of 3 ms at each point. 
 
  
 
(a) (b) 
Figure 6.5:  Representative QS images of breast tissue taken with the developed spatial high-resolution scanner: 
a) quantitative map of the scattering parameter As (mm
-1
); b) quantitative map of hemoglobin 
concentration (mg/dl). Each box represents approximately a 1.2 x 1.2 cm scanning area. 
 The values for parameters As, Bs, and cHb, extracted in two different normal tissue 
sites and in two different malignant tissue sites, are compiled in Table 6.2. 
 From Table 6.2, and as theoretically expected, it is possible to conclude that malignant 
tissue is characterized by lower scattering (low scattering parameter values, As) and higher 
absorption (high hemoglobin concentration values), when compared with normal tissue sites. 
The extraction of quantitative optical parameters, such as, for example, hemoglobin 
concentration and collagen, has proven to be helpful for the differentiation of normal and 
malignant breast tissues. Indeed, a recent study from Volynskaya et al. [15] has successfully 
demonstrated that higher hemoglobin concentrations and higher collagen values were more 
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likely to be found in ductal carcinoma of breast tissue than in normal breast tissue, and thus 
could be used as diagnostic parameters.  
Table 6.2:  Reflectance parameters (As, in mm
-1
, Bs, and cHb in mg/mL) measured from four different tissue 
sites in the breast tissue sample. 
 Normal tissue Malignant tissue 
Parameters Site 1 Site 2 Site 3 Site 4 
As 1.76 1.98 1.67 1.45 
Bs 1.37 1.38 1.09 1.2 
cHb 0.94 0.94 2.00 3.87 
 
 After the first set of experiments, the performance characteristics of the ex vivo QS 
system were demonstrated using an inherently high contrast sample with sharp regional 
boundaries (a section of formalin-fixed human brain cortex with gray and white matter, with 
an approximate size of 2 cm by 2 cm). A diffuse-reflectance map of the brain is shown in 
Figure 6.6 (a), obtained using a step size of 125 μm, and an integration time of 3 ms at each 
point. In this image, fine detail and high contrast between the gray and white matter of the 
brain cortex is clearly visible. For demonstration, high-resolution spectral maps of the 
scattering parameters, As and Bs, and measured hemoglobin concentration are shown in Figure 
6.6(b), Figure 6.6(c), and Figure 6.6(d), respectively. As expected, it is revealed a higher 
hemoglobin concentration on gray matter (related with higher blood volume) [16]. These 
results demonstrate the ability of ex vivo QS scanner to provide spectral contrast based on 
tissue parameters.   
 The concept of quantitative spectroscopy imaging has been demonstrated with the 
developed bench-top platform using DRS and small biological samples. However, as 
previously mentioned, the system is not limited to DRS and IFS. Other modalities, such as 
Raman and infrared spectroscopy can be readily integrated on the platform to provide 
additional and complementary tissue information for the establishment of a reliable diagnosis. 
 In summary, a quantitative multi-modal spectroscopy scanning platform was 
constructed for assessing ex vivo tissue biochemical and morphological information. This 
developed instrument is suitable for the characterization of surgically excised tissue margins, 
providing two major benefits over the current practice: (1) reduce patient anxiety and avoid 
follow-up surgery because on-the-fly real time data analysis can be performed; (2) reduce the 
probability of missing a lesion because the whole ex vivo tissue area can be assessed. The 
proof of principle has been demonstrated with bench-top prototype for quantitative 
spectroscopic scanning of biological samples.  
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(a) (b) 
    
(c) (d) 
Figure 6.6:  Representative QS images of brain cortex taken with the developed spatial high-resolution scanner: 
(a) total reflectance map (in arbitrary units); (b) quantitative map of the scattering parameter As 
(mm
-1
); (c) quantitative map of the scattering parameter Bs; (d) quantitative map of hemoglobin 
concentration (mg/dl). Each box represents approximately a 1 x 1 cm scanning area. 
 In the future, and to have a compact clinical unit, several instrumentation and software 
advances need to be performed: reduction of system size, increase in collection and analysis 
speed, and improved user interface with diagnostic algorithms. Further investigation is also 
needed to address the effect of excision in quantitative hemoglobin and fluorophores 
measurements. For instance, excised specimens contaminated by the presence of surface 
blood may absorb the majority of reflected light, significantly reducing the reflectance signal 
[15]. In addition, some fluorophores (e.g. collagen) might be stable in excised tissue, whereas 
others (e.g. NAD(P)H) might degrade over time, precluding an accurate extraction of its 
concentration. 
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7 Conclusions and Future Work 
Conclusions and  
Future Work 
 
 This chapter presents the final considerations and major achievements of the 
developed work. Future work is also proposed for subsequent investigations. 
7.1 Project overview 
This project had two major goals: (1) the development of a miniaturized spectroscopy 
system that can be integrated in small and less invasive devices for in vivo detection of early 
cancer in the GI tract; (2) development of an ex vivo spectroscopy system for the assessment 
of tissue margins in oncological surgeries. 
7.1.1 Miniaturized spectroscopy system  
 In this investigation preliminary steps have been taken towards the development of a 
miniaturized spectroscopy system for the detection of GI dysplasia, by studying, developing 
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and characterizing its several components and by assessing the clinical impact of such a 
system.  
 The proposed miniaturized spectroscopy instrument is based on thin-film optical 
filters and low-cost silicon photodiodes that are responsible for the selection and detection of 
the spectroscopy signal, respectively. 
 Thin-film optical filters, centered at specific wavelengths, were designed and 
fabricated, after the successful demonstration that using only 16 specific spectral bands 
enabled an accurate extraction of quantitative tissue information. The fabrication of the filters 
and its further optimization was a lengthy and complex process, with several problems 
associated in order to get reasonable results. 
 The feasibility of using the fabricated filters to establish a quantitative diagnosis was 
investigated by performing diffuse-reflectance measurements on tissue phantoms. The 
measurements corresponded to discrete spectral points that were successfully correlated with 
the phantoms original spectra values. The success of these results enabled an accurate 
reconstruction of the full spectrum in the 350 nm to 750 nm range using only 16 points. From 
the reconstructed spectrum, the information about tissue properties could be then reliably 
extracted using the described spectroscopy analytical models. With the obtained results it was 
possible to validate the replacement of the spectrograph by an array of thin-film optical filters 
for spectroscopy measurements. 
 A different approach, using only two optical filters, was theoretically assessed for the 
establishment of an empirical diagnosis. It was successfully demonstrated that the use of two 
spectral bands, one centered at 420 nm for the fluorescence emitted signal, and the other 
centered at 540 nm for the measured diffuse-reflectance signal, can be useful to differentiate 
dysplasia from clinically normal tissues. The developed diagnostic algorithm, based on these 
two spectral bands, is very simple and enabled a sensitivity and specificity of 77.8% and 
97.6%, respectively, for the identification of dysplastic tissues. This approach enables the use 
of a more compact system, but it doesn’t provide an insight about the biochemical and 
morphological properties of the tissue being analyzed, whereas the quantitative approach 
does. 
 The development of this work has highlighted the complexity and challenges 
associated with the scale-down of a spectroscopy instrument. The findings presented show a 
significant progress towards this final goal and serve as an important guide for how to build a 
miniaturized spectroscopy system that can be used in the future as a successful spectral 
diagnostic tool.  
 As a major clinical advantage, a miniaturized spectroscopy system, such as the one 
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described in this thesis, could be integrated in small and less invasive devices making the 
analysis of the GI tract more comfortable to the patient. From the engineering point of view, 
the integration of different optical components, all in a single chip, enables the achievement 
of a high level of reliability, when compared to what can be achieved by mounting several 
discrete optical components (e.g. high optical performance, optimized connections between 
components due to small-size spacing, fewer losses, less noise, etc.). 
7.1.2 Ex vivo spectroscopy system  
 An ex vivo spectroscopy system for wide-area assessment of tissue margins in real-
time was also developed and evaluated at the GR Harrison Spectroscopy Laboratory, MIT. 
The ex vivo quantitative spectroscopy system is based on a scanning platform which enables 
integration of different optical modalities for the assessment of tissue properties.  
 The quantitative spectroscopy scanner prototype combines DRS and IFS to provide a 
multidimensional image of tissue structural and biochemical properties. The wide area tissue 
coverage is achieved by mechanically scanning an optical probe. The spectroscopic data is 
taken one grid at a time with variable spatial resolution and FOV. The ex vivo tissue surface 
under examination can have a variable size (from a few millimeters to about 4 centimeters) 
since both spatial resolution and FOV can be controlled.  
 The clinical utility of the system was successfully demonstrated using breast and brain 
tissue samples: different images containing reliable quantitative tissue information could be 
obtained using analytical models. This information could be subsequently used to establish a 
diagnosis. 
 The introduction of a few improvements in the first prototype (e.g. reduction of system 
size, increase in collection and analysis speed, improved user interface) can have a huge 
impact in intra-operative diagnosis. Two major benefits of the system can be pointed out: the 
reduction of follow-up surgeries because a real-time tissue analysis can be performed; and, 
the reduction of the probability of missing a lesion because the entire excised tissue area can 
be evaluated. 
7.1.3 Application in endoscopic capsules 
The use of conventional endoscopes to perform endoscopy screening has some 
drawbacks. Among the key problems is the limited flexibility of the endoscope, which is 
associated to procedural pain, limiting the willingness of the patients to undergo endoscopic 
procedures, especially for cancer screening. In this sense, the introduction of the EC in 2001 
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has played an important role since it can greatly reduce the level of discomfort to be tolerated 
by patients [1-3]. The EC is a pill-sized swallowable camera that travels through the GI tract 
taking pictures. The use of capsule endoscopy has several advantages over conventional 
endoscopy: it is non-invasive method; it doesn’t require the presence of a physician; it 
eliminates the need for sedation or insufflation; it offers visual access in a less invasive way to 
parts of the small intestine that were previously accessed only by surgery; and, it is 
disposable [3-6].  
The accuracy of the EC for detecting BE was already, and successfully, evaluated in 
several studies, which also compared its performance with the conventional exam [5, 7-11]. 
The use of the EC appears feasible, safe, and is well tolerated by patients, who, ultimately, 
prefer this diagnostic method over conventional endoscopy. Still, and because its diagnosis is 
based mainly on white-light images, capsule endoscopy has the same drawbacks as 
conventional endoscopy: invisible dysplasia is not detected, even in a high-resolution image. 
In this context, the addition of spectroscopy functions would offer the possibility of detecting 
the very earliest mucosal changes at the microstructural and biochemical levels [12].  
For that reason, the future integration of the described miniaturized spectroscopy 
system in an EC would have a huge clinical utility since it would add essential diagnostic 
functions, e. g. the objective detection of invisible malignant lesions (dysplasia), to current 
capsule imaging functions. Kfouri and coworkers [13] have attempted to integrate 
fluorescence imaging functions in a miniaturized capsule endoscope for a non-invasive GI 
diagnosis. However, the full integrated prototype is still too large (2 cm in diameter and 10 
cm in length) to be swallowed and further miniaturization is compromised by the use of 
several incompatible CMOS IC components.  
The miniaturized spectroscopy system described in this work, in a final prototype, is 
not expected to exceed a few millimeters, and, this way, it can be placed near the current 
capsule camera with little space adjustment (Figure 7.1). Also, two of the available white 
LEDs can be kept for tissue illumination during standard images acquisition, whereas the 
other two must be replaced by one UV and one high luminous efficiency white LED for 
fluorescence and diffuse-reflectance measurements, respectively.  
Also, and as a next step, numerous microsystems (photodiodes plus optical filters) 
could be built and positioned around the capsule and not only in its front sides (such as the 
cameras of the commercial capsules), so that a wide tissue area can be assessed. Since point 
spectroscopy techniques may suffer from undersampling, missing contextual information 
often needed to distinguish diseased from surrounding normal tissues, the incorporation of 
optical detectors all around the capsule may solve this drawback [12].  
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Figure 7.1:  Picture representing the future integration of the miniaturized spectroscopy system in an EC. 
Example is shown for the collection of diffuse-reflectance data (i.e. illumination using one white 
LED), and for the integration in a capsule with a single camera. The current capsule CMOS image 
sensor is represented by the centre black square.  
7.2 Future work 
 Epithelial tissues emit fluorescence mainly in the violet/blue region of the spectrum. 
For this reason, optical filters were proposed to cover this spectral region. Unfortunately, the 
majority of these filters didn’t produce the expected results, i.e. their transmittances were not 
high enough to enable the discrimination of the different peaks. Moreover, it was 
demonstrated that the fabricated photodiodes didn’t have good quantum efficiency at low 
visible wavelengths. This way, future work should deal with the improvement of the selection 
and detection of wavelengths in near-UV/blue wavelength range. 
 Silicon photodiodes, fabricated in a standard CMOS process, with high sensitivity and 
selectivity, have already been proposed for this spectral region [14-15]. The selectivity is 
achieved using a shallow active region, limited by a high potential barrier at a depth of 
450 nm. The photodiodes have the maximum responsivity around 400-420 nm, with a 
quantum efficiency that can go up to 50%. 
 With a reliable and efficient detection system, the next direction of the project should 
be the deposition of the optical filters directly on top of the CMOS photodiodes array, and the 
integration of readout electronics, on the same chip. 
 Additionally, a CMOS-Compatible Linear Variable Optical Filter (LVOF), such as the 
one described by Emadi et al.,  that can be integrated with a CMOS photodiode array and 
readout circuitry, could be developed in a future step [16-17]. This LVOF structure is also 
based on a Fabry-Perot resonator, being composed by 21 layers of dielectric materials (SiO2 
and HfO2). This variable filter can be tuned from UV (where it has high resolution) to near-
infrared wavelengths, and, thus, has the potential to replace the 16 individual optical filters 
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that were developed. Theoretically, it can have a resolution better than 0.2 nm, in the visible 
range, using some processing techniques. In this sense, the LVOF can have a great impact in 
the described miniaturized spectroscopy system. Still, further study needs to be done on how 
to integrate, control and finally perform the intended spectroscopy measurements using this 
filter. 
Future investigations should also be directed for the integration of NBI functions in 
ECs using thin-film optical filters for the selection of the three excitation bands. In this 
particular application, it is very important to assess the quality of the acquired images using 
the ECs and to establish a comparison between these images and the ones acquired using a 
conventional endoscope with NBI performance. If the images obtained with the two 
instruments have similar quality and resolution, an important step is given towards providing 
patients a less invasive diagnosis. 
References 
[1] M. Delvaux and G. Gerard, "Capsule endoscopy in 2005: facts and perspectives," Best 
Pract Res Clin Gastroenterol, vol. 20, pp. 23-39, Feb 2006. 
[2] A. Moglia, et al., "Wireless capsule endoscopy: from diagnostic devices to 
multipurpose robotic systems," Biomedical Microdevices, vol. 9, pp. 235-43, Apr 
2007. 
[3] D. Fleischer, "Capsule imaging," Clin Gastroenterol Hepatol, vol. 3, pp. S30-2, Jul 
2005. 
[4] B. Koslowsky, et al., "PillCam ESO in esophageal studies: improved diagnostic yield 
of 14 frames per second (fps) compared with 4 fps," Endoscopy, vol. 38, pp. 27-30, 
Jan 2006. 
[5] I. M. Gralnek, et al., "Detecting esophageal disease with second-generation capsule 
endoscopy: initial evaluation of the PillCam ESO 2," Endoscopy, vol. 40, pp. 275-9, 
Apr 2008. 
[6] T. Nakamura and A. Terano, "Capsule endoscopy: past, present, and future," J 
Gastroenterol, vol. 43, pp. 93-9, 2008. 
[7] O. S. Lin, et al., "Blinded comparison of esophageal capsule endoscopy versus 
conventional endoscopy for a diagnosis of Barrett's esophagus in patients with chronic 
gastroesophageal reflux," Gastrointestinal Endoscopy, vol. 65, pp. 577-583, Apr 2007. 
[8] J. P. Galmiche, et al., "Screening for esophagitis and Barrett's esophagus with wireless 
esophageal capsule endoscopy: a multicenter prospective trial in patients with reflux 
symptoms," Am J Gastroenterol, vol. 103, pp. 538-45, Mar 2008. 
[9] R. Eliakim, et al., "A novel diagnostic tool for detecting oesophageal pathology: the 
PillCam oesophageal video capsule," Aliment Pharmacol Ther, vol. 20, pp. 1083-9, 
Nov 2004. 
[10] P. Sharma, et al., "The diagnostic accuracy of esophageal capsule endoscopy in 
patients with gastroesophageal reflux disease and Barrett's esophagus: a blinded, 
prospective study," Am J Gastroenterol, vol. 103, pp. 525-32, Mar 2008. 
[11] F. C. Ramirez, et al., "Screening of Barrett's esophagus with string-capsule 
endoscopy: a prospective blinded study of 100 consecutive patients using histology as 
the criterion standard," Gastrointest Endosc, vol. 68, pp. 25-31, Jul 2008. 
[12] R. S. Dacosta, et al., "New optical technologies for earlier endoscopic diagnosis of 
Spectroscopy systems for the detection of gastrointestinal dysplasia Chapter 7 
  133/137 
premalignant gastrointestinal lesions," J Gastroenterol Hepatol, vol. 17 Suppl, pp. 
S85-104, Feb 2002. 
[13] M. Kfouri, et al., "Toward a miniaturized wireless fluorescence-based diagnostic 
Imaging system," Ieee Journal of Selected Topics in Quantum Electronics, vol. 14, pp. 
226-234, Jan-Feb 2008. 
[14] A. Pauchard, et al., "A silicon blue/UV selective stripe-shaped photodiode," Sensors 
and Actuators, vol. 76, pp. 172-177, 1999. 
[15] A. Pauchard, et al., "Integrated microsystem for blue/UV detection," Sensors and 
Actuators, vol. 85 pp. 99-105, 2000. 
[16] A. Emadi, et al., "Fabrication and characterization of IC-Compatible Linear Variable 
Optical Filters with application in a microspectrometer," Sensors and Actuators a-
Physical, vol. 162, pp. 400-405, 2010. 
[17] A. Emadi, et al., "CMOS-compatible LVOF-based visible microspectrometer " 
presented at the Proceedings of the SPIE Conference, Orlando, Florida, USA 2010. 
 
 
 
. 
 
   135/137 
Annex   
Journal Publications 
Annex      Journal Publications 
Spectroscopy systems for the detection of gastrointestinal dysplasia Annex 
  137/137 
D. S. Ferreira, J. Mirkovic, R. F. Wolffenbuttel, J. H. Correia, M. S. Feld, and G. 
Minas, “Narrow-band pass filter array for integrated opto-electronic spectroscopy 
detectors to assess esophageal tissue”, Biomedical Optics Express, vol. 2, 2011, pp. 
1703-1716. 
D. S. Ferreira, V. Pinto, J. H. Correia, and G. Minas, “Spectroscopic Detection of 
Gastrointestinal Dysplasia Using Optical Microsensors”, IEEE Transactions on 
Biomedical Engineering, vol. 58, 2011, pp. 2633-2639. 
 
 
The full papers are attached in the following pages. 
 
 
Narrow-band pass filter array for integrated 
opto-electronic spectroscopy detectors to assess 
esophageal tissue 
Débora S. Ferreira,
1,*
 Jelena Mirkovic,
2
 Reinoud F. Wolffenbuttel,
3
 José H. Correia,
1
 
Michael S. Feld,
2
 and Graça Minas
1
 
1Department of Industrial Electronics, University of Minho, Campus de Azurém, 4800-058, Guimarães, Portugal 
2George R. Harrison Spectroscopy Laboratory, Massachusetts Institute of Technology, 77 Massachusetts Avenue, 
Cambridge, Massachusetts 02139, USA 
3Faculty of Electrical Engineering, Mathematics and Computer Science, Department of Microelectronics,  
Delft University of Technology, Mekelweg 4, 2628, CD Delft, The Netherlands 
*debora@dei.uminho.pt 
Abstract: A strategy for spectroscopy tissue diagnosis using a small 
number of wavelengths is reported. The feasibility to accurately quantify 
tissue information using only 16 wavelengths is demonstrated with several 
wavelength reduction simulations of the existing esophageal data set. These 
results are an important step for the development of a miniaturized, robust 
and low-cost spectroscopy system. This system is based on a sub-millimeter 
high-selective filter array that offers prospects for a simplified miniature 
spectrographic detector for a future diagnostic tool to improve the diagnosis 
of dysplasia. Several thin-film optical filters are optimized and fabricated 
and its spectral performance is shown to be sufficient for the selection of 
specific wavelength bands. 
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1. Introduction 
The majority of lower esophageal adenocarcinomas appear in patients with Barrett's 
esophagus (BE), a premalignant condition in which the normal squamous epithelium is 
replaced by metaplastic columnar epithelium. Adenocarcinomas develop through increasing 
grades of dysplasia, which is the precursor lesion of epithelial cancers. Detection of dysplasia 
is essential for managing this type of cancer since the chances of an effective treatment 
increase if the disease is diagnosed at an early stage, significantly improving the survival rate 
[1–4]. 
Dysplastic lesions arising in BE are difficult to identify and to diagnose using standard 
methods, such as conventional white-light endoscopy [5]. Therefore, clinicians take 
systematic patterned biopsies to screen for dysplasia. Moreover, dysplasia can be difficult to 
diagnose due to the poor intra- and inter-observer agreement among gastrointestinal 
pathologists [6–9]. 
#144832 - $15.00 USD Received 28 Mar 2011; revised 21 May 2011; accepted 23 May 2011; pub. 25 May 2011
(C) 2011 OSA 1 June 2011 / Vol. 2,  No. 6 / BIOMEDICAL OPTICS EXPRESS  1704
Optical techniques, such as diffuse reflectance and fluorescence spectroscopy, provide 
contrast based on tissue morphology and biochemistry to help differentiate non-dysplastic 
from dysplastic lesions in BE. These techniques can be used to guide biopsy during white-
light endoscopy [1,2,9,10]. Several groups have successfully applied diffuse reflectance and 
fluorescence spectroscopy for detecting and classifying dysplasia in BE [1,11–14]. 
Diffuse reflectance spectra can be analyzed using a well-developed analytical model to 
obtain tissue optical parameters, such as the wavelength dependent scattering parameter, and 
hemoglobin concentration and oxygen saturation [15]. Intrinsic fluorescence spectroscopy is 
used to extract the relative contributions of tissue fluorophores, such as NAD(P)H and 
collagen [16]. These parameters are subsequently correlated to histopathologic diagnosis and 
analyzed using statistical methods to develop quantitative diagnostic algorithms. 
Research prototypes designed to perform diffuse reflectance and fluorescence 
spectroscopy are generally accurate in the quantification of tissue parameters and in diagnosis. 
However, these prototypes suffer from several drawbacks. Regular optical fibers usually have 
low collection efficiency, thus requiring high quantum efficiency detectors (such as charge 
coupled device cameras - CCDs). In addition, these research prototypes (not yet commercially 
available) include costly, bulky and sophisticated illumination equipment (xenon arc lamps, 
UV lasers). Therefore, the development of a low complexity, miniature, and cost-effective 
spectroscopy system without the need of optical fibers, spectrograph or CCD cameras could 
potentially increase the collection efficiency, while simplifying the device. Previous studies 
have aimed to develop a system with some of these features using LEDs (light-emitting 
diodes) as the illumination sources and photodiodes as the detector [17,18]. Yu et al. [17] 
developed an optical device to quantitatively assess tissue optical properties using a silicon 
photodiode for detection. However, a xenon lamp, a monochromator and optical fibers were 
still used. Lo et al. [18] described a spectroscopy system that can integrate LEDs for 
illumination and wavelength selection, and silicon photodiodes for detection. Even though this 
study represents a big step towards decreasing the cost and size of conventional spectroscopy 
systems, only five LED wavelengths are used, which may not be enough to accurately extract 
other physiological parameters besides hemoglobin. The addition of extra LEDs can 
compromise a full integration and size reduction. 
In this study we propose the development of a potentially robust sub-millimeter narrow-
band pass filter array that offers prospects for a simplified miniature spectrographic detector 
for a future spectrographic diagnostic tool to improve diagnosis of dysplasia. 
In this paper we describe a strategy for spectroscopy diagnosis using a reduced number of 
wavelengths. The long term goal of this study is the development of a simple spectral 
instrument based on thin-film optical filters and silicon photodiodes for signal detection. Here 
we focus on diffuse reflectance spectroscopy. Nevertheless, the instrument has potential for 
fluorescence measurements which is the subject of future work. 
2. Diffuse reflectance spectroscopy model 
In diffuse reflectance spectroscopy (DRS) white-light is delivered to the tissue and photons 
are absorbed and elastically scattered multiple times by tissue constituents. The detected 
scattered photons carry information about tissue structure and composition. Using a well-
developed model based on the diffusion approximation [15], quantitative information about 
tissue constituents that contribute to reflectance can be extracted. In this method, the 
reflectance spectra are fit to the Zonios et al. [15] model to determine the values of the 
reduced scattering, ' ( )s  , and absorption, )(a , coefficients of the tissue (in mm
1
). These 
coefficients can be expressed as [19]: 
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 ( ) ( ). . ( ).blooda diff aC        (2) 
In Eq. (1), λ is the wavelength (in μm) and 
0  is equal to 0.7 μm ( 0  is the reference 
wavelength for the extraction of parameter A ). The second term is used to accurately model 
reflectance at wavelengths below 0.4 μm. 
For Eq. (2) 
diffC  is a correction factor to account for the vessel packaging effect (related to 
the fact that hemoglobin is restrained to blood vessels that are more or less transparent to light 
depending on the incident wavelength), and theta = Hbc / 150 and corresponds to the volume 
fraction of blood sampled, where a hemoglobin concentration of 150 mg/mL is assumed for 
whole blood. 
diffC is defined by: 
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where rb is the effective blood vessel radius (in mm) and )( blooda  is the absorption 
coefficient of whole blood (in mm
1
): 
 
2
( ) log10 .150 / . ( ) (1 ) ( ) ,blooda HbO Hbmg mL             (4) 
where   is the hemoglobin oxygen saturation; 
2HbO
 and 
Hb  are the molar extinction 
coefficient spectra of the oxygenated and deoxygenated hemoglobin, respectively. 
The measured reflectance spectra in the data set used in the present study were fit over the 
350 to 750 nm range using a nonlinear least-squares fitting algorithm. From the fitting six 
DRS parameters are extracted at each tissue spot: A, related to scatterer density (mm
1
); B, 
related to the average scatterer size; C, related to scattering by small particles; 
Hbc , the total 
concentration of hemoglobin (mg/mL); b r , the effective blood vessel radius (mm); and α, 
the oxygen saturation of hemoglobin. 
3. Instrumentation 
The designed system will be composed of thin-film optical filters and silicon photodiodes that 
will, respectively, select and detect several light wavelengths. In addition, commercial small-
size ultraviolet (UV) and white LEDs will be incorporated in the system as the illumination 
sources for fluorescence and diffuse reflectance spectroscopy, respectively. UV LEDs are 
already available at the die level (Nitride Semiconductors Co., Ltd., The Fox Group Inc., 
among others) whereas white LEDs with high luminous efficacy have already been developed 
[20]. The use of these components eliminates the need for expensive illumination and 
detection equipment (high-power xenon arc lamp, CCD camera, spectrograph), and optical 
fibers to delivery and collect light from tissues. 
This miniaturized spectroscopy system could be integrated in standard clinical endoscopes 
making these instruments more compact and portable. Its dimensional advantage can also 
enable a future integration in a smaller and less invasive device, such as the endoscopic 
capsule. Once a CMOS co-integration process is used, the dimensions of each optical 
microsensor (thin-film optical filter and photodiode) can be scaled down to 50x50 μm2 to 
enable integration into an endoscopic capsule. The fabrication of the system in a compatible 
CMOS process will also allow the mass production of the microsensors at reduced costs. With 
this integration essential diagnostic functions will be added to current capsule imaging 
functions. In this particular application, numerous microsystems should be built and 
positioned around the capsule and not only in its front (such as the cameras of the commercial 
capsules), so that a wide tissue area can be assessed. It is known that the majority of 
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endoscopes that integrate spectroscopy functions use point spectroscopy instead of imaging 
spectroscopy. Despite of being a promising method for detecting early stage cancer, point 
spectroscopy techniques suffer from undersampling, missing contextual information often 
needed to distinguish diseased from surrounding normal tissues. Incorporating optical 
detectors all around the capsule may solve this drawback. The promising developments in the 
field of the capsule locomotion and stopping mechanisms [21–23] will make it possible to 
place the capsule into gentle contact with the tissue when data are taken. The use of a 
detection system directly in contact with the tissue enables collection of most of the reemitted 
light, which represents a significant advantage over conventional systems [17,18]. Figure 1 
depicts the several components of a conventional and a miniaturized spectroscopy system. 
a) b)
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Fig. 1. Spectroscopy systems. (a) Conventional system with excitation and collection fibers, 
white-light and UV illumination sources, spectrograph and CCD for detection. (b) Miniaturized 
system with LEDs as light sources, optical filters and photodetectors for wavelength selection 
and detection, respectively (not scaled). Data transmission is intended to be wireless. 
3.1 Wavelength reduction analysis 
The possibility of replacing the spectrograph by a series of optical filters in the 350 to 750 nm 
spectral range was first investigated using an existing diffuse reflectance data set. These data 
were taken from esophageal tissue using a system described elsewhere [1]. For this study, 
simulations on wavelength reduction were performed on the data set in order to assess the 
feasibility of reducing the 400 wavelengths used to perform diagnosis to only 16, while still 
achieving a good accuracy in the extraction of tissue optical properties (sixteen was 
considered the minimum number of wavelengths from which one could accurately extract 
tissue information, as will be detailed in section 4.1). 
If that is feasible, the optical microsensors used for light collection will be composed by a 
16 narrow-band pass filter array (4 by 4), placed on top of an array of silicon photodiodes. 
The array area will be approximately 200x200 μm2. The final encapsulation of the dies on a 
single chip will also require some space for wiring that will depend on the number of bonding 
pads (each bonding pad has a maximum size of 100x100 μm2) and the encapsulation package. 
Each optical microsensor will be collecting different wavelength bands from slightly different 
locations in the tissue surface. However, since the maximum center to center separation of 
photodiodes will be around 150 μm it is reasonable to believe that no significant spatial 
heterogeneity will be introduced across wavelengths. Moreover, the analog photodiodes array 
readout electronics signals will be converted to digital using a compact Sigma-delta converter, 
already studied by the research group [24]. Each photodiode will have one converter. It is 
important to notice that the addition of readout electronics will not increase the size of the 
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optical microsensors since this converter can be designed with only 19 MOSFETs [24]. This 
scheme will be able to make a conversion in less than 1 microsecond. Thus, in order to avoid 
any potential spatial heterogeneity that might occur, the position of the optical array might be 
slightly moved to scan the tissue area under analysis, enabling several measurements, in 
different locations, by each optical microsensor. With this approach a matrix with 16 different 
spectral measurements in each specific location can be obtained. 
For the wavelength reduction analysis, diffuse reflectance algorithms (section 2) were 
implemented using MATLAB tools (from The MathWorks
TM
). Based on previously published 
results [1], several slightly different combinations of 16 wavelengths were chosen and 
simulated. For all the simulations the following wavelengths were fixed: 350 and 750 nm (the 
first and last wavelength in the analysis); 420, 540 and 580 nm (corresponding to oxy-
hemoglobin absorption peaks); and 700 nm (reference wavelength). The remaining 
wavelengths were selected to cover the full visible range. The spacing between selected points 
must take into account the filters fabrication constraints, namely their FWHM (Full-Width-
Half-Maximum), i.e., the filters transmittance spectrum should not considerably overlap. 
Thus, the best 16 wavelengths group is composed by those 6 fixed points and by 10 more 
wavelengths which are more or less equally spaced along the spectrum, corresponding to 
filters which by design don’t overlap. 
The diffuse reflectance data were then processed and data points from all wavelengths 
were eliminated, with exception for those corresponding to the selected 16 wavelengths. Thus, 
instead of having a continuous array of 400 wavelengths (from 350 to 750 nm), and the 
corresponding reflectance intensity values, a discrete set of 16 specific data points is obtained. 
The remaining spectrum intensities are achieved by linear interpolation within the range of the 
discrete data set. This newly generated spectrum is then used to extract the tissue spectroscopy 
parameters. In the system to be developed, optical microsensors will directly provide these 16 
intensity values from which the reflectance spectrum will be reconstructed. In this procedure 
unknown data points are being calculated, and therefore one must be aware that the results 
might not be exactly the same as when using the original spectrum. Still, the overall 
advantages of having such a miniaturized system may offset the error. 
The feasibility study outputs the group of the 16 wavelengths that better fits the original 
continuous spectrum. These 16 wavelengths will be selectively detected using one stack of 
TiO2 and SiO2 thin-films, as detailed next below. 
3.2 Thin-film optical filters 
A 16 narrow-band optical filter array has been designed based on Fabry-Perot thin-film 
optical resonators. In addition to the optical filter array only a white-light and a UV source for 
reflectance and fluorescence illumination, respectively, will be required, thus avoiding a full 
spectrograph. The filtering system should be designed to yield a narrow-band pass around the 
selected wavelengths. This way, the instrument will have the high selectivity, at the desired 
wavelength, required for the application. 
The Fabry-Perot resonators consist of two flat parallel mirrors separated by a pre-defined 
distance, with a resonance cavity in the middle. The thickness of the resonance cavity 
determines the transmitted wavelength. In this study, the mirrors are dielectric mirrors 
composed of a stack of TiO2 and SiO2 thin-films (high and low refractive index materials, 
respectively, in the visible spectrum) that offer good performance characteristics with high 
reflectivity and low absorption losses [25–27]. The refractive indexes of these materials (for a 
TiO2 thickness of 52 nm and a SiO2 thickness of 95 nm) were measured by ellipsometry 
(Table 1). Titania and silica have been selected because of the IC (integrated circuit) 
compatibility and the well characterization of their deposition process. Also, the refractive 
index of SiO2 for the spectral band between 350 nm and 750 nm is almost wavelength 
independent (1.476 to 1.455, respectively, with variations smaller than 3%). 
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Table 1. Measured Refractive Indexes (n) of the Dielectric Materials SiO2 and TiO2 
Wavelength (nm) 350 370 380 400 420 450 480 510 
n of SiO2 1.476 1.473 1.472 1.470 1.468 1.465 1.463 1.462 
n of TiO2 2.931 2.889 2.834 2.77 2.699 2.62 2.556 2.504 
Wavelength (nm) 540 560 580 600 620 650 700 750 
n of SiO2 1.460 1.459 1.459 1.458 1.458 1.457 1.456 1.455 
n of TiO2 2.461 2.434 2.411 2.39 2.375 2.351 2.318 2.294 
The selected wavelengths for this study are closely spaced. Hence, the optical filters must be 
highly selective with a FWHM less than 20 nm to avoid misidentification in the analysis by 
possible overlapping of emitted wavelengths. 
4. Results and discussion 
4.1 Wavelength reduction simulations 
The selection of wavelengths for the design of thin-film optical filters was based on 
simulations of wavelength reduction on an existing diffuse reflectance data set. The data set 
consisted of 53 histologically confirmed non-dysplastic tissue sites and 10 high-grade 
dysplastic esophageal tissue sites. The goal is to investigate if it is possible to accurately 
extract tissue properties using reflectance intensity values of only 16 wavelengths, and 
interpolating the remaining spectrum intensities to cover the whole 350 to 750 nm range. 
For the simulations diffuse reflectance parameters were extracted from high-grade 
dysplastic and normal squamous esophageal tissue. Several combinations of 16 wavelengths 
were simulated. The combination that provided the best results comprises the following 
discrete points: 350, 370, 380, 400, 420, 450, 480, 510, 540, 560, 580, 600, 620, 650, 700, and 
750 nm. For this wavelength selection a compromise between the accuracy in parameters 
extraction and the constraints inherent to the filters fabrication process (e.g. materials, number 
of layers, FWHM, and maximum transmission) had to be achieved. This wavelength choice is 
important for the intended diagnosis and will be dependent on the clinical situation for which 
the system is going to be used for. Since the esophagus is expected as the first application of 
the microsystem, the used clinical data set is suitable for the simulations. Examples of DRS 
spectra of high-grade dysplasia and non-dysplastic squamous tissue are shown in Fig. 2. 
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Fig. 2. Examples of DRS spectra for normal (upper line) and high-grade dysplastic tissue 
(bottom line), for (a) the full wavelength range (original spectrum) (b) and only 16 wavelengths 
(reconstructed spectrum). 
The reduced scattering and absorption coefficients were determined for 16 different 
wavelengths, using the original spectrum and the reconstructed spectrum of high-grade 
dysplastic and non-dysplastic tissue sites (Fig. 3). In general, the extracted coefficients using 
the reconstructed spectrum are in good agreement with the coefficients extracted from the 
original spectrum, with a strong and positive correlation: correlation coefficients of 0.951 and 
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0.933 for the reduced scattering coefficient of high-grade dysplasia and non-dysplastic tissue 
sites, respectively; and, 0.966 and 0.987 for the absorption coefficient of high-grade dysplasia 
and non-dysplastic tissue sites, in that order. Thus, it is expected that the miniaturized system 
and the conventional systems will have very comparable performance in the quantification of 
tissue optical information. 
a) b)
 
Fig. 3. Scatter plots with the (a) reduced scattering coefficient and (b) absorption coefficient, 
determined for several different wavelengths: 350, 370, 380, 400, 420, 450, 480, 510, 540, 560, 
580, 600, 620, 650, 700, and 750 nm. For each of these wavelengths, a different coefficient will 
be determined in each tissue site: a total of 10 high-grade dysplastic tissue sites and 53 non-
dysplastic tissue sites were used, corresponding to 160 (10 times 16) and 848 (53 times 16) 
different values of reduced scattering and absorption coefficient. Y-axis represents the values 
of the coefficients extracted with the original spectrum; X-axis represents the values of the 
coefficients determined with the reconstructed spectrum, using only 16 points. The 45 degree 
black line represents a perfect agreement between the expected values, from the original 
spectrum, and the extracted values, from the reconstructed spectrum. 
An even more reduced number of wavelengths for spectra analysis would be useful to 
further reduce the size and complexity of the optical microsensors. However a trade-off 
between this number and an accurate extraction of optical parameters had to be achieved. 
Sixteen was considered the limit beyond which one could accurately determine those 
parameters. 
For demonstration, Fig. 4 presents the same results of Fig. 3 but extracted using only 10 
wavelengths (350, 380, 400, 420, 480, 540, 580, 600, 700 and 750), instead of 16. In this 
approach, the extracted coefficients using the reconstructed spectrum have weaker correlations 
with the coefficients determined from the original spectrum, when compared with the 
previous strategy. Specifically, for the reduced scattering coefficient of non-dysplastic tissue 
sites, there is a weak and not very significant correlation between the expected and extracted 
values, with a correlation coefficient of 0.326. From the obtained results it is clear the 
performance improvement of using 16 over 10 wavelengths for quantitative spectroscopy. 
The theoretical parameters extraction performance of the miniaturized system was then 
assessed. Scatter plots displaying the expected (using the full spectrum) and extracted (using 
only 16 wavelengths) parameter values are presented in Fig. 5 for four DRS parameters: two 
parameters extracted from the reduced scattering coefficient (A and B), and two parameters 
extracted from the absorption coefficient (
Hbc  and rb ). 
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Fig. 4. Scatter plots with the (a) reduced scattering coefficient and (b) absorption coefficient, 
determined for several different wavelengths: 350, 370, 380, 400, 420, 450, 480, 510, 540, 560, 
580, 600, 620, 650, 700, and 750 nm. Y-axis represents the values of the coefficients extracted 
with the original spectrum; X-axis represents the values of the coefficients determined with the 
reconstructed spectrum, using only 10 points. 
 
Fig. 5. Scatter plots with the tissue parameter values for four DRS parameters: A, B, 
Hbc  
(hemoglobin concentration), and b r  (effective blood vessel radius), extracted using the full 
spectrum (expected values) and only 16 wavelengths (extracted values). 
Overall, the reported results demonstrate that reflectance tissue parameters can be 
relatively well determined using a reduced number of wavelengths, and thus these parameters 
can be used with confidence for the development of predictive models to identify normal and 
malignant tissues. Still, for some tissue sites, optical parameters could not be accurately 
extracted, which might be due to loss of spectral information with interpolation. The use of a 
different interpolation method could minimize this error. Also, in further studies an alternative 
approach will be evaluated: a model discretization will be applied and the parameter results 
will be compared to the ones obtained using linear interpolation. 
This rough methodology is applied as an initial approach to select the 16 central 
wavelengths to fabricate the optical filters, and to demonstrate the feasibility of wavelength 
reduction for the assessment of tissue optical properties. 
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4.2 Optical filtering system 
The obtained results show the viability of using 16 wavelengths to extract tissue biochemical 
and morphological information. The selection of these wavelengths can be achieved using a 
16 narrow-band pass optical filter array. This array is composed of three groups of optical 
filters to cover different regions of the spectrum: near-UV/violet (350 to 450 nm); red (620 to 
750 nm); central band of the visible spectrum (480 to 600 nm). Thin-film optics software 
TFCalc
TM
 3.5 was used for the structural optimization of the optical filters. Simulations were 
performed using the previously measured refractive indexes (Table 1). In each group, the 
filters are composed by 11 layers of TiO2 and SiO2, and can be easily tuned to a different 
wavelength by adjusting the thickness of the resonance cavity, e.g., the 6th layer (Table 2). 
This enables the fabrication of several optical filters in each region of the spectrum while 
minimizing the global deposition time. 
Table 2. Layer Thicknesses of the 16 Fabry-Perot Optical Filters 
 Maximum wavelength transmission 
 350 370 380 400 420 450 480 510 540 560 580 600 620 650 700 750 
 Layer thicknesses (nm) 
TiO2 36 52 72 
SiO2 68 95 116 
TiO2 36 52 72 
SiO2 68 95 116 
TiO2 36 52 72 
SiO2 94 110 120 136 154 182 140 164 192 206 227 242 182 210 255 301 
TiO2 36 52 72 
SiO2 68 95 116 
TiO2 36 52 72 
SiO2 68 95 116 
TiO2 36 52 72 
Meanwhile, 6 of the 16 optical filters were fabricated in order to adjust the manufacturing 
process before proceeding with the fabrication of the remaining filters. Thin-film optical 
filters fabrication needs to be well controlled and optimized, because the position of the peak 
is highly sensitive to thickness variation. For example, a thickness variation of only 1 nm in 
each of the TiO2 layers, relative to what was initially designed, is enough to move the peak to 
a different central wavelength. As demonstrated in Fig. 6, an increase of 1 nm in the thickness 
of each of the TiO2 layers significantly affects the central peak position of the 540 nm filter 
(this effect might be noticed not only in the peak central wavelength, but also in its FWHM 
and transmission efficiency). For that reason, the filters were deposited by Ion Beam 
Deposition (IBD) in a 1 nanometer resolution system (Nordiko 3000). 
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Fig. 6. Simulated spectral transmittance for the 540 nm optical filter, with maximum intensity 
peaks at: (a) 540 and (b) 543 nm, when there is an increase of 1 nm in the thickness of each of 
the TiO2 layers. 
Prior to filters fabrication, simple SiO2 and TiO2 films were deposited on silicon substrates 
to calibrate deposition rates and indexes of refraction. Subsequently, multilayer filters were 
deposited on a glass substrate. 
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The fabricated narrow-band pass filters were analyzed by cross section SEM (Scanning 
Electron Microscope) in order to assess layer thicknesses and interface quality between the 
SiO2 and TiO2 layers. Figure 7 depicts the cross-section of one of the analyzed optical filters 
(filter with peak centered at 560 nm). 
 
Fig. 7. SEM photograph showing the cross-section of the Fabry-Perot optical filter with the 
peak centered at 560 nm (magnification 200,000 times). 
Figure 7 demonstrates the clear separation between the SiO2 and TiO2 layers, with very 
low interface mixing (brighter layers correspond to TiO2). The mirrors thicknesses are in good 
agreement with the outlined values, whereas the resonance cavity thickness is slightly lower 
than what was initially designed (206 nm). Very good film flatness is shown along the entire 
area. This feature allows guarantee the parallelism of the mirrors concerning to the resonance 
cavity, which is crucial for reproducible optical measurements. 
The transmittance of the fabricated filters was then assessed using a spectrophotometer 
from Shimadzu (UV-3101PC), and is demonstrated in Fig. 8. All the measurements were 
performed with the placement of a wide-band pass filter (200 nm wide) on top of the optical 
filters. This wide-band pass filter eliminates the tails of the filters outside the 450-650 nm 
spectral region. At this stage, this filter was fabricated on a glass substrate and placed on top 
of the 6 Fabry-Perot optical filters. In the final device, a thin-film wide-band pass filter will be 
processed directly on top of the narrow-band optical filters array, and its effect will be 
combined in the measurements with the optical effect of the silicon photodiodes. A wide-band 
pass filter is easily obtained with a multilayer structure, composed by 11 layers of SiO2 and 
TiO2, which can be represented by: SiO2/TiO2/ SiO2/TiO2/ SiO2/TiO2/ SiO2/TiO2/ 
SiO2/TiO2/SiO2. All these layers have a thickness equal to 88 nm. 
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Fig. 8. Measured transmittance spectra for the 6 fabricated Fabry-Perot optical filters with the 
wide-band pass filter included. 
Optical spectra measurements show that a multilayer structure composed of 
(TiO2,SiO2)
2
TiO2/SiO2/TiO2(SiO2,TiO2)
2
 is the best option in terms of optical characteristics 
and fabrication process. The results show that each filter is sensitive to a specific spectral 
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band, with FWHM < 20 nm, and a ratio of maximum transmittance to background noise 
greater than 70/20. The FWHM translates the quality of the filter in terms of its ability to 
select a narrow band of the electromagnetic spectrum, and therefore, ideally, should be as low 
as possible. Additionally, the transmittance peak should be high, with at least twice the 
intensity of any background noise that might appear in the considered spectral range, so that 
we can clearly discriminate the specific wavelengths, without noise overlap (if it is less, the 
background noise will significantly affect the measurements) [25]. The filters peaks are 
slightly deviated from what was designed, being centered at: 478; 510; 540; 558; 574; and 598 
nm. These differences between the design and the outcome of the fabrication process are 
mainly explained by the etching that might occur in some of the layers immediately below, 
when the multilayer is deposited. Indeed, the total thickness of the multilayers was measured 
using a profilometer, and the result was 2% less than what was initially designed. This event 
will obviously shift the central transmitted wavelength. As mentioned before, the process is 
being optimized and adjustments on the deposition rates are on-going. The overall 
performance of the optical filters could be improved by increasing the number of dielectric 
layers, but the fabrication process complexity would also increase. 
The integration of optical filters, photodiodes and readout electronics on a single-chip 
requires the system to fit in a microelectronic process, preferably CMOS. The CMOS process 
provides three photosensitive structures as vertical junction photodiodes. At a particular 
wavelength, their quantum efficiency varies according to their junction depth. For this 
particular spectral region, we will use pn-junction photodiodes fabricated in a standard 0.7 μm 
CMOS process, without additional masks or steps. 
As an example, a simulation of the optical transmittance for the 540 nm filter was 
performed taking into account the effect of the previously described wide-band pass filter and 
the effect of using a n + /p-epilayer photodiode to read the signal. Previous studies from our 
group have shown the fabrication and characterization of this type of photodiode [28]. The 
thickness of the photodiode junction depth is fixed by the microelectronics foundry, and 
equals to 350 nm (this junction depth is included in the simulations). Figure 9(a) depicts the 
transmittance of the filter without the optical effect of the wide-band pass filter and 
photodiode, whereas Fig. 9(b) illustrates the transmittance of the narrow-band pass filter with 
both effects included in the simulation. From Fig. 9(b) it is clear the signal attenuation below 
450 nm and after 650 nm to less than 12%. Also, the maximum transmittance is lower due to 
the effect of the wide-band pass filter and photodiode. This approach enables the collection of 
spectroscopy data only around the filter central wavelength. 
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Fig. 9. Simulated transmittance spectra for the 540 nm Fabry-Perot optical filter: (a) not 
including and (b) including the optical effect of the wide-band pass filter and the n + /p-
epilayer photodiode. 
A new study was carried out for assessing the performance of the fabricated optical filters 
when used for spectroscopy. This study consisted in measuring diffuse reflectance spectrum 
from a tissue phantom using the fabricated optical filters (together with the wide-band pass 
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filter) placed in front of the UV-3101PC spectrophotometer detector, to determine how 
accurately each filter could detect the diffuse reflectance signal. The phantoms consist of a 
mixture of intralipid and hemoglobin (Sigma Aldrich Co.) and water. The intralipid and the 
water soluble hemoglobin are used for scattering and absorbing, respectively. All the collected 
spectra were normalized by the reflectance spectra measured from a standard (solid sample of 
BaSO4) to correct for the wavelength dependent response of the system. 
For this study, a diffuse reflectance spectrum measured from the tissue phantom without 
using optical filters was first acquired (Fig. 10(a)). After, consecutive diffuse reflectance 
measurements using each of the fabricated filters in front of the detection system were 
performed on the same tissue phantom (Fig. 10(b)). The resulting 6 Gaussian distributed 
spectra were integrated over the full wavelength range. The obtained 6 intensity values 
correspond to the signal that will be read by the optical microsensor. In a further processing, 
the filters transmittance spectra (Fig. 8) were also integrated, and the intensity read by the 
optical microsensor was divided by these 6 values. This way, one can obtain the final 6 data 
points that will compose the wavelength-reduced spectrum (Fig. 10(c)). 
The intensity values obtained with the fabricated filters are similar to the originally 
obtained reflectance intensities measured over the full wavelength range, except for the 540 
and 580 nm valleys that are not as noticeable as desired. This divergence might be explained 
by the filters FWHM. The on-going optimizations to the fabrication process should enable the 
fabrication of more accurate filters, correctly centered at the specific wavelengths, and with a 
smaller FWHM. Overall, it is reasonable to consider that the results validate the possibility of 
replacing the spectrograph by an array of thin-film narrow-band pass filters. 
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Fig. 10. Diffuse reflectance spectra: (a) measured with the UV-3101PC spectrophotometer; (b) 
measured with the 6 fabricated narrow-band pass optical filters; and, (c) together with the 6 
integrated intensity values that will be obtained using the miniaturized system. 
5. Conclusions 
Diffuse reflectance spectroscopy is used to analyze tissue and to extract quantitative 
information. This study demonstrates that it is possible to obtain tissue properties accurately 
using a small number of wavelengths. These results represent an important step towards the 
development of a much smaller, simpler, and cost-effective device compared with the 
conventional spectroscopy prototypes, and with similar throughput. 
The wavelength-reduction simulations were performed using real esophageal tissue data 
and the values of tissue properties obtained with the selected 16 wavelengths are comparable 
with those obtained using 400 wavelengths. However, it is important to notice the significance 
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of wavelength selection which may be different when using the system for other tissue types. 
After this feasibility study, thin-film narrow-band pass filters were fabricated and its optical 
performance was assessed. Reflectance measurements, performed on tissue phantoms, using 
the full wavelength range and the fabricated optical filters provided comparable results. 
Overall, the results show the feasibility of replacing the spectrograph in a conventional 
system by a series of narrow-band pass optical filters in the new spectroscopy system. Also, 
with a future integration of LEDs for illumination and silicon photodiodes for detection, the 
instrument will be fully miniaturized while still providing similar results in terms of 
quantitative diagnostic information. The described results open the way to explore the 
integration of the developed instrument into endoscopic devices with clinical potential. Due to 
its reduced size, it could be incorporated in standard endoscopes making it more compact and 
portable. Moreover, it has a potential to be integrated, in the future, into smaller, less-invasive 
devices, such as the endoscopic capsules. The future directions include: filter optimization 
(specified band pass, FWHM, signal-to-noise ratio, and reliable reproducibility); assembling 
the 16 filters with the silicon photodiodes (in a 4 by 4 array), on a single-chip with readout 
electronics; accommodate on the same chip UV and white-light miniaturized sources. 
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Spectroscopic Detection of Gastrointestinal
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Abstract—The detection of dysplasia in the gastrointestinal tract
can be performed using optical microsensors based on thin-film
optical filters and silicon photodiodes. This paper describes two
optical microsensors that can be used for spectroscopy data collec-
tion in two different spectral bands (one in the violet/blue region
and the other in the green region) for which two optical filters were
designed and fabricated. An empirical analysis of gastrointestinal
spectroscopic data using these specific spectral bands is performed.
The obtained results show that it is possible to accurately differen-
tiate dysplastic lesions from normal tissue, with a sensitivity and
specificity of 77.8% and 97.6%, respectively. Therefore, the devel-
oped filters can be used as a tool to aid in diagnosis. The small size
of the optical microsensors can enable, in the future, integration in
endoscopic capsules.
Index Terms—Diffuse-reflectance, Fabry–Perot optical filters,
fluorescence, spectroscopy tissue diagnosis.
I. INTRODUCTION
GASTROINTESTINAL (GI) cancers, in particular cancersof the esophagus, stomach, and colorectum, are among
the fifth leading causes of cancer-related deaths worldwide [1].
These epithelial cancers are usually preceded by dysplastic
changes. An early identification of cancer is very important
since the chances of an effective treatment considerably in-
crease when the disease is detected at the dysplastic stage,
improving the survival rate [2], [3]. The World Health Orga-
nization has estimated that nearly one-third of cancer burden
could be decreased if lesions were diagnosed and treated at its
earliest stages. Unfortunately, dysplastic lesions are difficult to
detect using standard screening methods: dysplasia is not readily
identifiable by visual inspection during routine endoscopy. As a
consequence, physicians often take a large number of undirected
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biopsies to increase the chances of detecting invisible lesions,
which results in sampling errors and high costs associated with
the procedure [2]–[4].
Optical techniques may overcome some limitations of current
screening methods and enhance detection of dysplasia in vivo.
Diffuse-reflectance and fluorescence spectroscopy have been
proven to be highly sensitive for the identification of dysplasia,
by exhibiting different spectral features that can be correlated
with normal and cancerous tissue [2], [3]. Such techniques have
the ability to reveal biochemical and morphological tissue infor-
mation that can be used to characterize changes that take place
during disease transformation [3], [4].
Several studies have successfully applied diffuse-reflectance
and fluorescence spectroscopy for detecting and classifying dys-
plasia in a variety of GI structures [5]–[7]. In these studies, data
collection is performed using costly and bulky clinical instru-
ments, usually composed by a spectrograph, a detector, and op-
tical fibers. This instrument configuration has some drawbacks:
regular optical fibers might have low collection efficiency, thus
requiring high quantum efficiency detectors (such as charge-
coupled device (CCD) cameras), and, the detector is placed at
the distal end of the collection fiber, where considerable light
might be lost [8]. Moreover, catheter-based endoscopy systems
are invasive and very uncomfortable for the patient. The devel-
opment of a miniature spectroscopy system without using op-
tical fibers, spectrograph or CCDs would enable integration in
small and less-invasive devices for GI tract evaluation. Kfouri
et al. [9] have already developed a miniaturized fluorescence
imaging device for noninvasive diagnosis of diseases in the GI
tract. However, the full-integrated prototype is still too large
(2 cm in diameter and 10 cm in length), and further miniaturiza-
tion is compromised by the use of several incompatible CMOS
IC components. Also, only fluorescence images are acquired
to perform diagnosis. To the best of our knowledge, it was
not yet developed a miniaturized device that integrates both
fluorescence and diffuse-reflectance functions for early cancer
diagnosis.
In this study, it is described a strategy for the detection of
dysplasia in the upper GI tract and proposed the development
of a low complexity, miniaturized device for spectroscopy data
collection (fluorescence together with diffuse-reflectance). This
system, named as optical microsensor, is based on thin-film
optical filters and CMOS silicon photodiodes, for the selection
and detection of two different spectral bands that are significant
for the identification of GI dysplastic lesions. This approach re-
quires the development of two optical filters, one of which will
be used for fluorescence measurements, while the other will be
0018-9294/$26.00 © 2011 IEEE
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used to collect the reflectance signal. Both filters will have a
Fabry–Perot multilayer structure made with dielectric materials
that are Si compatible, thus compatible with standard micro-
electronics fabrication and processing techniques (which is an
asset toward the development of a fully miniaturized device,
in a single chip). Also, the use of all-dielectric layers allows a
narrow and a high peak transmittance spectral band, as required
for the application [10]–[12].
The proposed device has three major advantages over pre-
vious systems: 1) it is miniaturized and, thus, suitable for a
future integration in a less-invasive medical device (e.g., endo-
scopic capsule); 2) it integrates components that are compati-
ble with standard microelectronics fabrication and processing
techniques; and 3) it combines two different spectroscopy tech-
niques: diffuse-reflectance and fluorescence.
II. DIFFUSE-REFLECTANCE AND
FLUORESCENCE SPECTROSCOPY
In diffuse-reflectance spectroscopy, white light delivered to
the tissue is absorbed and multiple scattered by tissue con-
stituents and part of it returns, carrying information about tissue
optical properties (scattering and absorption) [4], [13]. Scatter-
ing is mainly originated by collagen fibers in connective tissue,
whereas absorption is mainly due to hemoglobin. The major
hemoglobin absorption peaks are nearly the 420 nm and 540–
580 nm regions [4]. A decrease in scattering is associated with
increasing dysplasia: epithelial thickness increases, and there-
fore the amount of light propagating to the connective tissue with
collagen is reduced. Additionally, with dysplasia some enzymes
are released that will cleave the collagen cross links [3], [14].
An increased hemoglobin concentration, which translates into
an increased absorption, may be associated with angiogenesis
that is proved to be linked with some types of early cancers [15].
Epithelial tissues produce fluorescence when excited by ultra-
violet (UV) or short-wavelength visible light. This fluorescence
is originated by several fluorophores that are related to the struc-
tural arrangement and metabolism of cells. Each fluorophore is
excited by a specific wavelength and has particular emission
characteristics, supplying different biochemical information. A
modification in fluorescence emission may be related to the
emergence of pathological conditions. The dominant fluorescent
tissue layer is the submucosa, where collagen and elastin emit
around the 400 nm spectral band [4], [16], [17]. NAD(P)H and
collagen are considered fluorescent biomarkers of precancerous
changes in epithelial tissues [14]. An increase in NAD(P)H is
associated with an increase in cellular metabolic activity and
proliferation, both of which occur with the progression of dys-
plasia. A decrease in collagen can be an indicator of loss of
structural integrity and is translated by low fluorescence inten-
sity. Thus, fluorescence intensity of dysplastic epithelial tissue
is generally lower compared to healthy tissue [14], [18], [19].
This concept, together with diffuse-reflectance signal informa-
tion, can be used to distinguish the presence and absence of
malignancy.
An empirical analysis of fluorescence and diffuse-reflectance
signal from GI tissue is described. The intensity of fluorescence
Fig. 1. Cross-sectional view of the optical microsensor with optical filters and
photodiodes (not scaled).
and diffuse-reflectance within only two specific spectral bands
will be used for the discrimination of dysplastic and normal
tissue.
III. DESIGN OF THE OPTICAL MICROSENSOR
An optical microsensor for spectroscopy data collection was
designed (see Fig. 1). This device is based on thin-film opti-
cal filters and silicon photodiodes that will, respectively, select
and detect several light wavelengths of interest for the diag-
nosis of GI dysplasia. The use of these components obviates
the need for expensive and sophisticated detection equipment
and optical fibers for light collection from tissues. In addi-
tion, small-size UV and white light-emitting diodes (LEDs)
could be incorporated in the instrument as the illumination
sources for fluorescence and diffuse-reflectance measurements,
respectively.
The designed microsensor can be scaled down to a few mil-
limeters, and like that has potential to be integrated in very small
and thus less-invasive devices, such as the endoscopic capsule.
For this particular application, a control of the capsule direction
and distance to the tissue surface has first to be achieved. Promis-
ing developments in this field have already been made, which
may allow, in the future, to place the capsule into gentle con-
tact with the tissue, in a controlled way, to collect spectroscopy
data [20], [21]. This placement of the detection system close to
the sample allows us collecting most of the reemitted light.
Concerning power supply requirements, for the proposed op-
tical microsensor, it will be similar to the one used in commercial
endoscopic capsules. A 50-mAh capacity with a 3-V nominal
voltage would be used, being enough for 6-h work. Also, it is
important to notice that the illumination sources will not spend
more energy than the one currently available since when the UV
LEDs are turned ON, the white LEDs are turned OFF and vice
versa.
A. Optical Filters Structure and Materials
The detection of specific spectral bands requires the use of
thin-film optical filters placed on top of silicon photodiodes.
The filtering system is based on Fabry–Perot thin-film optical
resonators. These consist of two flat parallel mirrors separated
by a specific distance, with a resonance cavity in the middle (see
Fig. 2). The thickness of the resonance cavity determines the
transmitted wavelength band, as explained by the equation λq
= 2nd, where n is the refractive index of the cavity medium, d is
the cavity length or thickness, λ is the transmitted wavelength,
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Fig. 2. Designed Fabry–Perot resonator, composed by 11 layers, and with
dielectric mirrors.
Fig. 3. Diffuse-reflectance (dashed lines) and fluorescence (solid lines) spectra
examples. Higher intensity spectra correspond to normal tissue, whereas dys-
plastic tissue sites exhibit low-intensity spectra. For this illustration, reflectance
and fluorescence intensity spectra were normalized to their maximum intensity
values for a better comparison of their spectral shape (peaks and valleys).
and q is the interference order. For the designed filters (see
Fig. 2), the mirrors are dielectric mirrors composed of a stack of
TiO2 and SiO2 thin-films (materials with high and low refractive
index in the visible spectrum, respectively) which offer good
optical performance characteristics, high transmittance and low
full-width half-maximum (FWHM), with low-absorption losses
[12], [22].
B. Optical Filters Simulations
To design the optical microsensors, i.e., to define the two spe-
cific transmittance spectral bands of the optical filters, diffuse-
reflectance and fluorescence data from normal and dysplastic GI
tissue were used (examples are shown in Fig. 3). This dataset
comprised nine dysplastic tissue sites and 42 normal tissue sites.
From Fig. 3, and using only two spectral bands, the optical
filters should be able to select one fluorescence band in the
violet/blue region of the spectrum (centered at 420 nm) and one
reflectance band in the green region of the spectrum (centered
at 540 nm). These central wavelengths were selected in order
to detect approximately the maximum fluorescence emission of
tissues, and to detect one of the hemoglobin absorption peaks in
the reflectance signal. Previous studies [23] have shown that it is
very important to take into account a green reflectance band, to
help in the differentiation of inflammation from tumors, and thus
reduce the number of false positives. For this reason, the 540 nm
spectral band was selected for the reflectance measurements,
instead of the 420 nm spectral band.
Fig. 4. Simulated spectral transmittance of the two Fabry–Perot optical filters:
(a) violet/blue region; (b) green region. Maximum intensity peaks at (a) 420 and
(b) 540 nm.
For the violet/blue region, the mirrors are composed by
45 nm-thick TiO2 and 70 nm-thick SiO2 layers, whereas for the
green region, the mirrors are composed by 52 nm-thick TiO2
and 95 nm-thick SiO2 layers. The resonance cavity thickness,
i.e., the sixth layer, is equal to 138 and 192 nm for the violet/blue
and green filter, respectively. In each spectral region, the optical
filters can be easily tuned to a different central wavelength by
adjusting only the thickness of the sixth layer, and keeping the
same mirror layers. Thus, it would be possible to produce a fil-
ter centered at 450 nm by simply increasing the cavity thickness
from 138 to 180 nm, or to create a filter centered at 500 nm by
reducing only the cavity thickness from 192 to 155 nm. This
procedure enables the fabrication of several optical filters in
each region of the spectrum, whereas, minimizing the global
deposition time.
Thin-film optics software TFCalc 3.5 (Software Spectra, Inc.,
Portland, OR) was used for the structural optimization of the
optical filters. In Fig. 4, the simulated transmittances for the two
Fabry–Perot optical channels are presented.
The simulated results show that each filter is sensitive to its
specific spectral band, with FWHM less than 12 nm. Also, the
peaks transmittance is higher than 90%. However, the tails of
both filters at wavelengths farther from its transmittance peak
may raise some concerns. For the violet/blue optical filter, the
transmittance increases from 550 to 650 nm. Given that this op-
tical filter is going to be used solely for fluorescence measure-
ments, this collection of out-of-band light is not a problem once
fluorescence emission in this band tends to zero (see Fig. 3). On
the other hand, as it is designed, the green optical filter will be
collecting significant out-of-band light that will confound the
reflectance analysis. Still, this problem can also be exceeded
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Fig. 5. Simulated spectral transmittance of the green filter with the optical
effect of the n+/p-epilayer photodiode included.
when the effect of the silicon photodiode is integrated in the
measurements, together with the green filter, to produce the
final device.
The integration of optical filters, photodiodes, and readout
electronics on a single chip requires the system to fit in a mi-
croelectronic process, preferably CMOS. This technology fea-
tures electronics in a small silicon area and offers low power
consumption, an important requirement for the reported appli-
cation. For the violet/blue spectral band, a photodiode with im-
proved quantum efficiency at low-visible wavelengths is being
designed. Regarding the green spectral band, we will use p-n
junction photodiodes fabricated in a standard 0.7-μm CMOS
process, without additional masks or steps.
The CMOS process provides three photosensitive structures
as vertical junction photodiodes. At a particular wavelength,
their quantum efficiency varies according to their junction depth.
In the visible spectrum, blue light is more efficiently collected
by a shallower junction (p+/n-well and n+/p-epilayer) and red
light by a deeper junction (n-well/p-epilayer). However, despite
its shallow junction, the n+/p-epilayer photodiode has high
quantum efficiency around 550 nm due to the different doping
concentration between the n- and the p-side. This extends the
p-side depletion area more deeply [24]. Therefore, this photo-
diode was selected for the microsystem. The green optical filter
will be vertically aligned with the photodiode to build the op-
tical channel for the collection of reflectance data. A detailed
characterization of the fabricated n+/p-epilayer photodiode can
be found in [24].
New computational simulations were then performed for the
green optical filter taking into account the effect of using an
n+/p-epilayer photodiode to read the signal. The thickness of
the photodiode junction depth is fixed by the microelectronics
foundry, and equals to 350 nm. Fig. 5 illustrates the signal at-
tenuation in the violet/blue region to less than 20%. The peak
transmittance is also lower than what was initially simulated
due to the optical effect of the detector.
IV. RESULTS AND DISCUSSION
A. Thin-Film Optical Filters Characterization
Before the optical filters fabrication, single layers of SiO2 and
TiO2 were deposited on silicon substrates to calibrate deposition
rates and indexes of refraction. After, the multilayer filters were
Fig. 6. SEM photograph showing the cross section of the green Fabry–Perot
optical filter (magnification 100 000 times).
Fig. 7. Surface 3-D map of the green Fabry–Perot optical filter.
deposited by ion–beam deposition on a glass substrate using a
Nordiko 3000 deposition tool. Multilayer filters were analyzed
by a cross-sectional scanning electron microscope (SEM) in
order to assess layer thicknesses and interface quality between
the different layers (see Fig. 6).
In Fig. 6, it is noticeable the separation between the SiO2
and TiO2 layers, with very low interface mixing (brighter lay-
ers correspond to elements with high atomic number—TiO2 ).
The film thicknesses are in good agreement with the outlined
values. It is also shown very good film flatness along the entire
area. This feature allows us to guarantee the parallelism of the
mirrors concerning to the resonance cavity, which is crucial for
reproducible optical measurements.
The multilayer surface roughness was also evaluated, in a
400 by 400 μm area, using a profilometer (Dektak 150 Surface
Profiler, Veeco Instruments, Inc., Plainview, TX). The surface
3-D map for the green optical filter is shown in Fig. 7.
From Fig. 7, it can be seen that, in general, the optical filter’s
surface is smooth, as would be desirable in order to minimize
potential interferences to the incident light beam. Its roughness
profile is in average equal to 2.31 nm. Several tiny irregularities
inherent to the filters manufacturing process are present in the
surface; yet, these are not a major concern due to their small
size.
Finally, the transmittance performance of the optical filters
was assessed (see Fig. 8). Optical spectra measurements on the
filters show that they are sensitive to their particular spectral
band. However, the violet/blue filter peak is slightly deviated
from what was initially simulated, being centered at 422 nm,
which is explained by the fabrication process tolerance. This
process has a tolerance of 2% in the thickness of the thin-film
layers being deposited, which is more evident in the SiO2 : some
SiO2 layers might have been deposited about 1 or 2 nm thicker
than what was initially designed; an increase in the layers thick-
ness shifts the spectral peak to the right. Still, this is a very small
deviation that does not affect the performance of the overall
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Fig. 8. Measured transmittance spectra of the two Fabry–Perot optical fil-
ters: (a) violet/blue filter, measured with the UV-3101 PC spectrophotometer (a
CMOS photodiode is currently being designed and optimized for this spectral re-
gion); (b) green filter (measured with the fabricated n+/p-epilayer photodiode).
Maximum intensity peaks at (a) 422 and (b) 540 nm.
system. This filter spectral shape is in good agreement with the
simulations, with a maximum transmittance around 70% and an
FWHM of 12 nm. The FWHM of the green filter is a little wider
than expected by computational simulations (around 23 nm). Its
ratio of maximum transmittance to background noise is greater
than 50/15, which is acceptable for the interference filter since
the transmittance peak has more than twice the intensity of any
background noise that appears in the considered spectral range.
The overall performance of the optical filters could be im-
proved by increasing the number of dielectric layers, but the
fabrication process complexity would also increase. Therefore,
it must be achieved a compromise between the filters accuracy
to perform diagnosis and the constraints inherent to the filters
fabrication process (e.g., materials, number of layers, FWHM,
and maximum transmission).
B. Diffuse-Reflectance and Fluorescence Spectra Analysis
A new strategy based on the use of only two spectral bands
for the detection of dysplasia in the upper GI tract was studied.
The feasibility of using the developed optical microsensors for
distinguishing dysplasia from normal tissue was theoretically
assessed with a spectral analysis. For this study, the optical fil-
ters transmittance curves were used together with spectroscopy
diffuse-reflectance and fluorescence data. Histopathology diag-
noses are used as the standard against which the spectroscopic-
qualitative diagnoses are compared.
In this analysis, all diffuse-reflectance and fluorescence spec-
tra (not normalized) were first multiplied by the green and vio-
let/blue filters measured transmittance curves, respectively (see
Fig. 8). The resulting Gaussian distributed spectra were then in-
tegrated over the full transmittance range (from 350 to 650 nm).
The obtained integrated intensity values correspond to the signal
that will be read by the photodiodes.
Subsequently, a statistical analysis was performed on the
processed spectral data using the Student’s t-test, the Mann–
Whitney test, and the logistic regression model. This analysis is
performed in order to extract any relevant diagnostic algorithm
that provides diagnostic differences between normal and dys-
plastic tissues. A statistical software (IBM R© SPSS R©) was used
for this study.
The Student’s t-test and the Mann–Whitney test, respectively,
were used to compare normally and not normally distributed
continuous variables (diffuse-reflectance intensity in the green
spectral band and fluorescence intensity in the violet/blue spec-
tral band) for two distinct groups of tissue sites: dysplastic
and normal. A p-value less than 0.05 was considered to be
statistically significant. For both variables, the null hypothesis
was rejected. This means that the measured intensity values of
diffuse-reflectance at 540 nm, and of fluorescence at 420 nm,
are significantly different between the two groups. In nearly all
cases, compared with dysplasia, normal tissue sites exhibit sig-
nificantly higher intensity values, both for diffuse-reflectance
and fluorescence, as it was theoretical expected. As explained in
Section II, a decrease in the fraction of collagen fibers with
progression of dysplasia is translated by low fluorescence
intensities, and by a reduced reflectance signal as a result
of low scattering. Also, a high hemoglobin concentration,
which is characteristic of dysplastic tissues, may attenuate the
diffuse-reflectance and endogenous fluorescence signals due to
absorption.
The spectral algorithm for classifying tissue as normal or
dysplastic was developed by using binary logistic regression.
A model with a good predictive capability includes both the
diffuse-reflectance and fluorescence data. The accuracy of the
final logistic regression model is evaluated by the area under
the receiver operating characteristic (ROC) curve (AUC), and
the sensitivity and specificity. The box plots of the reflectance
and fluorescence variables, as well as the ROC curve for the
differentiation of dysplasia from normal tissue are presented in
Fig. 9.
From the results of Fig. 9, one can say that the violet/blue
fluorescence and green diffuse-reflectance intensities are good
predictors for the discrimination of tissue disease status. The
model has an overall accuracy of 94.1%. Dysplasia and nor-
mal tissue can be distinguished with an AUC, sensitivity, and
specificity of 0.995, 77.8%, and 97.6%, respectively. Sensi-
tivity is defined as the fraction of dysplastic tissue sites cor-
rectly identified by the model, whereas specificity is defined as
the fraction of correctly identified normal tissue sites. The not
very high value of sensitivity might be explained by the small
number of dysplastic tissue sites used, which is a limitation in
this study. The positive predictive value, which is the probability
that a positive result is accurate equals to 87.5%. The negative
predictive value (NPV), which is the probability that a negative
result is accurate, is equal to 95.3%. A high NPV (low num-
ber of false negatives) is very important for an effective clinical
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Fig. 9. Discrimination of normal from dysplastic tissue sites. (a) ROC curve
for the logistic regression algorithm: ROC curve (blue solid line); 45◦ green
line (AUC = 0.5). The AUC measures the accuracy of the model to correctly
classify normal and diseased tissue. A perfect discrimination is achieved with
an AUC value of 1; an AUC value of 0.5 indicates an inability to differentiate
the two tissue types. Box plots of the two variables included in the model.
(b) Fluorescence data from the violet/blue spectral region for the two tissue
types. (c) Reflectance data from the green spectral region for the two tissue
types. Outliers are symbolized by circles.
practice, especially when the system is going to be used to guide
biopsies, since the physician has to be confident that none of the
dysplastic lesions are identified as normal, and consequently
not subjected to biopsy. A low NPV might be indicative that
cancerous tissue is left in the patient without being identified.
Mayinger et al. [18] described a measurement system that
uses differences in the fluorescence spectral intensities to iden-
tify cancerous tissue in the upper GI tract. Tissues were excited
with violet-blue light and fluorescence spectra were collected
using an optical fiber and analyzed with a spectrograph. The
developed algorithm was based on the intensity ratio in the
green and red spectral bands and provided a sensitivity of 97%
and a specificity of 95% for the diagnosis of esophageal can-
cer. However, in this study, it was not included data for benign
lesions (e.g., inflammations) that might influence fluorescence
spectroscopy. Uedo et al. [23] found that a superficial neoplasm
and an inflamed tissue with edema could be misunderstood us-
ing only fluorescence measurements. In this study, the addition
of green reflectance information proved to be helpful for the
differentiation of inflammation from tumors.
Bourg-Heckly et al. [6] also used a fluorescence spectroscopy
system for the detection of dysplasia in the upper GI tract. The
instrument was composed by a UV xenon lamp, bandpass filters,
optical fibers for light delivery and collection, and a spectrome-
ter with a CCD camera for detection. Overall, this optical setup
is not portable and compact, which might be cumbersome in the
clinical environment. In this study, a model based only on the flu-
orescence intensity ratio at two different wavelengths (390 and
550 nm) was able to discriminate neoplastic tissue from normal
mucosa with a sensitivity of 86% and specificity of 95%.
In our study, we not only combine information from diffuse-
reflectance and fluorescence, which combination was shown
to be helpful for the discrimination of benign and malignant
lesions, but we also demonstrate that it is possible to identify
dysplastic and healthy tissue sites, with a suitable sensitivity and
specificity, using a much smaller instrument, compared with the
instruments used in similar studies. Replacing the spectrograph
by thin-film optical filters and the CCDs by silicon photodiodes
will enable the development of a more portable, low cost, and
simple spectroscopy system, with similar throughput.
The obtained results with only two optical filters are very
promising but further study should be done. As an important
next step, the performance of the presented diagnostic algo-
rithm should be tested in a large clinical study using the optical
microsensor incorporated in a conventional endoscope. This
optical microsensor must have not only the optical filters post-
processed directly on top of the CMOS photodiodes but also
the readout electronics, all bonded together on the same chip.
A separated fabrication was used as a first approach, since it
enabled the characterization and optimization of the different
parts.
V. CONCLUSION
Diffuse-reflectance and fluorescence spectroscopy proved to
be sensitive methods for the detection of early cancerous le-
sions in the GI tract. This study reports a new approach for
the identification of dysplasia using a simple and miniaturized
system for spectroscopy data collection. The proposed device is
based on thin-film optical filters and silicon photodiodes for the
selection and detection of two spectral bands that will provide
information for diagnosis.
An empirical study was performed using spectroscopy data
from dysplastic and normal GI tissue sites to demonstrate the
feasibility of replacing the spectrograph in standard clinical
prototypes by two optical filters in the miniaturized system. The
spectral performance of the fabricated interference filters was
shown to be sufficient for the intended final goal. The over-
all results have proven that healthy and diseased tissue can be
differentiated with a sensitivity and specificity of 77.8% and
97.6%, respectively.
It is reasonable to envision an important clinical utility for
the proposed optical microsensor since due its reduced size it
could be incorporated in a standard endoscope making it more
compact and portable. Moreover, it could also be, in the future,
integrated in an endoscopic capsule platform for guiding biopsy
of invisible lesions in the GI tract. With this device, the sampling
error and healthcare costs associated with unnecessary biopsies
could be significantly reduced.
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